Automatically generated by Mendeley Desktop 1.19
Any changes to this file will be lost if it is regenerated by Mendeley.

BibTeX export options can be customized via Preferences -> BibTeX in Mendeley Desktop

@article{Pacak2007,
abstract = {Pheochromocytomas are rare neuroendocrine tumors with a highly variable clinical presentation, but they most commonly present as spells of headaches, sweating, palpitations, and hypertension. Patients with pheochromocytoma may develop complicated and potentially lethal cardiovascular and other complications, especially in the setting of diagnostic or interventional procedures (e.g. upon induction of anesthesia or during surgery). The serious and potentially lethal nature of such complications is due to the potent effect of paroxysmal release of catecholamines. Because this warrants prompt diagnosis and treatment, the physician should be aware of the clinical manifestations and complications of catecholamine excess and be able to provide proper preoperative management to minimize catecholamine-related pre-, intra-, and postoperative adverse events. The following clinical scenario and discussion aim to enhance the knowledge of the physician regarding the behavior of pheochromocytoma and to outline current approaches to comprehensive preoperative management of patients suffering from this tumor.},
author = {Pacak, Karel},
doi = {10.1210/jc.2007-1720},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2007 - Pacak - Approach to the patient Preoperative management of the pheochromocytoma patient.pdf:pdf},
isbn = {0021-972X},
issn = {0021972X},
journal = {Journal of Clinical Endocrinology and Metabolism},
number = {11},
pages = {4069--4079},
pmid = {17989126},
title = {{Approach to the patient: Preoperative management of the pheochromocytoma patient}},
volume = {92},
year = {2007}
}
@article{Fanaroff2015,
abstract = {Importance: About 10% of patients with acute chest pain are ultimately diagnosed with acute coronary syndrome (ACS). Early, accurate estimation of the probability of ACS in these patients using the clinical examination could prevent many hospital admissions among low-risk patients and ensure that high-risk patients are promptly treated. Objective: To review systematically the accuracy of the initial history, physical examination, electrocardiogram, and risk scores incorporating these elements with the first cardiac-specific troponin. Study Selection Medline and Emcase: were searched (January 1, 1995-July 31, 2015), along with reference lists from retrieved articles, to identify prospective studies of diagnostic test accuracy among patients admitted to the emergency department with symptoms suggesting ACS. Data Extraction and Synthesis: We identified 2992 unique articles; 58 met inclusion criteria. Main Outcomes and Measures: Sensitivity, specificity, and likelihood ratio (LR) of findings for the diagnosis of ACS. The reference standard for ACS was either a final hospital diagnosis of ACS or occurrence of a cardiovascular event within 6 weeks. Results: The clinical findings and risk factors most suggestive of ACS were prior abnormal stress test (specificity, 96%; LR, 3.1 [95%CI, 2.0-4.7]), peripheral arterial disease (specificity, 97%; LR, 2.7 [95%CI, 1.5-4.8]), and pain radiation to both arms (specificity, 96%; LR, 2.6 [95%CI, 1.8-3.7]). The most useful electrocardiogram findings were ST-segment depression (specificity, 95%; LR, 5.3 [95%CI, 2.1-8.6]) and any evidence of ischemia (specificity, 91%; LR, 3.6 [95%CI,1.6-5.7]). Both the History, Electrocardiogram, Age, Risk Factors, Troponin (HEART) and Thrombolysis in Myocardial Infarction (TIMI) risk scores performed well in diagnosing ACS: LR, 13 (95%CI, 7.0-24) for the high-risk range of the HEART score (7-10) and LR, 6.8 (95%CI, 5.2-8.9) for the high-risk range of the TIMI score (5-7). The most useful for identifying patients less likely to have ACS were the low-risk range HEART score (0-3) (LR, 0.20 [95%CI, 0.13-0.30]), low-risk range TIMI score (0-1) (LR, 0.31 [95%CI, 0.23-0.43]), or low to intermediate risk designation by the Heart Foundation of Australia and Cardiac Society of Australia and New Zealand risk algorithm (LR, 0.24 [95%CI, 0.19-0.31]). Conclusions and Relevance: Among patients with suspected ACS presenting to emergency departments, the initial history, physical examination, and electrocardiogram alone did not confirm or exclude the diagnosis of ACS. Instead, the HEART or TIMI risk scores, which incorporate the first cardiac troponin, provided more diagnostic information. (PsycINFO Database Record (c) 2015 APA, all rights reserved). (journal abstract)},
author = {Fanaroff, Alexander C. and Rymer, Jennifer A. and Goldstein, Sarah A. and Simel, David L. and Newby, L. Kristin},
doi = {10.1001/jama.2015.12735},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2015 - Fanaroff et al. - Does this patient with chest pain have acute coronary syndrome The rational clinical examination systematic rev.pdf:pdf},
issn = {15383598},
journal = {JAMA - Journal of the American Medical Association},
number = {18},
pages = {1955--1965},
pmid = {26547467},
title = {{Does this patient with chest pain have acute coronary syndrome?: The rational clinical examination systematic review}},
volume = {314},
year = {2015}
}
@article{Ruys2013,
abstract = {Although its prevalence is relatively low in pregnant women, heart disease is the most important cause of maternal mortality. Problems may arise due to hemodynamic burden and the hypercoagulable state of pregnancy. Heart disease may be congenital or acquired. In developed countries, the former composes the biggest part of women with heart disease. Patients with unrepaired lesions, cyanotic lesions, diminished systemic ventricular function, complex congenital heart disease, left ventricular outflow tract obstruction, pulmonary hypertension, or mechanical valves are at highest risk of developing complications during pregnancy. All patients with known cardiac disease should preferably be counseled before conception. Pre-pregnancy evaluation should include risk assessment for the mother and fetus, including medication use and information on heredity of the cardiac lesion. Management of pregnancy and delivery should be planned accordingly on individual bases. The types of complications are related to the cardiac diagnosis, with arrhythmias and heart failure being most common. Treatment options should be discussed with the future parents, as they may affect both mother and child. In general, the preferred route of delivery is vaginal. The optimal care for pregnant women with heart disease requires multidisciplinary involvement and is best concentrated in tertiary centers. ?? 2012 Japanese College of Cardiology.},
author = {Ruys, Titia P E and Cornette, J??r??me and Roos-Hesselink, Jolien W},
doi = {10.1016/j.jjcc.2012.11.001},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2013 - Ruys, Cornette, Roos-Hesselink - Pregnancy and delivery in cardiac disease.pdf:pdf},
isbn = {1876-4738 (Electronic)\r0914-5087 (Linking)},
issn = {09145087},
journal = {Journal of Cardiology},
keywords = {Counseling,Delivery,Fetal outcome,Heart disease,Pregnancy},
month = {feb},
number = {2},
pages = {107--112},
pmid = {23290155},
title = {{Pregnancy and delivery in cardiac disease}},
url = {https://ac-els-cdn-com.proxy.library.emory.edu/S0914508712003139/1-s2.0-S0914508712003139-main.pdf?_tid=85e52989-62a1-4a47-babe-122d426ffc98&acdnat=1531442370_6f9d35fa2274780fc6cef7c5a7fa1d45 http://linkinghub.elsevier.com/retrieve/pii/S0914508712003139 h},
volume = {61},
year = {2013}
}
@article{Han2011,
abstract = {Background: The purpose of this study was to measure lumbar epidural pressure (EP) during the insertion of a Tuohy needle under general anesthesia and to evaluate the influence of airway pressure on EP. Methods: Lumbar EP was measured directly through a Tuohy needle during intermittent positive pressure ventilation in fifteen patients. Mean and peak EP were recorded after peak inspiratory pressures (PIP) of 0, 15, and 25 cmH2O. Results: All measured lumbar EPs were positive, with the pressure increasing during inspiration and decreasing during expiration. Median EP was 6.0 mmHg (interquartile range, 4.0-8.0) at 0 cmH2O of PIP, 6.5 mmHg (4.5-8.5) at 15 cmH2O, and 8.5 mmHg (6.0-10.5) at 25 cmH2O, increasing significantly at 15 cm H2O PIP, and further increasing at 25 cmH2O (P < 0.001). Conclusions: We demonstrate the influence of increased airway pressure on lumbar EP measured directly through a Tuohy needle. Lumbar EPs were positive, and increasing PIP levels significantly increased lumbar EP.},
author = {Han, Sun Sook and Lim, Young Jin and Jeon, Yunseok and Min, Kyoung Beom and Ahn, Won Sik and Lee, Sang Chul},
doi = {10.4097/kjae.2011.61.2.138},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2011 - Han et al. - Effect of airway pressure on lumbar epidural pressure during positive pressure ventilation.pdf:pdf},
isbn = {8227475639},
issn = {20057563},
journal = {Korean Journal of Anesthesiology},
keywords = {Epidural pressure,General anesthesia,Lumbar},
number = {2},
pages = {138--142},
pmid = {21390171},
title = {{Effect of airway pressure on lumbar epidural pressure during positive pressure ventilation}},
volume = {61},
year = {2011}
}
@article{Wilcox2014,
abstract = {IMPORTANCE: Thoracentesis is performed to identify the cause of a pleural effusion. Although generally safe, thoracentesis may be complicated by transient hypoxemia, bleeding, patient discomfort, reexpansion pulmonary edema, and pneumothorax. OBJECTIVE: To identify the best means for differentiating between transudative and exudative effusions and also to identify thoracentesis techniques for minimizing the risk of complications by performing a systematic review the evidence. DATA SOURCES: We searched The Cochrane Library, MEDLINE, and Embase from inception to February 2014 to identify relevant studies. STUDY SELECTION: We included randomized and observational studies of adult patients undergoing thoracentesis that examined diagnostic tests for differentiating exudates from transudates and evaluated thoracentesis techniques associated with a successful procedure with minimal complications. DATA EXTRACTION AND SYNTHESIS: Two investigators independently appraised study quality and extracted data from studies of laboratory diagnosis of pleural effusion for calculation of likelihood ratios (LRs; n = 48 studies) and factors affecting adverse event rates (n = 37 studies). RESULTS: The diagnosis of an exudate was most accurate if cholesterol in the pleural fluid was greater than 55 mg/dL (LR range, 7.1-250), lactate dehydrogenase (LDH) was greater than 200 U/L (LR, 18; 95% CI, 6.8-46), or the ratio of pleural fluid cholesterol to serum cholesterol was greater than 0.3 (LR, 14; 95% CI, 5.5-38). A diagnosis of exudate was less likely when all Light's criteria (a ratio of pleural fluid protein to serum protein >0.5, a ratio of pleural fluid LDH to serum LDH >0.6, or pleural fluid LDH >two-thirds the upper limit of normal for serum LDH) were absent (LR, 0.04; 95% CI, 0.02-0.11). The most common complication of thoracentesis was pneumothorax, which occurred in 6.0% of cases (95% CI, 4.0%-7.0%). Chest tube placement was required in 2.0% of procedures (95% CI, 0.99%-2.9%) in which a patient was determined to have radiographic evidence of a pneumothorax. With ultrasound, a radiologist's marking the needle insertion site was not associated with decreased pneumothorax events (skin marking vs no skin marking odds ratio [OR], 0.37; 95% CI, 0.08-1.7). Use of ultrasound by any experienced practitioner also was not associated with decreased pneumothorax events (OR, 0.55; 95% CI, 0.06-5.3). CONCLUSIONS AND RELEVANCE: Light's criteria, cholesterol and pleural fluid LDH levels, and the pleural fluid cholesterol-to-serum ratio are the most accurate diagnostic indicators for pleural exudates. Ultrasound skin marking by a radiologist or ultrasound-guided thoracentesis were not associated with a decrease in pneumothorax events.},
author = {Wilcox, M. Elizabeth and Chong, Christopher A.K.Y. and Stanbrook, Matthew B. and Tricco, Andrea C. and Wong, Camilla and Straus, Sharon E.},
doi = {10.1001/jama.2014.5552},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2014 - Wilcox et al. - Does this patient have an exudative pleural effusion The rational clinical examination systematic review.pdf:pdf},
isbn = {0098-7484},
issn = {15383598},
journal = {JAMA - Journal of the American Medical Association},
number = {23},
pages = {3422--3431},
pmid = {24938565},
title = {{Does this patient have an exudative pleural effusion? The rational clinical examination systematic review}},
volume = {311},
year = {2014}
}
@article{Johns2010,
abstract = {We report a case of phenytoin-induced pseudolymphoma in a 28-year-old male with a history of autism and seizure disorder. The patient presented with bilateral cervical lymphadenopathy that was shown to be moderately to markedly FDG-avid on a whole body PET/CT scan. Flow cytometry analysis of peripheral blood and bone marrow mononuclear cells detected identical T cell population with aberrant immunophenotype. Additionally, a TCR beta gene was found to be clonally rearranged in both peripheral blood and bone marrow supporting a clonal origin of atypical T cells. However, no such clonal population of T-cells could be detected in a pathologic specimen obtained from an excisional biopsy of one of the patients cervical lymph nodes. After discontinuing the patients phenytoin, his lymphadenopathy has nearly completely resolved and circulation clonal T cell population disappeared with 12 months of follow-up.},
author = {Johns, Mark E. and Moscinski, Lynn C. and Sokol, Lubomir},
doi = {10.4084/MJHID.2010.028},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2010 - Johns, Moscinski, Sokol - Phenytoin-associated lymphoadenopathy mimicking a peripheral T-cell lymphoma.pdf:pdf},
issn = {20353006},
journal = {Mediterranean Journal of Hematology and Infectious Diseases},
number = {2},
pmid = {21415974},
title = {{Phenytoin-associated lymphoadenopathy mimicking a peripheral T-cell lymphoma}},
volume = {2},
year = {2010}
}
@article{Kumar2009a,
abstract = {At the most severe end of the spectrum of acute coronary syndromes is ST-segment elevation myocardial infarction (STEMI), which usually occurs when a fibrin-rich thrombus completely occludes an epicardial coronary artery. The diagnosis of STEMI is based on clinical characteristics and persistent ST-segment elevation as demonstrated by 12-lead electrocardiography. Patients with STEMI should undergo rapid assessment for reperfusion therapy, and a reperfusion strategy should be implemented promptly after the patient's contact with the health care system. Two methods are currently available for establishing timely coronary reperfusion: primary percutaneous coronary intervention and fibrinolytic therapy. Percutaneous coronary intervention is the preferred method but is not always available. Antiplatelet agents and anticoagulants are critical adjuncts to reperfusion. This article summarizes the current evidence-based guidelines for the diagnosis and management of STEMI. This summary is followed by a brief discussion of the role of noninvasive stress testing in the assessment of patients with acute coronary syndrome and their selection for coronary revascularization. {\textcopyright} 2009 Mayo Foundation for Medical Education and Research.},
author = {Kumar, Amit and Cannon, Christopher P.},
doi = {10.4065/84.10.917},
file = {:Users/shahbook/Box Sync/Mendeley_Articles//2009 - Kumar, Cannon - Acute coronary syndromes Diagnosis and management.pdf:pdf;:Users/shahbook/Box Sync/Mendeley_Articles//2009 - Kumar, Cannon - Acute coronary syndromes Diagnosis and management.pdf:pdf},
isbn = {0025-6196 1942-5546},
issn = {00256196},
journal = {Mayo Clinic Proceedings},
number = {11},
pages = {917--938},
pmid = {19880693},
publisher = {Mayo Foundation for Medical Education and Research},
title = {{Acute coronary syndromes: Diagnosis and management}},
url = {http://dx.doi.org/10.4065/84.11.1021 http://dx.doi.org/10.4065/84.10.917},
volume = {84},
year = {2009}
}
@article{Giles1974,
author = {Giles, Thomas D. and Martinez, Enrique C. and Burch, George E.},
doi = {10.1001/archinte.1974.00320220149021},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/1974 - Giles, Martinez, Burch - Gallavardin Phenomenon in Aortic Stenosis A Possible Mechanism.pdf:pdf},
issn = {15383679},
journal = {Archives of Internal Medicine},
number = {4},
pages = {747--749},
pmid = {4278106},
title = {{Gallavardin Phenomenon in Aortic Stenosis: A Possible Mechanism}},
volume = {134},
year = {1974}
}
@article{Gumz2015,
abstract = {The plasma potassium level is normally maintained within narrow limits by multiple mechanisms. This article reviews the mechanisms that regulate potassium homeostasis and describes the important role that the circadian clock exerts on these processes.},
author = {Gumz, Michelle L. and Rabinowitz, Lawrence and Wingo, Charles S.},
doi = {10.1056/NEJMra1313341},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2015 - Gumz, Rabinowitz, Wingo - An Integrated View of Potassium Homeostasis.pdf:pdf},
isbn = {0028-4793},
issn = {0028-4793},
journal = {New England Journal of Medicine},
number = {1},
pages = {60--72},
pmid = {26132942},
title = {{An Integrated View of Potassium Homeostasis}},
url = {http://www.nejm.org/doi/10.1056/NEJMra1313341},
volume = {373},
year = {2015}
}
@incollection{Wu2017,
author = {Wu, Willis M},
booktitle = {Manual of Cardiovascular Medicine, 4th Edition},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2017 - Wu - Commonly Used Cardiovascular Formulae.pdf:pdf},
pages = {1127--1132},
title = {{Commonly Used Cardiovascular Formulae}},
year = {2017}
}
@article{Fillmore1977,
abstract = {The subsequent course of 173 women with severe congestive heart failure hospitalized within 6 months of delivery has been analyzed after 4 to 7 year follow-up periods. Forty-seven normotensive women and 50 women hypertensive only during the initial 48 hours have little long term morbidity. Thirty-six women with hypertension initially improved, but many are now showing enlarging cardiac silhouettes. Morbidity is increasing in this group. A similar, less severe pattern is developing in 36 women with intermittent hypertension. The uniquely high incidence of this condition in Zaria is associated with several locale factors. These Hausa-Fulani women eat large quantities of a local lake salt, kanwa, for 40 days postpartum. The syndrome is markedly more common in the hot rainy season, when evaporative water loss is less, than in the dry season. The first postpartum days are spent confined to bed in a small heated room. Once or twice daily the new mother is given hot baths with branches which have been dipped in boiling water. The combination of excessive sodium intake and diminished evaporative water excretion seems to precipitate failure in both normotensive and hypertensive patients.},
author = {Fillmore, S J and Parry, E H.O.},
doi = {10.1161/01.CIR.56.6.1058},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/1977 - Fillmore, Parry - The evolution of peripartal heart failure in Zaria, Nigeria. Some etiologic factors.pdf:pdf},
issn = {00097322},
journal = {Circulation},
month = {dec},
number = {6},
pages = {1058--1061},
pmid = {923045},
publisher = {American Heart Association, Inc.},
title = {{The evolution of peripartal heart failure in Zaria, Nigeria. Some etiologic factors}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/923045 http://circ.ahajournals.org/cgi/doi/10.1161/01.CIR.56.6.1058},
volume = {56},
year = {1977}
}
@article{Ford2016,
author = {Ford, Alexander C and Talley, Nicholas J and Simel, David L},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2016 - Ford, Talley, Simel - CLINICIAN ' S CORNER Will the History and Physical Examination Help Establish That Irritable Bowel Synd.pdf:pdf},
number = {15},
pages = {1793--1805},
title = {{CLINICIAN ' S CORNER Will the History and Physical Examination Help Establish That Irritable Bowel Syndrome Is Causing This Patient ' s Lower Gastrointestinal Tract Symptoms ? PATIENT SCENARIO}},
volume = {300},
year = {2016}
}
@article{Ge2016,
abstract = {This guide to the practical treatment of patients with cirrhosis summarizes recent developments. It includes advice on medical management, invasive procedures, nutrition, prevention, and strategies to protect the cirrhotic liver from harm.},
author = {Ge, Phillip S. and Runyon, Bruce A.},
doi = {10.1056/NEJMra1504367},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2016 - Ge, Runyon - Treatment of Patients with Cirrhosis.pdf:pdf},
isbn = {1533-4406 (Electronic)\r0028-4793 (Linking)},
issn = {0028-4793},
journal = {New England Journal of Medicine},
number = {8},
pages = {767--777},
pmid = {27959723},
title = {{Treatment of Patients with Cirrhosis}},
url = {http://www.nejm.org/doi/10.1056/NEJMra1504367},
volume = {375},
year = {2016}
}
@article{Natarajan2007,
author = {Natarajan, Girija and Lulic-botica, Mirjana and Aranda, J V},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2007 - Natarajan, Lulic-botica, Aranda - Clinical Pharmacology of(2).pdf:pdf},
keywords = {956396,Adis International Limited,Opioid-receptor-agonists,pharmacokinetics Opioid-},
number = {5},
pages = {879--923},
title = {{Clinical Pharmacology of}},
volume = {8},
year = {2007}
}
@incollection{Griffin2012,
author = {Griffin, Brian P. and Callahan, Thomas Dr. and Menon, Venu},
booktitle = {Manual of Cardiovascular Medicine, 4th Edition},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2012 - Griffin, Callahan, Menon - Section IV Arrhythmias.pdf:pdf},
isbn = {978-1451131604},
pages = {356--444},
title = {{Section IV Arrhythmias}},
year = {2012}
}
@article{Berbari2015,
abstract = {These guidelines are intended for use by infectious disease specialists, orthopedic surgeons, neurosurgeons, radiologists, and other healthcare professionals who care for patients with native vertebral osteomyelitis (NVO). They include evidence and opinion-based recommendations for the diagnosis and management of patients with NVO treated with antimicrobial therapy, with or without surgical intervention.},
author = {Berbari, Elie F. and Kanj, Souha S. and Kowalski, Todd J. and Darouiche, Rabih O. and Widmer, Andreas F. and Schmitt, Steven K. and Hendershot, Edward F. and Holtom, Paul D. and Huddleston, Paul M. and Petermann, Gregory W. and Osmon, Douglas R.},
doi = {10.1093/cid/civ482},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2015 - Berbari et al. - 2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment.pdf:pdf},
isbn = {1537-6591 (Electronic) 1058-4838 (Linking)},
issn = {15376591},
journal = {Clinical Infectious Diseases},
keywords = {Staphylococcus aureus,discitis,osteomyelitis,spine infection,spondylodiscitis},
number = {6},
pages = {e26--e46},
pmid = {26229122},
title = {{2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults}},
volume = {61},
year = {2015}
}
@article{White2014,
abstract = {Objectives This study tested the diagnostic and prognostic utility of a rapid, visual T1 assessment method for identification of cardiac amyloidosis (CA) in a "real-life" referral population undergoing cardiac magnetic resonance for suspected CA. Background In patients with confirmed CA, delayed-enhancement cardiac magnetic resonance (DE-CMR) frequently shows a diffuse, global hyperenhancement (HE) pattern. However, imaging is often technically challenging, and the prognostic significance of diffuse HE is unclear. Methods Ninety consecutive patients referred for suspected CA and 64 hypertensive patients with left ventricular hypertrophy (LVH) were prospectively enrolled and underwent a modified DE-CMR protocol. After gadolinium administration a method for rapid, visual T1 assessment was used to identify the presence of diffuse HE during the scan, allowing immediate optimization of settings for the conventional DE-CMR that followed. The primary endpoint was all-cause mortality. Results Among patients with suspected CA, 66% (59 of 90) demonstrated HE, with 81% (48 of 59) of these meeting pre-specified visual T1 assessment criteria for diffuse HE. Among hypertensive LVH patients, 6% (4 of 64) had HE, with none having diffuse HE. During 29 months of follow-up (interquartile range: 12 to 44 months), there were 50 (56%) deaths in patients with suspected CA and 4 (6%) in patients with hypertensive LVH. Multivariable analysis demonstrated that the presence of diffuse HE was the most important predictor of death in the group with suspected CA (hazard ratio: 5.5, 95% confidence interval: 2.7 to 11.0; p < 0.0001) and in the population as a whole (hazard ratio: 6.0, 95% confidence interval 3.0 to 12.1; p < 0.0001). Among 25 patients with myocardial histology obtained during follow-up, the sensitivity, specificity, and accuracy of diffuse HE in the diagnosis of CA were 93%, 70%, and 84%, respectively. Conclusions Among patients suspected of CA, the presence of diffuse HE by visual T1 assessment accurately identifies patients with histologically-proven CA and is a strong predictor of mortality.},
author = {White, James A. and Kim, Han W. and Shah, Dipan and Fine, Nowell and Kim, Ki Young and Wendell, David C. and Al-Jaroudi, Wael and Parker, Michele and Patel, Manesh and Gwadry-Sridhar, Femida and Judd, Robert M. and Kim, Raymond J.},
doi = {10.1016/j.jcmg.2013.09.019},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2014 - White et al. - CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis.pdf:pdf},
isbn = {1876-7591 (Electronic)},
issn = {1936878X},
journal = {JACC: Cardiovascular Imaging},
keywords = {amyloid,delayed enhancement,magnetic resonance imaging},
number = {2},
pages = {143--156},
pmid = {24412191},
title = {{CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis}},
volume = {7},
year = {2014}
}
@article{Khanna2017,
abstract = {BackgroundVasodilatory shock that does not respond to high-dose vasopressors is associated with high mortality. We investigated the effectiveness of angiotensin II for the treatment of patients with this condition. MethodsWe randomly assigned patients with vasodilatory shock who were receiving more than 0.2 $\mu$g of norepinephrine per kilogram of body weight per minute or the equivalent dose of another vasopressor to receive infusions of either angiotensin II or placebo. The primary end point was a response with respect to mean arterial pressure at hour 3 after the start of infusion, with response defined as an increase from baseline of at least 10 mm Hg or an increase to at least 75 mm Hg, without an increase in the dose of background vasopressors. ResultsA total of 344 patients were assigned to one of the two regimens; 321 received a study intervention (163 received angiotensin II, and 158 received placebo) and were included in the analysis. The primary end point was reached by more patients in the angiote...},
author = {Khanna, Ashish and English, Shane W. and Wang, Xueyuan S. and Ham, Kealy and Tumlin, James and Szerlip, Harold and Busse, Laurence W. and Altaweel, Laith and Albertson, Timothy E. and Mackey, Caleb and McCurdy, Michael T. and Boldt, David W. and Chock, Stefan and Young, Paul J. and Krell, Kenneth and Wunderink, Richard G. and Ostermann, Marlies and Murugan, Raghavan and Gong, Michelle N. and Panwar, Rakshit and H{\"{a}}stbacka, Johanna and Favory, Raphael and Venkatesh, Balasubramanian and Thompson, B. Taylor and Bellomo, Rinaldo and Jensen, Jeffrey and Kroll, Stew and Chawla, Lakhmir S. and Tidmarsh, George F. and Deane, Adam M.},
doi = {10.1056/NEJMoa1704154},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2017 - Khanna et al. - Angiotensin II for the Treatment of Vasodilatory Shock.pdf:pdf},
isbn = {2168-6114 (Electronic)\r2168-6106 (Linking)},
issn = {0028-4793},
journal = {New England Journal of Medicine},
number = {5},
pages = {419--430},
pmid = {28528561},
title = {{Angiotensin II for the Treatment of Vasodilatory Shock}},
url = {http://www.nejm.org/doi/10.1056/NEJMoa1704154},
volume = {377},
year = {2017}
}
@article{Zimmer2002,
author = {Zimmer, Heinz-gerd},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2002 - Zimmer - Who Discovered the Frank-Starling Mechanism.pdf:pdf},
number = {1840 1911},
pages = {181--184},
title = {{Who Discovered the Frank-Starling Mechanism ?}},
year = {2002}
}
@article{Lip2016,
abstract = {Atrial fibrillation occurs when cardiac electrical impulses become disordered, leading to a rapid and irregular heartbeat. Lip and colleagues discuss the mechanisms that underlie this common arrhythmia and outline current strategies and potential future developments for its diagnosis and management.},
author = {Lip, Gregory Y. H. and Fauchier, Laurent and Freedman, Saul B. and {Van Gelder}, Isabelle and Natale, Andrea and Gianni, Carola and Nattel, Stanley and Potpara, Tatjana and Rienstra, Michiel and Tse, Hung-Fat and Lane, Deirdre A.},
doi = {10.1038/nrdp.2016.16},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2016 - Lip et al. - Atrial fibrillation.pdf:pdf},
issn = {2056-676X},
journal = {Nature Reviews Disease Primers},
pages = {16016},
pmid = {27159789},
publisher = {Macmillan Publishers Limited},
title = {{Atrial fibrillation}},
url = {http://www.nature.com/articles/nrdp201616},
volume = {2},
year = {2016}
}
@article{Maeda1987,
author = {Maeda, Koichi and Markowitz, Norman and Ristic, Miodrag and Cox, Donald and McDade, Joseph E.},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/1987 - Maeda et al. - The New England Journal of Medicine Downloaded from nejm.org at EMORY UNIVERSITY on August 6, 2015. For personal.pdf:pdf},
journal = {The New England Journal of Medicine},
title = {{The New England Journal of Medicine Downloaded from nejm.org at EMORY UNIVERSITY on August 6, 2015. For personal use only. No other uses without permission. From the NEJM Archive. Copyright {\textcopyright} 2010 Massachusetts Medical Society. All rights reserved.}},
volume = {316},
year = {1987}
}
@misc{MÃ¦hle2014,
abstract = {Critical Care 2014, :. doi:},
author = {M{\ae}hle, Kjersti and Haug, Bj{\o}rn and Flaatten, Hans and Nielsen, Erik W.},
booktitle = {Critical Care},
doi = {10.1186/cc13802},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2014 - M{\ae}hle et al. - Metabolic alkalosis is the most common acid-base disorder in ICU patients(2).pdf:pdf},
issn = {1466609X},
month = {mar},
number = {2},
pages = {420},
pmid = {25001067},
publisher = {BioMed Central},
title = {{Metabolic alkalosis is the most common acid-base disorder in ICU patients}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/25001067 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4056091 http://ccforum.biomedcentral.com/articles/10.1186/cc13802},
volume = {18},
year = {2014}
}
@article{Lip2010,
abstract = {BACKGROUND: Contemporary clinical risk stratification schemata for predicting stroke and thromboembolism (TE) in patients with atrial fibrillation (AF) are largely derived from risk factors identified from trial cohorts. Thus, many potential risk factors have not been included. METHODS: We refined the 2006 Birmingham/National Institute for Health and Clinical Excellence (NICE) stroke risk stratification schema into a risk factor-based approach by reclassifying and/or incorporating additional new risk factors where relevant. This schema was then compared with existing stroke risk stratification schema in a real-world cohort of patients with AF (n = 1,084) from the Euro Heart Survey for AF. RESULTS: Risk categorization differed widely between the different schemes compared. Patients classified as high risk ranged from 10.2% with the Framingham schema to 75.7% with the Birmingham 2009 schema. The classic CHADS(2) (Congestive heart failure, Hypertension, Age > 75, Diabetes, prior Stroke/transient ischemic attack) schema categorized the largest proportion (61.9%) into the intermediate-risk strata, whereas the Birmingham 2009 schema classified 15.1% into this category. The Birmingham 2009 schema classified only 9.2% as low risk, whereas the Framingham scheme categorized 48.3% as low risk. Calculated C-statistics suggested modest predictive value of all schema for TE. The Birmingham 2009 schema fared marginally better (C-statistic, 0.606) than CHADS(2). However, those classified as low risk by the Birmingham 2009 and NICE schema were truly low risk with no TE events recorded, whereas TE events occurred in 1.4% of low-risk CHADS(2) subjects. When expressed as a scoring system, the Birmingham 2009 schema (CHA(2)DS(2)-VASc acronym) showed an increase in TE rate with increasing scores (P value for trend = .003). CONCLUSIONS: Our novel, simple stroke risk stratification schema, based on a risk factor approach, provides some improvement in predictive value for TE over the CHADS(2) schema, with low event rates in low-risk subjects and the classification of only a small proportion of subjects into the intermediate-risk category. This schema could improve our approach to stroke risk stratification in patients with AF.},
author = {Lip, Gregory YH Y.H. and Nieuwlaat, Robby and Pisters, Ron and Lane, Deirdre A. and Crijns, Harry J.G.M.},
doi = {10.1378/chest.09-1584},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2010 - Lip et al. - Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel.pdf:pdf},
isbn = {1931-3543 (Electronic)\r0012-3692 (Linking)},
issn = {19313543},
journal = {Chest},
month = {feb},
number = {2},
pages = {263--272},
pmid = {19762550},
title = {{Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on atrial fibrillation}},
url = {www.chestjournal.orgCHEST/137/ http://www.ncbi.nlm.nih.gov/pubmed/19762550 http://linkinghub.elsevier.com/retrieve/pii/S0012369210600670},
volume = {137},
year = {2010}
}
@article{Carson2012,
abstract = {Description: Although approximately 85 million units of red blood cells (RBCs) are transfused annually worldwide, transfusion practices vary widely. The AABB (formerly, the American Association of Blood Banks) developed this guideline to provide clinical recom- mendations about hemoglobin concentration thresholds and other clinical variables that trigger RBC transfusions in hemodynamically stable adults and children. Methods: These guidelines are based on a systematic review of randomized clinical trials evaluating transfusion thresholds. We per- formed a literature search from 1950 to February 2011 with no language restrictions. We examined the proportion of patients who received any RBC transfusion and the number of RBC units trans- fused to describe the effect of restrictive transfusion strategies on RBC use. To determine the clinical consequences of restrictive trans- fusion strategies, we examined overall mortality, nonfatal myocar- dial infarction, cardiac events, pulmonary edema, stroke, thrombo- embolism, renal failure, infection, hemorrhage, mental confusion, functional recovery, and length of hospital stay. Recommendation 1: The AABB recommends adhering to a restric- tive transfusion strategy (7 to 8 g/dL) in hospitalized, stable pa- tients (Grade: strong recommendation; high-quality evidence). Recommendation 2: The AABB suggests adhering to a restrictive strategy in hospitalized patients with preexisting cardiovascular dis- ease and considering transfusion for patients with symptoms or a hemoglobin level of 8 g/dL or less (Grade: weak recommendation; moderate-quality evidence). Recommendation 3: The AABB cannot recommend for or against a liberal or restrictive transfusion threshold for hospi- talized, hemodynamically stable patients with the acute cor- onary syndrome (Grade: uncertain recommendation; very low-quality evidence). Recommendation 4: The AABB suggests that transfusion decisions be influenced by symptoms as well as hemoglobin concentration (Grade: weak recommendation; low-quality evidence).},
author = {Carson, Jeffrey L and Grossman, Brenda J and Kleinman, Steven and Tinmouth, Alan T and Marques, Marisa B and Fung, Mark K and Holcomb, John B and Illoh, Orieji and Kaplan, Lewis J and Katz, Louis M and Rao, Sunil V and Roback, John D and Shander, Aryeh and Tobian, Aaron A R and Weinstein, Robert and Grace, Lisa and Mclaughlin, Swinton and Djulbegovic, Benjamin and Transfusion, Clinical and Committee, Medicine},
doi = {10.7326/0003-4819-157-1-201206190-00429},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2012 - Carson et al. - Annals of Internal Medicine Clinical Guideline Red Blood Cell Transfusion A Clinical Practice Guideline From the.pdf:pdf},
issn = {1539-3704},
journal = {Ann.Intern.Med.},
number = {157},
pages = {49--58},
pmid = {22751760},
title = {{Annals of Internal Medicine Clinical Guideline Red Blood Cell Transfusion : A Clinical Practice Guideline From the AABB *}},
volume = {1},
year = {2012}
}
@article{Jacob2011,
author = {Jacob, Sony and Shahzad, Muhammad A. and Maheshwari, Rahul and Panaich, Sidakpal S. and Aravindhakshan, Rajeev},
doi = {10.1016/j.hrthm.2011.01.012},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2011 - Jacob et al. - Cardiac rhythm device identification algorithm using X-rays CaRDIA-X.pdf:pdf},
isbn = {1556-3871 (Electronic)\n1547-5271 (Linking)},
issn = {15475271},
journal = {Heart Rhythm},
keywords = {Cardiac rhythm management devices,Implantable cardioverter- defibrillator,Implantable loop recorder,Pacemaker,Radiological identification},
number = {6},
pages = {915--922},
pmid = {21220049},
publisher = {Elsevier Inc.},
title = {{Cardiac rhythm device identification algorithm using X-rays: CaRDIA-X}},
url = {http://dx.doi.org/10.1016/j.hrthm.2011.01.012},
volume = {8},
year = {2011}
}
@article{Birnbaum2002,
author = {Birnbaum, Yochai and Fishbein, Michael C. and Blanche, Carlos and Siegel, Robert J.},
doi = {10.1056/NEJMra020228},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2002 - Birnbaum et al. - Ventricular Septal Rupture after Acute Myocardial Infarction.pdf:pdf},
issn = {0028-4793},
journal = {New England Journal of Medicine},
month = {oct},
number = {18},
pages = {1426--1432},
title = {{Ventricular Septal Rupture after Acute Myocardial Infarction}},
url = {http://www.nejm.org/doi/abs/10.1056/NEJMra020228},
volume = {347},
year = {2002}
}
@article{Gossage1998,
author = {Gossage, JR and Kanj, G},
doi = {10.1164/ajrccm.158.2.9711041},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/1998 - Gossage, Kanj - Pulmonary arteriovenous malformations. A state of the art review.pdf:pdf},
isbn = {1073-449X (Print)\r1073-449X (Linking)},
journal = {American Journal of Respiratory and Critical Care Medicine},
pages = {643--661},
pmid = {9700146},
title = {{Pulmonary arteriovenous malformations. A state of the art review}},
volume = {158},
year = {1998}
}
@article{Magder2015,
abstract = {Although invasive hemodynamic monitoring requires considerable skill, studies have shown a striking lack of knowledge of the measurements obtained with the pulmonary artery catheter (PAC). This article reviews monitoring using a PAC. Issues addressed include basic physiology that determines cardiac output and blood pressure; methodology in the measurement of data obtained from a PAC; use of the PAC in making a diagnosis and for patient management, with emphasis on a responsive approach to management; and uses of the PAC that are not indications by themselves for placing the catheter, but can provide useful information when a PAC is in place.},
author = {Magder, Sheldon and Rajaram, S.S. and Desai, N.K. and Kalra, A. and et Al. and Richard, C. and Warszawski, J. and Anguel, N. and et Al. and Harvey, S. and Harrison, D.A. and Singer, M. and et Al. and Sandham, J.D. and Hull, R.D. and Brant, R.F. and et Al. and Wheeler, A.P. and Bernard, G.R. and Thompson, B.T. and et Al. and Iberti, T.J. and Fisher, E.P. and Leibowitz, A.B. and et Al. and Iberti, T.J. and Daily, E.K. and Leibowitz, A.B. and et Al. and Magder, S. and Magder, S. and Scharf, S.M. and Rothe, C. and Bishop, V.S. and Stone, H.L. and Guyton, A.C. and Magder, S. and Bafaqeeh, F. and Magder, S. and Varennes, B. De and Deschamps, A. and Magder, S. and Magder, S. and Magder, S. and O'Grady, N.P. and Alexander, M. and Burns, L.A. and et Al. and Mermel, L.A. and Maki, D.G. and Magder, S. and Magder, S.A. and Magder, S. and Magder, S. and Carter, R.S. and Snyder, J.V. and Pinsky, M.R. and Teboul, J.L. and Pinsky, M.R. and Mercat, A. and et Al. and Magder, S. and Cariou, A. and Monchi, M. and Dhainaut, J.F. and Medin, D.L. and Brown, D.T. and Wesley, R. and et Al. and Critchley, L.A. and Lee, A. and Ho, A.M. and Challand, C. and Struthers, R. and Sneyd, J.R. and et Al. and Magder, S. and Potter, B.J. and Varennes, B.D. and et Al. and Potter, B.J. and Deverenne, B. and Doucette, S. and et Al. and Datta, P. and Magder, S. and Swan, H.J. and Ganz, W. and Forrester, J. and et Al. and Forrester, J.S. and Diamond, G. and McHugh, T.J. and et Al. and Schuller, D. and Schuster, D.P. and Mitchell, J.P. and Schuller, D. and Calandrino, F.S. and et Al. and Wood, P. and Gattinoni, L. and Brazzi, L. and Pelosi, P. and et Al. and Magder, S. and Lagonidis, D. and Erice, F. and Bellemare, P. and Goldberg, P. and Magder, S. and Magder, S.A. and Lichtenstein, S. and Adelman, A.G. and Connors, A.F. and Speroff, T. and Dawson, N.V.},
doi = {10.1016/j.ccc.2014.08.004},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2015 - Magder et al. - Invasive hemodynamic monitoring.pdf:pdf},
issn = {1557-8232},
journal = {Critical care clinics},
keywords = {Cardiac output,Central venous pressure,Pulmonary artery catheter,Pulmonary artery occlusion pressure,Pulmonary pressure},
number = {1},
pages = {67--87},
pmid = {25435479},
publisher = {Elsevier Inc},
title = {{Invasive hemodynamic monitoring.}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/25435479},
volume = {31},
year = {2015}
}
@article{Gibson2016,
abstract = {BackgroundIn patients with atrial fibrillation undergoing percutaneous coronary intervention (PCI) with placement of stents, standard anticoagulation with a vitamin K antagonist plus dual antiplatelet therapy (DAPT) with a P2Y12 inhibitor and aspirin reduces the risk of thrombosis and stroke but increases the risk of bleeding. The effectiveness and safety of anticoagulation with rivaroxaban plus either one or two antiplatelet agents are uncertain. MethodsWe randomly assigned 2124 participants with nonvalvular atrial fibrillation who had undergone PCI with stenting to receive, in a 1:1:1 ratio, low-dose rivaroxaban (15 mg once daily) plus a P2Y12 inhibitor for 12 months (group 1), very-low-dose rivaroxaban (2.5 mg twice daily) plus DAPT for 1, 6, or 12 months (group 2), or standard therapy with a dose-adjusted vitamin K antagonist (once daily) plus DAPT for 1, 6, or 12 months (group 3). The primary safety outcome was clinically significant bleeding (a composite of major bleeding or minor bleeding according...},
archivePrefix = {arXiv},
arxivId = {arXiv:1011.1669v3},
author = {Gibson, C. Michael and Mehran, Roxana and Bode, Christoph and Halperin, Jonathan and Verheugt, Freek W. and Wildgoose, Peter and Birmingham, Mary and Ianus, Juliana and Burton, Paul and van Eickels, Martin and Korjian, Serge and Daaboul, Yazan and Lip, Gregory Y.H. and Cohen, Marc and Husted, Steen and Peterson, Eric D. and Fox, Keith A.},
doi = {10.1056/NEJMoa1611594},
eprint = {arXiv:1011.1669v3},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2016 - Gibson et al. - Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI.pdf:pdf},
isbn = {2012001491},
issn = {0028-4793},
journal = {New England Journal of Medicine},
number = {25},
pages = {2423--2434},
pmid = {27959713},
title = {{Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI}},
url = {http://www.nejm.org/doi/10.1056/NEJMoa1611594},
volume = {375},
year = {2016}
}
@article{Connors2017,
abstract = {Most patients with venous thromboembolism do not require thrombophilia testing, since the results will not affect management. Testing may be considered in younger patients with weak provoking factors, a strong family history, or recurrence at a young age.},
author = {Connors, Jean M.},
doi = {10.1056/NEJMra1700365},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2017 - Connors - Thrombophilia Testing and Venous Thrombosis.pdf:pdf},
isbn = {1533-4406},
issn = {0028-4793},
journal = {New England Journal of Medicine},
number = {12},
pages = {1177--1187},
pmid = {28930509},
title = {{Thrombophilia Testing and Venous Thrombosis}},
url = {http://www.nejm.org/doi/10.1056/NEJMra1700365},
volume = {377},
year = {2017}
}
@article{Pisters2010,
abstract = {OBJECTIVE Despite extensive use of oral anticoagulation (OAC) in patients with atrial fibrillation (AF) and the increased bleeding risk associated with such OAC use, no handy quantification tool for assessing this risk exists. We aimed to develop a practical risk score to estimate the 1-year risk for major bleeding (intracranial, hospitalization, hemoglobin decrease > 2 g/L, and/or transfusion) in a cohort of real-world patients with AF. METHODS Based on 3,978 patients in the Euro Heart Survey on AF with complete follow-up, all univariate bleeding risk factors in this cohort were used in a multivariate analysis along with historical bleeding risk factors. A new bleeding risk score termed HAS-BLED (Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile international normalized ratio, Elderly (> 65 years), Drugs/alcohol concomitantly) was calculated, incorporating risk factors from the derivation cohort. RESULTS Fifty-three (1.5%) major bleeds occurred during 1-year follow-up. The annual bleeding rate increased with increasing risk factors. The predictive accuracy in the overall population using significant risk factors in the derivation cohort (C statistic 0.72) was consistent when applied in several subgroups. Application of the new bleeding risk score (HAS-BLED) gave similar C statistics except where patients were receiving antiplatelet agents alone or no antithrombotic therapy, with C statistics of 0.91 and 0.85, respectively. CONCLUSION This simple, novel bleeding risk score (HAS-BLED) provides a practical tool to assess the individual bleeding risk of real-world patients with AF, potentially supporting clinical decision making regarding antithrombotic therapy in patients with AF.},
author = {Pisters, Ron and Lane, Deirdre A. and Nieuwlaat, Robby and {De Vos}, Cees B. and Crijns, Harry J.G.M. and Lip, Gregory Y.H.},
doi = {10.1378/chest.10-0134},
isbn = {1931-3543 (Electronic)\r0012-3692 (Linking)},
issn = {19313543},
journal = {Chest},
month = {nov},
number = {5},
pages = {1093--1100},
pmid = {20299623},
title = {{A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The euro heart survey}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/20299623 http://linkinghub.elsevier.com/retrieve/pii/S0012369210605855},
volume = {138},
year = {2010}
}
@article{Wellens2001,
abstract = {When confronted with a tachycardia having a broad QRS complex, it is important to be able to differentiate between a supraventricular and a ventricular tachycardia. Medication given for the treatment of a supraventricular tachycardia (SVT) may be harmful to a patient with a ventricular tachycardia (VT).1 2 A reasonable haemodynamic condition during a tachycardia may erroneously lead to the wrong diagnosis of SVT.3 Familiarity with the ECG signs allowing the diagnosis of a VT is therefore essential. But as will be discussed here, the ECG should not only tell you how to distinguish VT from other tachycardias with a broad QRS complex, but also to suspect its aetiology and its site of origin in the ventricle. Both aspects are important in decision making about the prognostic significance of VT and correct treatment.\n\nAs shown in fig 1, broad QRS tachycardia can be divided in three groups.},
author = {Wellens, H. J.},
doi = {10.1136/heart.86.5.579},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2001 - Wellens - ELECTROPHYSIOLOGY Ventricular tachycardia diagnosis of broad QRS complex tachycardia.pdf:pdf},
isbn = {13556037},
issn = {00070769},
journal = {Heart},
number = {5},
pages = {579--585},
pmid = {11602560},
title = {{ELECTROPHYSIOLOGY: Ventricular tachycardia: diagnosis of broad QRS complex tachycardia}},
url = {http://heart.bmj.com/cgi/doi/10.1136/heart.86.5.579},
volume = {86},
year = {2001}
}
@article{Pratt2014,
abstract = {OBJECTIVES To review left ventricular assist device physiology, initial postoperative management, common complications, trouble shooting and management of hypotension, and other common ICU problems. DATA SOURCE Narrative review of relevant medical literature. DATA SYNTHESIS Left ventricular assist devices prolong the lives of patients with end-stage heart failure, and their use is increasing. Continuous-flow left ventricular assist devices have replaced first-generation pulsatile devices. These patients present unique management concerns. In the immediate postimplant period, care must be taken to support the unassisted right ventricle. Invasive monitors for blood pressure, pulmonary artery catheterization, and echocardiography are essential to optimize left ventricular assist device settings and cardiac performance. Anticoagulation is necessary to prevent devastating thrombotic and embolic complications, but bleeding is a major source of morbidity due to inherent bleeding diatheses and prescribed anticoagulants. Infection of the device can be life threatening, and all infections must be aggressively treated to avoid seeding the device. Patients are at risk of ventricular arrhythmias because of their underlying disease, as well as the placement and position of the inflow cannula. Aortic valve stenosis and insufficiency develop over time and can lead to thrombosis or heart failure. Cardiopulmonary resuscitation with chest compressions must be performed with care or not at all due to risk of dislodging the device. CONCLUSION Intensivists are increasingly likely to encounter patients requiring mechanical circulatory support with left ventricular assist devices at various points in the trajectory of their disease, from the immediate postimplant period to subsequent admissions for complications, and at end of life. A basic understanding of left ventricular assist device physiology is essential to the safe and effective care of these patients.},
author = {Pratt, Alexandra K. and Shah, Nimesh S. and Boyce, Steven W.},
doi = {10.1097/01.ccm.0000435675.91305.76},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2014 - Pratt, Shah, Boyce - Left ventricular assist device management in the ICU.pdf:pdf},
isbn = {1530-0293 (Electronic)\r0090-3493 (Linking)},
issn = {00903493},
journal = {Critical Care Medicine},
keywords = {HeartMate II,HeartWare,continuous-flow left ventricular assist device,left ventricular assist device},
number = {1},
pages = {158--168},
pmid = {24240731},
title = {{Left ventricular assist device management in the ICU}},
volume = {42},
year = {2014}
}
@article{Sardesai1990,
abstract = {Phaeochromocytoma is rare and usually presents as paroxysmal or sustained hypertension; none the less, it can also cause severe acute pulmonary oedema in normotensive individuals. Six patients with phaeochromocytoma presenting in Cornwall and West Devon between 1982 and 1986 are described. Five of them died of pulmonary oedema within 24 hours of the onset of symptoms. At necropsy all five had normal sized hearts and in the four hearts examined by histology there was evidence of catecholamine induced heart disease in the form of focal myocardial necrosis. The sixth patient presented with arterial spasms and pulmonary oedema. Surgical removal of the causative tumour was successful in this patient.},
author = {Sardesai, S H and Mourant, a J and Sivathandon, Y and Farrow, R and Gibbons, D O},
doi = {10.1136/hrt.63.4.234},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/1990 - Sardesai et al. - Phaeochromocytoma and catecholamine induced cardiomyopathy presenting as heart failure.pdf:pdf},
issn = {1355-6037},
journal = {British heart journal},
number = {4},
pages = {234--237},
pmid = {2337495},
title = {{Phaeochromocytoma and catecholamine induced cardiomyopathy presenting as heart failure.}},
volume = {63},
year = {1990}
}
@article{Jazrawi2017,
abstract = {INTRODUCTION Although metabolic alkalosis is a common occurrence in intensive care units (ICUs), no study has evaluated its prevalence or outcomes in patients with severe sepsis or septic shock. METHODS This is a retrospective cohort study of critically ill patients suffering from severe sepsis and septic shock admitted to the ICUs of Halmstad and Varberg County hospitals. From 910 patient records, 627 patients met the inclusion criteria. We investigated the relationship between metabolic alkalosis and mortality. Further, we studied the relationship between metabolic alkalosis and ICU length of stay (LOS). RESULTS Metabolic alkalosis was associated with decreased 30-day and 12-month mortalities. This effect was however lost when a multivariate analysis was conducted, correcting for age, gender, pH on admission, base excess (BE) on admission, Simplified Acute Physiology Score III (SAPS III) and acute kidney injury (AKI). We then analyzed for any dose-response effect between the severity of metabolic alkalosis and mortality and found no relationship. Bivariate analysis showed that metabolic alkalosis had a significant effect on the length of ICU stay. When adjusting for age, sex, pH at admission, BE at admission, SAPS III and AKI in a multivariate analysis, metabolic alkalosis significantly contributed to prolonged ICU length of stay. In two separate sensitivity analyses pure metabolic alkalosis and late metabolic alkalosis (time of onset >48 hours) were the only significant predictor of increased ICU length of stay. CONCLUSION Metabolic alkalosis did not have any effect on 30-day and 12-month mortalities after adjusting for age, sex, SAPS III-score, pH and BE on admission and AKI in a multivariate analysis. The presence of metabolic alkalosis was independently associated with an increased ICU length of stay.},
author = {Jazrawi, Allan and Miller, Jan and Baigi, Amir and Chew, Michelle},
doi = {10.1371/journal.pone.0168563},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2017 - Jazrawi et al. - Alkalosis in Critically Ill Patients with Severe Sepsis and Septic Shock.pdf:pdf},
isbn = {1111111111},
issn = {19326203},
journal = {PLoS ONE},
number = {1},
pages = {1--10},
pmid = {28045915},
publisher = {Public Library of Science},
title = {{Alkalosis in Critically Ill Patients with Severe Sepsis and Septic Shock}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/28045915 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC5207677},
volume = {doi:10.137},
year = {2017}
}
@article{Thuny2014,
abstract = {Infective endocarditis (IE) is among the most severe infectious disease, the prevention of which has not decreased its incidence. The age of patients and the rate of health care-associated IE have increased as a consequence of medical progress. The prevention strategies have been subjected to an important debate and nonspecific hygiene measures are now placed above the use of antibiotic prophylaxis. Indeed, the level of evidence of antibiotic prophylaxis efficiency is low and the indications of its prescription have been restricted in the recent international guidelines. In cases carrying a high suspicion of IE, efforts should be made to rapidly identify patients with a definite or highly probable diagnosis of IE and to find the causative pathogen to ensure that appropriate treatment, including urgent valvular surgery, begins promptly. Although echocardiography remains the main accurate imaging modality to identify endocardial lesions associated with IE, it can be negative or inconclusive especially in cases of prosthetic valve or other intracardiac devices. Recent studies demonstrated the diagnostic value of other imaging strategies including cardiac computed tomography (CT), positron emission tomography/CT, radiolabelled leukocyte single-photon emission CT/CT, and cerebral magnetic resonance imaging. Novel perspectives on the management of endocarditis are emerging and offer a hope for decreasing the rate of residual deaths by accelerating the processes of diagnosis, risk stratification, and instauration of antimicrobial therapy. Moreover, the rapid transfer of high-risk patients to specialized mediosurgical centres (IE team), the development of new surgical modalities, and close long-term follow-up are of crucial importance. {\textcopyright} 2014 Canadian Cardiovascular Society.},
author = {Thuny, Franck and Grisoli, Dominique and Cautela, Jennifer and Riberi, Alberto and Raoult, Didier and Habib, Gilbert},
doi = {10.1016/j.cjca.2014.03.042},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2014 - Thuny et al. - Infective endocarditis Prevention, diagnosis, and management.pdf:pdf},
isbn = {1916-7075 (Electronic) 0828-282X (Linking)},
issn = {0828282X},
journal = {Canadian Journal of Cardiology},
number = {9},
pages = {1046--1057},
pmid = {25151287},
publisher = {Canadian Cardiovascular Society},
title = {{Infective endocarditis: Prevention, diagnosis, and management}},
url = {http://dx.doi.org/10.1016/j.cjca.2014.03.042},
volume = {30},
year = {2014}
}
@article{Chakravartty2013,
abstract = {AIM: Stercoral perforation is a rarely suspected life-threatening condition. Early diagnosis is difficult but essential. A comprehensive systematic review was performed to evaluate its presentation, diagnosis and treatment.\n\nMETHOD: A systematic review was carried out of Embase, MEDLINE, PubMed and Cochrane databases for all articles published between 1998 and 2011. Only studies describing stercoral perforation were included.\n\nRESULTS: Twenty-four relevant articles were found including 137 patients (median age = 62 years) with stercoral perforation, of whom 81% had chronic constipation. Stercoral perforation was diagnosed by CT scan in 90% of 31 patients, with the commonest findings being a combination of faecal impaction (84%) and subphrenic (90%) or extraluminal air (61%). The commonest site of perforation was the sigmoid colon (50%) followed by the rectosigmoid junction (24%). The overall mortality was 34%.\n\nCONCLUSION: Stercoral perforation should be suspected in elderly and chronically constipated patients with unexplained abdominal pain and investigated appropriately with a CT scan to allow timely and optimal treatment.},
author = {Chakravartty, S. and Chang, A. and Nunoo-Mensah, J.},
doi = {10.1111/codi.12123},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2013 - Chakravartty, Chang, Nunoo-Mensah - A systematic review of stercoral perforation.pdf:pdf},
isbn = {1463-1318 (Electronic)\r1462-8910 (Linking)},
issn = {14628910},
journal = {Colorectal Disease},
keywords = {Constipation,Rectal perforation,Stercoral,Stercoral perforation},
number = {8},
pages = {930--935},
pmid = {23331762},
title = {{A systematic review of stercoral perforation}},
volume = {15},
year = {2013}
}
@article{Kakouros2010,
abstract = {Right ventricular (RV) ischaemia complicates up to 50% of inferior myocardial infarctions (MIs), though isolated RV myocardial infarction (RVMI) is extremely rare. Although the RV shows good long term recovery, in the short term RV involvement portends a worse prognosis to uncomplicated inferior MI, with haemodynamic and electrophysiologic complications increasing in-hospital morbidity and mortality. Acute RV shock has an equally high mortality to left ventricular (LV) shock. Identification of RV involvement, particularly in the setting of hypotension, can help anticipate and prevent complications and has important management implications which are distinct from the management of patients presenting with LV infarction. Reperfusion therapy, particularly by primary percutaneous coronary intervention, hastens and enhances RV functional recovery that occurs to near normality in most patients. The diagnostic methods for RVMI are discussed, including clinical, electrocardiographic, and various imaging modalities as well as the RV pathophysiology that underpins the specifics of RVMI management.},
author = {Kakouros, Nicholaos and Cokkinos, Dennis V.},
doi = {10.1136/pgmj.2010.103887},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2010 - Kakouros, Cokkinos - Right ventricular myocardial infarction Pathophysiology, diagnosis, and management.pdf:pdf},
issn = {00325473},
journal = {Postgraduate Medical Journal},
number = {1022},
pages = {719--728},
pmid = {20956396},
title = {{Right ventricular myocardial infarction: Pathophysiology, diagnosis, and management}},
volume = {86},
year = {2010}
}
@article{Liu2015,
abstract = {BACKGROUND The purpose of this study was to assess the relationship of smoking duration with respiratory symptoms and history of chronic obstructive pulmonary disease (COPD) in the South Carolina Behavioral Risk Factor Surveillance System survey in 2012. METHODS Data from 4,135 adults aged â¥45 years with a smoking history were analyzed using multivariable logistic regression that accounted for sex, age, race/ethnicity, education, and current smoking status, as well as the complex sampling design. RESULTS The distribution of smoking duration ranged from 19.2% (1-9 years) to 36.2% (â¥30 years). Among 1,454 respondents who had smoked for â¥30 years, 58.3% were current smokers, 25.0% had frequent productive cough, 11.2% had frequent shortness of breath, 16.7% strongly agreed that shortness of breath affected physical activity, and 25.6% had been diagnosed with COPD. Prevalence of COPD and each respiratory symptom was lower among former smokers who quit â¥10 years earlier compared with current smokers. Smoking duration had a linear relationship with COPD (P<0.001) and all three respiratory symptoms (P<0.001) after adjusting for smoking status and other covariates. While COPD prevalence increased with prolonged smoking duration in both men and women, women had a higher age-adjusted prevalence of COPD in the 1-9 years, 20-29 years, and â¥30 years duration periods. CONCLUSION These state population data confirm that prolonged tobacco use is associated with respiratory symptoms and COPD after controlling for current smoking behavior.},
author = {Liu, Yong and Pleasants, Roy A. and Croft, Janet B. and Wheaton, Anne G. and Heidari, Khosrow and Malarcher, Ann M. and Ohar, Jill A. and Kraft, Monica and Mannino, David M. and Strange, Charlie},
doi = {10.2147/COPD.S82259},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2015 - Liu et al. - Smoking duration, respiratory symptoms, and COPD in adults aged Â³45 years with a smoking history.pdf:pdf},
issn = {11782005},
journal = {International Journal of COPD},
keywords = {Chronic obstructive pulmonary disease,Population-based study,Respiratory symptoms,Tobacco use},
pages = {1409--1416},
pmid = {26229460},
title = {{Smoking duration, respiratory symptoms, and COPD in adults aged Â³45 years with a smoking history}},
volume = {10},
year = {2015}
}
@article{Berend2014,
author = {Berend, Kenrick and de Vries, Aiko P J and Gans, Rijk O B},
doi = {10.1056/NEJMra1003327},
editor = {Ingelfinger, Julie R.},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2014 - Berend, de Vries, Gans - Physiological approach to assessment of acid-base disturbances.pdf:pdf},
isbn = {1533-4406 (Electronic) 0028-4793 (Linking)},
issn = {1533-4406},
journal = {The New England journal of medicine},
month = {oct},
number = {15},
pages = {1434--45},
pmid = {25295502},
title = {{Physiological approach to assessment of acid-base disturbances.}},
url = {http://www.nejm.org/doi/10.1056/NEJMra1003327 http://www.ncbi.nlm.nih.gov/pubmed/25295502},
volume = {371},
year = {2014}
}
@article{Cunha2016,
abstract = {Summary Since first identified in early 1977, bacteria of the genus Legionella are recognised as a common cause of community-acquired pneumonia and a rare cause of hospital-acquired pneumonia. Legionella bacteria multisystem manifestations mainly affect susceptible patients as a result of age, underlying debilitating conditions, or immunosuppression. Water is the major natural reservoir for Legionella, and the pathogen is found in many different natural and artificial aquatic environments such as cooling towers or water systems in buildings, including hospitals. The term given to the severe pneumonia and systemic infection caused by Legionella bacteria is Legionnaires' disease. Over time, the prevalence of legionellosis or Legionnaires' disease has risen, which might indicate a greater awareness and reporting of the disease. Advances in microbiology have led to a better understanding of the ecological niches and pathogenesis of the condition. Legionnaires' disease is not always suspected because of its non-specific symptoms, and the diagnostic tests routinely available do not offer the desired sensitivity. However, effective antibiotics are available. Disease notification systems provide the basis for initiating investigations and limiting the scale and recurrence of outbreaks. This report reviews our current understanding of this disease.},
author = {Cunha, Burke A. and Burillo, Almudena and Bouza, Emilio},
doi = {10.1016/S0140-6736(15)60078-2},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2016 - Cunha, Burillo, Bouza - Legionnaires' disease.pdf:pdf},
isbn = {9789401798761},
issn = {1474547X},
journal = {The Lancet},
number = {10016},
pages = {376--385},
pmid = {26231463},
publisher = {Elsevier Ltd},
title = {{Legionnaires' disease}},
url = {http://dx.doi.org/10.1016/S0140-6736(15)60078-2},
volume = {387},
year = {2016}
}
@article{Nunes2006,
abstract = {BACKGROUND Pulmonary hypertension (PH) is a rare complication of sarcoidosis, although it is not uncommon in advanced disease. METHODS A retrospective series of 22 sarcoidosis patients (16 men) of mean (SD) age 46 (13) years with PH was divided into two groups depending on the absence (stage 0: n = 2, stage II: n = 4, stage III: n = 1) or presence (n = 15) of radiographic pulmonary fibrosis at the time of PH diagnosis. RESULTS In both groups PH was moderate to severe and there was no response to acute vasodilator challenge. In non-fibrotic cases no other cause of PH was found, suggesting a specific sarcoidosis vasculopathy, although no histological specimens were available. In cases with fibrosis there was no correlation between haemodynamics and lung volumes or arterial oxygen tensions, suggesting other mechanisms for PH in addition to pulmonary destruction and hypoxaemia. These included extrinsic arterial compression by lymphadenopathies in three cases and histologically proven pulmonary veno-occlusive disease in the five patients who underwent lung transplantation. Ten patients received high doses of oral prednisone for PH (stage 0: n = 1, stage II: n = 4 and stage IV: n = 5); three patients without pulmonary fibrosis experienced a sustained haemodynamic response. Survival of the overall population was poor (59% at 5 years). Mortality was associated with NYHA functional class IV but not with haemodynamic parameters or with lung function. CONCLUSION Two very different phenotypes of sarcoidosis combined with PH are observed depending on the presence or absence of pulmonary fibrosis. PH is a severe complication of sarcoidosis.},
author = {Nunes, H. and Humbert, M. and Capron, F. and Brauner, M. and Sitbon, O. and Battesti, J. P. and Simonneau, G. and Valeyre, D.},
doi = {10.1136/thx.2005.042838},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2006 - Nunes et al. - Pulmonary hypertension associated with sarcoidosis Mechanisms, haemodynamics and prognosis.pdf:pdf},
isbn = {0040-6376 (Print)\r0040-6376},
issn = {00406376},
journal = {Thorax},
number = {1},
pages = {68--74},
pmid = {16227329},
title = {{Pulmonary hypertension associated with sarcoidosis: Mechanisms, haemodynamics and prognosis}},
volume = {61},
year = {2006}
}
@article{Gatell2008a,
author = {Felker, G. Michael and Lee, Kerry L. and Bull, David A. and Redfield, Margaret M. and Stevenson, Lynne W. and Goldsmith, Steven R. and LeWinter, Martin M. and Deswal, Anita and Rouleau, Jean L. and Ofili, Elizabeth O. and Anstrom, Kevin J. and Hernandez, Adrian F. and McNulty, Steven E. and Velazquez, Eric J. and Kfoury, Abdallah G. and Chen, Horng H. and Givertz, Michael M. and Semigran, Marc J. and Bart, Bradley A. and Mascette, Alice M. and Braunwald, Eugene and O'Connor, Christopher M.},
doi = {10.1056/NEJMoa1005419},
file = {:Users/shahbook/Box Sync/Mendeley_Articles//2011 - Felker et al. - Diuretic Strategies in Patients with Acute Decompensated Heart Failure.pdf:pdf},
isbn = {1260900026626},
issn = {0028-4793},
journal = {New England Journal of Medicine},
keywords = {p1},
mendeley-tags = {p1},
month = {mar},
number = {9},
pages = {797--805},
pmid = {19038878},
title = {{Diuretic Strategies in Patients with Acute Decompensated Heart Failure}},
url = {http://www.nejm.org/doi/10.1056/NEJMoa1411087 http://www.nejm.org/doi/10.1056/NEJMoa1005419},
volume = {364},
year = {2011}
}
@article{Williams1992,
abstract = {JAMA physical examination series for Ascites},
author = {Williams, John W. and Simel, David L.},
doi = {10.1001/jama.1992.03480190087038},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/1992 - Williams, Simel - Does This Patient Have Ascites How to Divine Fluid in the Abdomen.pdf:pdf},
issn = {15383598},
journal = {JAMA: The Journal of the American Medical Association},
number = {19},
pages = {2645--2648},
pmid = {1573754},
title = {{Does This Patient Have Ascites?: How to Divine Fluid in the Abdomen}},
volume = {267},
year = {1992}
}
@article{Galie2016,
abstract = {ALAT : alanine aminotransferase ASAT : aspartate aminotransferase APAH : associated pulmonary arterial hypertension BAS : balloon atrial septostomy BMPR2 : bone morphogenetic protein receptor 2 BNP : brain natriuretic peptide BPA : balloon pulmonary angioplasty BREATHE : Bosentan Randomised trial of Endothelin Antagonist THErapy CAV1 : caveolin-1 CCB : calcium channel blocker cGMP : cyclic guanosine monophosphate CHD : congenital heart disease CI : cardiac index CMR : cardiac magnetic resonance CO : cardiac output COPD : chronic obstructive pulmonary disease Cpc-PH : combined post-capillary and pre-capillary pulmonary hypertension CPET : cardiopulmonary exercise testing CPFE : combined pulmonary fibrosis and emphysema CT : computed tomography CTD : connective tissue disease CTPA : computed tomography pulmonary angiogram CTEPH : chronic thromboembolic pulmonary hypertension DLCO : diffusing capacity of the lung for carbon monoxide DPAH : drug-induced pulmonary arterial hypertension DPG : diastolic pressure gradient (diastolic PAP â mean PAWP) EACVI : European association of cardiovascular imaging ECG : electrocardiogram ECMO : extracorporeal membrane oxygenation EIF2AK4 : eukaryotic translation initiation factor 2 alpha kinase 4 EMA : European Medicines Agency ERA : endothelin receptor antagonist FC : functional class FDA : US Food and Drug Administration HAART : highly active antiretroviral therapy HIV : human immunodeficiency virus HF-pEF : heart failure with preserved left ventricular ejection fraction HPAH : heritable pulmonary arterial hypertension HRCT : high resolution computed tomography ICU : intensive care unit INR : international normalized ratio IPAH : idiopathic pulmonary arterial hypertension Ipc-PH : isolated post-capillary pulmonary hypertension IPF : idiopathic pulmonary fibrosis i.v. : intravenous IVC : inferior vena cava LA : left atrium/atrial LHD : left heart disease LV : left ventricle/ventricular MR : magnetic resonance NYHA : New York Heart Association NO : nitric oxide NT-proBNP : N-terminal pro-brain natriuretic peptide PA : pulmonary artery PaCO2 : arterial carbon dioxide pressure PaO2 : arterial oxygen pressure PAH : pulmonary arterial hypertension PAP : pulmonary arterial pressure PAPm : mean pulmonary arterial pressure PAPs : systolic pulmonary arterial pressure PAWP : pulmonary artery wedge pressure PASP : pulmonary artery systolic pressure PCH : pulmonary capillary haemangiomatosis PDE-5i : phosphodiesterase type 5 inhibitor PE : pulmonary embolism PEA : pulmonary endarterectomy PFTs : pulmonary function tests PH : pulmonary hypertension PoPH : porto-pulmonary hypertension PPHN : persistent pulmonary hypertension of the newborn PVOD : pulmonary veno-occlusive disease PVR : pulmonary vascular resistance RA : right atrium RAP : right atrial pressure RCT : randomized controlled trial RHC : right heart catheterization RV : right ventricle/ventricular 6MWD/6MWT : 6-minute walking distance/6-minute walking test SCD : sickle cell disease sGC : soluble guanylate cyclase SSc : systemic sclerosis SvO2 : mixed venous oxygen saturation SVR : systemic vascular resistance TAPSE : tricuspid annular plane systolic excursion t.i.d. : three times a day TGF-$\beta$ : transforming growth factor $\beta$ TPG : transpulmonary pressure gradient (mean PAP â mean PAWP) TRV : tricuspid regurgitant velocity VE/VCO2 : minute ventilation â carbon dioxide production relationship V/Q : ventilation/perfusion WHO-FC : World Health Organization functional class WU : Wood units Guidelines summarize and evaluate all available evidence on a particular issue at the time of the writing process, with the aim of assisting health professionals in selecting the best management strategies for an individual patient with a given condition, taking into account the impact on outcome, as well as the riskâbenefit ratio of particular diagnostic or therapeutic means. Guidelines and recommendations should help health professionals to make decisions in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible health professional(s) in consultation with the patient and caregiver as appropriate. A great number of Guidelines have been issued in recent years by the European Society of Cardiology (ESC) and by the European Respiratory Society (ERS), as well as by other societies and organisations. Because of the impact on clinical practice, quality criteria for the development of guidelines have been established in order to make all decisions transparent to the user. The recommendations for formulating and issuing ESC Guidelines can be found on the ESC website (http://www.escardio.org/Guidelines-&-Education/Clinical-Practice-Guidelines/Guidelines-development/Writing-ESC-Guidelines). ESC Guidelines represent the official position of the ESC on a given topic and are regularly updated. Members of this Task Force were selected by the ESC and ERS to represent professionals involved with the medical care of patients with this pathology. Selected experts in the field undertook a comprehensive review of the published evidence for management (including diagnosis, treatment, prevention and rehabilitation) of a given condition according to ESC Committee for Practice Guidelines (CPG) policy and approved by the ERS. A critical evaluation of diagnostic and therapeutic procedures was performed, including assessment of the riskâbenefit ratio. Estimates of expected health outcomes for larger populations were included, where data exist. The level of evidence and the strength of the recommendation of particular management options were weighed and {\ldots}},
author = {Gali{\`{e}}, Nazzareno and Humbert, Marc and Vachiery, Jean-Luc and Gibbs, Simon and Lang, Irene and Torbicki, Adam and Simonneau, G{\'{e}}rald and Peacock, Andrew and {Vonk Noordegraaf}, Anton and Beghetti, Maurice and Ghofrani, Ardeschir and {Gomez Sanchez}, Miguel Angel and Hansmann, Georg and Klepetko, Walter and Lancellotti, Patrizio and Matucci, Marco and McDonagh, Theresa and Pierard, Luc A. and Trindade, Pedro T. and Zompatori, Maurizio and Hoeper, Marius},
doi = {10.1093/eurheartj/ehv317},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2016 - Gali{\`{e}} et al. - 2015 ESCERS Guidelines for the diagnosis and treatment of pulmonary hypertension.pdf:pdf},
isbn = {1522-9645},
issn = {0195-668X},
journal = {European Heart Journal},
keywords = {chronic thromboembolic,congenital heart disease,connective tissue disease,endothelin receptor antagonists,failure,guidelines,heart failure,phosphodiesterase type 5 inhibitors,prostacyclin analogues,pulmonary arterial hypertension,pulmonary hypertension,respiratory},
number = {1},
pages = {67--119},
pmid = {26320113},
title = {{2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension}},
url = {https://academic.oup.com/eurheartj/article-lookup/doi/10.1093/eurheartj/ehv317},
volume = {37},
year = {2016}
}
@article{Adams2015,
author = {Adams, Jacob R. and Tonelli, Adriano R. and Rokadia, Haala K. and Duggal, Abhijit},
doi = {10.1513/AnnalsATS.201410-453CC},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2015 - Adams et al. - Cardiac tamponade in severe pulmonary hypertension A therapeutic challenge revisited.pdf:pdf},
issn = {23256621},
journal = {Annals of the American Thoracic Society},
number = {3},
pages = {455--460},
pmid = {25786153},
title = {{Cardiac tamponade in severe pulmonary hypertension: A therapeutic challenge revisited}},
volume = {12},
year = {2015}
}
@article{Unemo2016,
author = {Unemo, Magnus and {Del Rio}, Carlos and Shafer, William M.},
doi = {10.1128/microbiolspec.EI10-0009-2015.Antimicrobial},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2016 - Unemo, Del Rio, Shafer - HHS Public Access.pdf:pdf},
journal = {Microbiol. Spectr.},
number = {3},
pages = {1--32},
title = {{HHS Public Access}},
volume = {4},
year = {2016}
}
@article{Beard2011,
abstract = {Based on observations that as cardiac output (as determined by an artificial pump) was experimentally increased the right atrial pressure decreased, Arthur Guyton and coworkers proposed an interpretation that right atrial pressure represents a back pressure restricting venous return (equal to cardiac output in steady state). The idea that right atrial pressure is a back pressure limiting cardiac output and the associated idea that "venous recoil" does work to produce flow have confused physiologists and clinicians for decades because Guyton's interpretation interchanges independent and dependent variables. Here Guyton's model and data are reanalyzed to clarify the role of arterial and right atrial pressures and cardiac output and to clearly delineate that cardiac output is the independent (causal) variable in the experiments. Guyton's original mathematical model is used with his data to show that a simultaneous increase in arterial pressure and decrease in right atrial pressure with increasing cardiac output is due to a blood volume shift into the systemic arterial circulation from the systemic venous circulation. This is because Guyton's model assumes a constant blood volume in the systemic circulation. The increase in right atrial pressure observed when cardiac output decreases in a closed circulation with constant resistance and capacitance is due to the redistribution of blood volume and not because right atrial pressure limits venous return. Because Guyton's venous return curves have generated much confusion and little clarity, we suggest that the concept and previous interpretations of venous return be removed from educational materials},
author = {Beard, Daniel A. and Feigl, Eric O.},
doi = {10.1152/ajpheart.00228.2011},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2011 - Beard, Feigl - Understanding Guyton's venous return curves.pdf:pdf},
isbn = {1522-1539},
issn = {0363-6135},
journal = {AJP: Heart and Circulatory Physiology},
keywords = {cardiac output,mathematical modeling,vacular function curve},
month = {sep},
number = {3},
pages = {H629--H633},
pmid = {21666119},
publisher = {American Physiological Society Bethesda, MD},
title = {{Understanding Guyton's venous return curves}},
url = {http://www.physiology.org/doi/10.1152/ajpheart.00228.2011 http://ajpheart.physiology.org/cgi/doi/10.1152/ajpheart.00228.2011},
volume = {301},
year = {2011}
}
@article{LUKE1964,
abstract = {EDITORIAL SYNOPSIS These experimental observations on patients in whom blood was introduced into the caecum at appendicectomy suggest that the rate of passage of the blood rather than the level of its insertion determines the colour of the stool.},
author = {LUKE, R. G. and LEES, W. and RUDICK, J.},
doi = {10.1136/gut.5.1.77},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/1964 - LUKE, LEES, RUDICK - Appearances of the Stools After the Introduction of Blood Into the Caecum.pdf:pdf},
isbn = {0017-5749 (Print)\r0017-5749 (Linking)},
issn = {00175749},
journal = {Gut},
pages = {77--79},
pmid = {14127514},
title = {{Appearances of the Stools After the Introduction of Blood Into the Caecum.}},
volume = {5},
year = {1964}
}
@article{Yamada2000,
abstract = {A mathematical model was developed to analyze the mechanisms of expiratory asynchrony during pressure support ventilation (PSV). Solving the model revealed several results. 1) Ratio of the flow at the end of patient neural inspiration to peak inspiratory flow (VTI/V(peak)) during PSV is determined by the ratio of time constant of the respiratory system (tau) to patient neural inspiratory time (TI) and the ratio of the set pressure support (Pps) level to maximal inspiratory muscle pressure (Pmus max). 2) VTI/V(peak) is affected more by tau/TI than by Pps/Pmus max. VTI/V(peak) increases in a sigmoidal relationship to tau/TI. An increase in Pps/Pmus max slightly shifts the VTI/V(peak)-tau/TI curve to the right, i.e., VTI/V(peak) becomes lower as Pps/Pmus max increases at the same tau/TI. 3) Under the selected adult respiratory mechanics, VTI/V(peak) ranges from 1 to 85% and has an excellent linear correlation with tau/TI. 4) In mechanical ventilators, single fixed levels of the flow termination criterion will always have chances of both synchronized termination and asynchronized termination, depending on patient mechanics. An increase in tau/TI causes more delayed and less premature termination opportunities. An increase in Pps/Pmus max narrows the synchronized zone, making inspiratory termination predisposed to be in asynchrony. Increasing the expiratory trigger sensitivity of a ventilator shifts the synchronized zone to the right, causing less delayed and more premature termination. Automation of expiratory trigger sensitivity in future mechanical ventilators may also be possible. In conclusion, our model provides a useful tool to analyze the mechanisms of expiratory asynchrony in PSV.},
author = {Yamada, Y and Du, HL L},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2000 - Yamada, Du - Analysis of the mechanisms of expiratory asynchrony in pressure support ventilation a mathematical approach.pdf:pdf},
issn = {8750-7587},
journal = {Journal of Applied Physiology},
keywords = {Adult,Artificial,Humans,Models,Pressure,Pulmonary Ventilation,Pulmonary Ventilation: physiology,Regression Analysis,Respiration,Respiratory Mechanics,Respiratory Muscles,Respiratory Muscles: physiology,Theoretical,Time Factors},
number = {6},
pages = {2143--50},
pmid = {10846029},
title = {{Analysis of the mechanisms of expiratory asynchrony in pressure support ventilation: a mathematical approach}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/10846029%5Cnhttp://jap.physiology.org/content/88/6/2143.short},
volume = {88},
year = {2000}
}
@article{Ouweneel2012,
abstract = {Cardiogenic shock (CS) is a physiological state in which inadequate tissue perfusion results from cardiac dysfunction, most commonly following acute myocardial infarction. Non-ischaemic causes include myocarditis, end-stage cardiomyopathy or sustained arrhythmias.

The use of reperfusion therapy has substantially reduced 30-day mortality in acute ST-segment elevation myocardial infarction (STEMI) patients.w1âw3 Currently, the optimal reperfusion therapy is timely primary percutaneous coronary intervention (PCI). The improvement in clinical outcome has been mostly observed in STEMI patients without cardiogenic shock. Despite reperfusion therapy, approximately 6â10% of STEMI patients develop cardiogenic shock during initial hospitalisation.1 ,2 w4 The large multicentre Should we Emergently Revascularise Occluded Coronaries for Cardiogenic Shock? (SHOCK) trial and registry demonstrated that early revascularisation, including PCI or coronary artery bypass grafting, in cardiogenic shock patients improves clinical outcome, but the overall 6-month mortality of cardiogenic shock patients remained 50%3 in accordance with other reports.1 w4 Despite reperfusion by primary PCI, cardiogenic shock remains the leading cause of death for hospitalised STEMI patients.1 w5

Cardiogenic shock after STEMI is mostly a consequence of decreased myocardial contractility due to the infarction, resulting in a cascade of decreased cardiac output, hypotension and decreased coronary blood flow (CBF), which will further reduce contractility and cardiac output. This vicious circle may not only lead to further myocardial ischaemia, but also to diminished organ perfusion and may ultimately result in multiple organ failure and death. Additional aggravation of the downward spiral is caused by a systemic inflammatory response and excess nitric oxide synthesis induced by the myocardial infarction, which further induces vasodilatation.2

Clinically, cardiogenic shock is characterised by hypotension and defined by a systolic blood pressure of less {\ldots}},
author = {Ouweneel, Dagmar M. and Henriques, Jos{\'{e}} P S},
doi = {10.1136/heartjnl-2012-301963},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2012 - Ouweneel, Henriques - Percutaneous cardiac support devices for cardiogenic shock Current indications and recommendations.pdf:pdf},
isbn = {1468-201X},
issn = {13556037},
journal = {Heart},
number = {16},
pages = {1246--1254},
pmid = {22826561},
title = {{Percutaneous cardiac support devices for cardiogenic shock: Current indications and recommendations}},
volume = {98},
year = {2012}
}
@article{Payne2017,
abstract = {Cefepime is a widely used antibiotic with neurotoxicity attributed to its ability to cross the bloodâbrain barrier and exhibit concentration-dependent Ï-aminobutyric acid (GABA) antagonism. Neurotoxic symptoms include depressed consciousness, encephalopathy, aphasia, myoclonus, seizures, and coma. Data suggest that up to 15% of ICU patients treated with cefepime may experience these adverse effects. Risk factors include renal dysfunction, excessive dosing, preexisting brain injury, and elevated serum cefepime concentrations. We aimed to characterize the clinical course of cefepime neurotoxicity and response to interventions. A librarian-assisted search identified publications describing cefepime-associated neurotoxicity from January 1980 to February 2016 using the CINAHL and MEDLINE databases. Search terms included cefepime, neurotoxicity, encephalopathy, seizures, delirium, coma, non-convulsive status epilepticus, myoclonus, confusion, aphasia, agitation, and death. Two reviewers independently assessed identified articles for eligibility and used the Preferred Reporting Items for Systematic review and Meta-Analysis Protocols (PRISMA-P) for data reporting. Of the 123 citations identified, 37 (representing 135 patient cases) were included. Patients had a median age of 69Â years, commonly had renal dysfunction (80%) and required intensive care (81% of patients with a reported location). All patients exhibited altered mental status, with reduced consciousness (47%), myoclonus (42%), and confusion (42%) being the most common symptoms. All 98 patients (73% of cohort) with electroencephalography had abnormalities, including non-convulsive status epilepticus (25%), myoclonic status epilepticus (7%), triphasic waves (40%), and focal sharp waves (39%). As per Food and Drug Administration (FDA)-approved dosing guidance, 48% of patients were overdosed; however, 26% experienced neurotoxicity despite appropriate dosing. Median cefepime serum and cerebrospinal fluid (CSF) concentrations were 45Â mg/L (nâ=â21) and 13Â mg/L (nâ=â4), respectively. Symptom improvement occurred in 89% of patients, and 87% survived to hospital discharge. The median delay from starting the drug to symptom onset was 4Â days, and resolution occurred a median of 2Â days after the intervention, which included cefepime discontinuation, antiepileptic administration, or hemodialysis. Cefepime-induced neurotoxicity is challenging to recognize in the critically ill due to widely varying symptoms that are common in ICU patients. This adverse reaction can occur despite appropriate dosing, usually resolves with drug interruption, but may require additional interventions such as antiepileptic drug administration or dialysis.},
author = {Payne, Lauren E. and Gagnon, David J. and Riker, Richard R. and Seder, David B. and Glisic, Elizabeth K. and Morris, Jane G. and Fraser, Gilles L.},
doi = {10.1186/s13054-017-1856-1},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2017 - Payne et al. - Cefepime-induced neurotoxicity A systematic review.pdf:pdf},
isbn = {1305401718561},
issn = {1466609X},
journal = {Critical Care},
keywords = {Adverse events,Blood-brain barrier,Cefepime,Cephalosporin,Coma,Intensive care units,Myoclonus,Seizures,Status epilepticus},
number = {1},
pages = {1--8},
pmid = {29137682},
publisher = {Critical Care},
title = {{Cefepime-induced neurotoxicity: A systematic review}},
volume = {21},
year = {2017}
}
@article{Bohadana2014,
abstract = {Computer-assisted techniques allow detailed analysis of the acoustic and physiological aspects of lung sounds. This short review of classic lung sounds includes both audio clips and interpretations made in the light of modern pulmonary acoustics.},
author = {Bohadana, Abraham and Izbicki, Gabriel and Kraman, Steve S.},
doi = {10.1056/NEJMra1302901},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2014 - Bohadana, Izbicki, Kraman - Fundamentals of Lung Auscultation.pdf:pdf},
isbn = {0028-4793 1533-4406},
issn = {0028-4793},
journal = {New England Journal of Medicine},
number = {8},
pages = {744--751},
pmid = {24552321},
title = {{Fundamentals of Lung Auscultation}},
url = {http://www.nejm.org/doi/10.1056/NEJMra1302901},
volume = {370},
year = {2014}
}
@article{Molyneux2012,
abstract = {Burkitt's lymphoma is a highly aggressive B-cell non-Hodgkin lymphoma and is the fastest growing human tumour. The disease is associated with Epstein-Barr virus and was one of the first tumours shown to have a chromosomal translocation that activates an oncogene (c-MYC). Burkitt's lymphoma is the most common childhood cancer in areas where malaria is holoendemic. The incidence is very high in immunosuppressed patients in non-endemic areas, especially when associated with HIV infection. Outcome with intensive chemotherapy has improved and is now excellent in children, but the prognosis is poor in elderly adults. The success of intensive treatment relies on good supportive care. The therapy offered in oncology units in low-income countries is not as aggressive as in centres in high-income countries and outcomes are less successful. Adjuvant monoclonal antibody therapy with rituximab shows promise for improved outcomes and reduced toxic effects in the future. {\textcopyright} 2012 Elsevier Ltd.},
author = {Molyneux, Elizabeth M. and Rochford, Rosemary and Griffin, Beverly and Newton, Robert and Jackson, Graham and Menon, Geetha and Harrison, Christine J. and Israels, Trijn and Bailey, Simon},
doi = {10.1016/S0140-6736(11)61177-X},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2012 - Molyneux et al. - Burkitt's lymphoma.pdf:pdf},
isbn = {0140-6736},
issn = {01406736},
journal = {The Lancet},
number = {9822},
pages = {1234--1244},
pmid = {22333947},
title = {{Burkitt's lymphoma}},
volume = {379},
year = {2012}
}
@article{Mottet2009,
abstract = {Traveler's diarrhea is generally a benign condition which resolves spontaneously in 48 h. Information on dietary hygiene, severity of symptoms and dehydration, as well as their management, is essential. Chemoprophylaxis and antibiotic treatment are not recommended, except in very specific situations. The incidence of chronic diarrhea in HIV-positive patients has dramatically decreased since the introduction of HAART. In the absence of any correlation with the initiation of HAART, a stepwise diagnostic workup is indicated (bacteriological cultures and microscopic examination of fecal samples followed by ileocolonoscopy and gastroduodenoscopy). Specific treatment of any pathogens identified, and HAART in the case of microsporidiasis or cryptosporidiosis, constitute the mainstay of therapeutic management of chronic diarrhea in these patients.},
author = {Mottet, C and {El Wafa}, a a and Cavassini, M and D'Acremont, V and Delarive, J},
doi = {10.1002/9781118148594.ch5},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2009 - Mottet et al. - Bacterial diarrhea.pdf:pdf},
isbn = {1660-9379 (Print)\r1660-9379 (Linking)},
issn = {0028-4793},
journal = {The New England Journal of Medicine},
keywords = {*Antiretroviral Therapy,Anti-Bacterial Agents/*therapeutic use,Antibiotic Prophylaxis,Chronic Disease,Diarrhea/drug therapy/*microbiology/*prevention &,HIV Infections/complications,Highly Active,Humans,Travel},
pages = {1560--9},
pmid = {15770815},
title = {{Bacterial diarrhea}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/15770815},
volume = {361},
year = {2009}
}
@article{Villanueva2013,
abstract = {BACKGROUND: The hemoglobin threshold for transfusion of red cells in patients with acute gastrointestinal bleeding is controversial. We compared the efficacy and safety of a restrictive transfusion strategy with those of a liberal transfusion strategy. METHODS: We enrolled 921 patients with severe acute upper gastrointestinal bleeding and randomly assigned 461 of them to a restrictive strategy (transfusion when the hemoglobin level fell below 7 g per deciliter) and 460 to a liberal strategy (transfusion when the hemoglobin fell below 9 g per deciliter). Randomization was stratified according to the presence or absence of liver cirrhosis. RESULTS: A total of 225 patients assigned to the restrictive strategy (51%), as compared with 61 assigned to the liberal strategy (14%), did not receive transfusions (P<0.001) [corrected].The probability of survival at 6 weeks was higher in the restrictive-strategy group than in the liberal-strategy group (95% vs. 91%; hazard ratio for death with restrictive strategy, 0.55; 95% confidence interval [CI], 0.33 to 0.92; P=0.02). Further bleeding occurred in 10% of the patients in the restrictive-strategy group as compared with 16% of the patients in the liberal-strategy group (P=0.01), and adverse events occurred in 40% as compared with 48% (P=0.02). The probability of survival was slightly higher with the restrictive strategy than with the liberal strategy in the subgroup of patients who had bleeding associated with a peptic ulcer (hazard ratio, 0.70; 95% CI, 0.26 to 1.25) and was significantly higher in the subgroup of patients with cirrhosis and Child-Pugh class A or B disease (hazard ratio, 0.30; 95% CI, 0.11 to 0.85), but not in those with cirrhosis and Child-Pugh class C disease (hazard ratio, 1.04; 95% CI, 0.45 to 2.37). Within the first 5 days, the portal-pressure gradient increased significantly in patients assigned to the liberal strategy (P=0.03) but not in those assigned to the restrictive strategy. CONCLUSIONS: As compared with a liberal transfusion strategy, a restrictive strategy significantly improved outcomes in patients with acute upper gastrointestinal bleeding. (Funded by Fundacio Investigacio Sant Pau; ClinicalTrials.gov number, NCT00414713.).},
author = {Villanueva, C{\`{a}}ndid and Colomo, Alan and Bosch, Alba and Concepci{\'{o}}n, Mar and Hernandez-Gea, Virginia and Aracil, Carles and Graupera, Isabel and Poca, Mar{\'{i}}a and Alvarez-Urturi, Cristina and Gordillo, Jordi and Guarner-Argente, Carlos and Santal{\'{o}}, Miquel and Mu{\~{n}}iz, Eduardo and Guarner, Carlos},
doi = {10.1056/NEJMoa1211801},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2013 - Villanueva et al. - Transfusion Strategies for Acute Upper Gastrointestinal Bleeding.pdf:pdf},
isbn = {1533-4406 (Electronic)\r0028-4793 (Linking)},
issn = {0028-4793},
journal = {New England Journal of Medicine},
number = {1},
pages = {11--21},
pmid = {23281973},
title = {{Transfusion Strategies for Acute Upper Gastrointestinal Bleeding}},
url = {http://www.nejm.org/doi/10.1056/NEJMoa1211801},
volume = {368},
year = {2013}
}
@article{MeyerhoffWL1990,
author = {{Meyerhoff WL}, Roland PS},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/1990 - Meyerhoff WL - Physical examination of the ear.pdf:pdf},
journal = {Otolaryngology, Volume II},
number = {3},
pages = {195--199},
title = {{Physical examination of the ear}},
volume = {24},
year = {1990}
}
@article{Anderson2017,
abstract = {This review focuses on the initial presentation and in-hospital management of acute myocardial infarction, including selection of a management strategy and options for antithrombotic therapy.},
author = {Anderson, Jeffrey L. and Morrow, David A.},
doi = {10.1056/NEJMra1606915},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2017 - Anderson, Morrow - Acute Myocardial Infarction.pdf:pdf},
isbn = {9780323311601},
issn = {0028-4793},
journal = {New England Journal of Medicine},
number = {21},
pages = {2053--2064},
pmid = {24996601},
title = {{Acute Myocardial Infarction}},
url = {http://www.nejm.org/doi/10.1056/NEJMra1606915},
volume = {376},
year = {2017}
}
@article{Pellegrino2005,
abstract = {... with equations derived from measurements observed in a representative sample of healthy subjects in a general population. ... As equipment and techniques for lung function testing improve, advanced mathematical models to describe lung function data are implemented. ... \n},
author = {Pellegrino, R. and Viegi, G. and Brusasco, Vito and Crapo, R. O. and Burgos, F. and Casaburi, R. and Coates, A. and van der Grinten, C. P M and Gustafsson, P. and Hankinson, J. and Jensen, R. and Johnson, D. C. and MacIntyre, N. and McKay, R. and Miller, M. R. and Navajas, D. and Pedersen, O. F. and Wanger, J.},
doi = {10.1183/09031936.05.00035205},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2005 - Pellegrino et al. - Interpretative strategies for lung function tests.pdf:pdf},
isbn = {0040-6376 (Print)\n0040-6376 (Linking)},
issn = {09031936},
journal = {European Respiratory Journal},
number = {5},
pages = {948--968},
pmid = {16936234},
title = {{Interpretative strategies for lung function tests}},
volume = {26},
year = {2005}
}
@article{Tan2017,
abstract = {Left ventricular outflow tract velocity time integral (LVOT VTI) is a measure of cardiac systolic function and cardiac output. Heart failure patients with low cardiac output are known to have poor cardiovascular outcomes. Thus, extremely low LVOT VTI may predict heart failure patients at highest risk for mortality. Patients with heart failure and extremely low LVOT VTI were identified from a single-center database. Baseline characteristics and heart failure related clinical outcomes (death, LVAD) were obtained at 12 months. Correlation between clinical endpoints and the following variables were analyzed: ejection fraction (EF), pulmonary artery systolic pressure (PASP), NYHA class, renal function, Doppler cardiac output (CO), and LVOT VTI. Study cohort consisted of 100 patients. At the 12-month follow up period, 30 events (28 deaths, 2 LVADs) were identified. Occurrence of death and LVAD implantation was statistically associated with a lower LVOT VTI (p = 0.039) but not EF (p = 0.169) or CO (p = 0.217). In multivariate analysis, LVOT VTI (p = 0.003) remained statistically significant, other significant variables were age (p = 0.033) and PASP (p = 0.022). Survival analysis by LVOT VTI tertile demonstrated an unadjusted hazard ratio of 4.755 (CI 1.576-14.348, p = 0.006) for combined LVAD and mortality at one year. Extremely low LVOT VTI strongly predicts adverse outcomes and identifies patients who may benefit most from advanced heart failure therapies.},
author = {Tan, Christina and Rubenson, David and Srivastava, Ajay and Mohan, Rajeev and Smith, Michael R and Billick, Kristen and Bardarian, Samuel and {Thomas Heywood}, J},
doi = {10.1186/s12947-017-0109-4},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2017 - Tan et al. - Left ventricular outflow tract velocity time integral outperforms ejection fraction and Doppler-derived cardiac outp.pdf:pdf},
isbn = {1476-7120; 1476-7120},
issn = {14767120},
journal = {Cardiovascular Ultrasound},
keywords = {Congestive heart failure,Echocardiography,Time velocity integral,Velocity time integral},
month = {jul},
number = {1},
pages = {18},
pmid = {28673293},
publisher = {BioMed Central},
title = {{Left ventricular outflow tract velocity time integral outperforms ejection fraction and Doppler-derived cardiac output for predicting outcomes in a select advanced heart failure cohort}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/28673293 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC5496262},
volume = {15},
year = {2017}
}
@article{Schneider2012,
abstract = {With continued advances in early treatment, babies with congenital heart disease now usually survive to adulthood. They are therefore increasingly presenting as adults for medical care to non-specialist centres. A simple classification of adult congenital heart disease (ACHD) according to complexity can help clinicians to understand the implications of the cardiac anomaly presented. Issues specific to the conduct of anaesthesia in ACHD patients include the need to maintain euvolaemia, sinus rhythm and cardiac output, and in complex situations to balance the flow between the pulmonary and systemic circulations. It should be recognized that patients with pulmonary hypertension or Eisenmenger's syndrome are at extremely high risk of death in the perioperative period, and in all but life-threatening situations they should be cared for in specialist centres. Furthermore, an understanding of the need for antibiotic and thromboprophylaxis in specific groups is essential, as are strategies to control bleeding.},
author = {Schneider, Frank and Kelleher, Andrea},
doi = {10.1016/j.mpaic.2012.08.008},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2012 - Schneider, Kelleher - Adult congenital heart disease.pdf:pdf},
isbn = {14720299},
issn = {14720299},
journal = {Anaesthesia & Intensive Care Medicine},
number = {10},
pages = {513--518},
title = {{Adult congenital heart disease}},
url = {http://linkinghub.elsevier.com/retrieve/pii/S1472029912001889},
volume = {13},
year = {2012}
}
@article{Peguero2017,
abstract = {Background Current electrocardiographic (ECG) criteria for the diagnosis of left ventricular hypertrophy (LVH) have low sensitivity. Objectives The goal of this study was to test a new method to improve the diagnostic performance of the electrocardiogram. Methods The study was divided into 2 groups, a test and a validation cohort. In the test cohort, 94 patients were analyzed, including 47 with the diagnosis of hypertensive crisis and 47 with normal blood pressure at admission. Echocardiography was used to estimate the left ventricular mass index. Area under the curve (AUC) analysis was used for comparison of single and combined leads. The McNemar test was used to assess agreement among the ECG criteria against the left ventricular mass index. The proposed ECG criteria involved measuring the amplitude of the deepest SÂ wave (SD) in any single lead and adding it to the S wave amplitude of lead V4(SV4). Currently accepted LVH ECG criteria such as Cornell voltage and Sokolow-Lyon were used for comparison. The validation cohort consisted of 122 consecutive patients referred for an echocardiogram regardless of the admitting diagnosis. Results The SDwas the most accurate single lead measurement for the diagnosis of LVH (AUC: 0.80; pÂ < 0.001). When both cohorts were analyzed, the SDÂ + SV4criteria outperformed Cornell voltage with a significantly higher sensitivity (62% [95% confidence interval [CI]: 50% to 72%] vs. 35% [95% CI: 24% to 46%]). The specificities of all theÂ criteria wereÂ â¥90%, with no significant difference among them. Conclusions The proposed criteria for the ECG diagnosis of LVH improved the sensitivity and overall accuracy of the test.},
author = {Peguero, Julio G. and {Lo Presti}, Saberio and Perez, Jorge and Issa, Omar and Brenes, Juan C. and Tolentino, Alfonso},
doi = {10.1016/j.jacc.2017.01.037},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2017 - Peguero et al. - Electrocardiographic Criteria for the Diagnosis of Left Ventricular Hypertrophy.pdf:pdf},
issn = {15583597},
journal = {Journal of the American College of Cardiology},
keywords = {electrocardiogram,left ventricular hypertrophy,novel criteria},
number = {13},
pages = {1694--1703},
pmid = {28359515},
publisher = {Elsevier},
title = {{Electrocardiographic Criteria for the Diagnosis of Left Ventricular Hypertrophy}},
url = {http://dx.doi.org/10.1016/j.jacc.2017.01.037},
volume = {69},
year = {2017}
}
@article{Sager2017,
abstract = {Several controlled clinical studies have evaluated the potential of the infection biomarker procalcitonin (PCT) to improve the diagnostic work-up of patients with bacterial infections and its influence on decisions regarding antibiotic therapy. Most research has focused on lower respiratory tract infections and critically ill sepsis patients. A clinical utility for PCT has also been found for patients with urinary tract infections, postoperative infections, meningitis, and patients with acute heart failure with possible superinfection (i.e., pneumonia). In these indications, PCT levels measured on hospital admission were found to substantially reduce the initiation of antibiotic treatment in low-risk situations (i.e., bronchitis, chronic obstructive pulmonary disease exacerbation). For more severe infections (i.e., pneumonia, sepsis), antibiotic stewardship by monitoring of PCT kinetics resulted in shorter antibiotic treatment durations with early cessation of therapy. Importantly, these strategies appear to be safe without increasing the risk for mortality, recurrent infections, or treatment failures. PCT kinetics also proved to have prognostic value correlating with disease severity (i.e., pancreatitis, abdominal infection) and resolution of illness (i.e., sepsis). Although promising findings have been published in these different types of infections, there are a number of limitations regarding PCT, including suboptimal sensitivity and/or specificity, which makes a careful interpretation of PCT in the clinical context mandatory. This narrative review aims to update clinicians on the strengths and limitations of PCT for patient management, focusing on research conducted within the last 4 years.},
author = {Sager, Ramon and Kutz, Alexander and Mueller, Beat and Schuetz, Philipp},
doi = {10.1186/s12916-017-0795-7},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2017 - Sager et al. - Procalcitonin-guided diagnosis and antibiotic stewardship revisited.pdf:pdf},
isbn = {1755-5922},
issn = {17417015},
journal = {BMC Medicine},
keywords = {Antibiotic stewardship,Pneumonia,Procalcitonin,Respiratory tract infection,Sepsis},
number = {1},
pages = {1--11},
pmid = {28114931},
publisher = {BMC Medicine},
title = {{Procalcitonin-guided diagnosis and antibiotic stewardship revisited}},
url = {http://dx.doi.org/10.1186/s12916-017-0795-7},
volume = {15},
year = {2017}
}
@article{Babbs2012,
abstract = {BACKGROUND: The oscillometric method of measuring blood pressure with an automated cuff yields valid estimates of mean pressure but questionable estimates of systolic and diastolic pressures. Existing algorithms are sensitive to differences in pulse pressure and artery stiffness. Some are closely guarded trade secrets. Accurate extraction of systolic and diastolic pressures from the envelope of cuff pressure oscillations remains an open problem in biomedical engineering.\n\nMETHODS: A new analysis of relevant anatomy, physiology and physics reveals the mechanisms underlying the production of cuff pressure oscillations as well as a way to extract systolic and diastolic pressures from the envelope of oscillations in any individual subject. Stiffness characteristics of the compressed artery segment can be extracted from the envelope shape to create an individualized mathematical model. The model is tested with a matrix of possible systolic and diastolic pressure values, and the minimum least squares difference between observed and predicted envelope functions indicates the best fit choices of systolic and diastolic pressure within the test matrix.\n\nRESULTS: The model reproduces realistic cuff pressure oscillations. The regression procedure extracts systolic and diastolic pressures accurately in the face of varying pulse pressure and arterial stiffness. The root mean squared error in extracted systolic and diastolic pressures over a range of challenging test scenarios is 0.3 mmHg.\n\nCONCLUSIONS: A new algorithm based on physics and physiology allows accurate extraction of systolic and diastolic pressures from cuff pressure oscillations in a way that can be validated, criticized, and updated in the public domain.},
author = {Babbs, Charles F.},
doi = {10.1186/1475-925X-11-56},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2012 - Babbs - Oscillometric measurement of systolic and diastolic blood pressures validated in a physiologic mathematical model.pdf:pdf},
isbn = {1475-925X},
issn = {1475925X},
journal = {BioMedical Engineering Online},
pages = {1--22},
pmid = {22913792},
title = {{Oscillometric measurement of systolic and diastolic blood pressures validated in a physiologic mathematical model}},
volume = {11},
year = {2012}
}
@article{Wilson2007,
abstract = {Predicting the binding mode of flexible polypeptides to proteins is an important task that falls outside the domain of applicability of most small molecule and proteinâprotein docking tools. Here, we test the small molecule flexible ligand docking program Glide on a set of 19 non-$\alpha$-helical peptides and systematically improve pose prediction accuracy by enhancing Glide sampling for flexible polypeptides. In addition, scoring of the poses was improved by post-processing with physics-based implicit solvent MM- GBSA calculations. Using the best RMSD among the top 10 scoring poses as a metric, the success rate (RMSD â¤ 2.0 {\AA} for the interface backbone atoms) increased from 21% with default Glide SP settings to 58% with the enhanced peptide sampling and scoring protocol in the case of redocking to the native protein structure. This approaches the accuracy of the recently developed Rosetta FlexPepDock method (63% success for these 19 peptides) while being over 100 times faster. Cross-docking was performed for a subset of cases where an unbound receptor structure was available, and in that case, 40% of peptides were docked successfully. We analyze the results and find that the optimized polypeptide protocol is most accurate for extended peptides of limited size and number of formal charges, defining a domain of applicability for this approach.},
archivePrefix = {arXiv},
arxivId = {arXiv:1011.1669v3},
author = {Wilson, Dodd},
doi = {10.1017/CBO9781107415324.004},
eprint = {arXiv:1011.1669v3},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2007 - Wilson - Hematemesis, Melena, and Hematochezia.pdf:pdf},
isbn = {9788578110796},
issn = {1098-6596},
journal = {Clinical methods: the history, physical, and laboratory examinations},
pages = {439--442},
pmid = {25246403},
title = {{Hematemesis, Melena, and Hematochezia}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/21250251},
year = {2007}
}
@article{Staib1989,
abstract = {The single-dose absorption kinetics of ciprofloxa-tin in different regions of the human gastrointes-tinal tract were investigated using a remote-control drug delivery device (HF-capsule). Doses of 180 to 200 mg ciprofloxacin (as a lactic acid solution) were placed in the HF-capsule and ad-ministered to four healthy male adults. The posi-tion of the HF-capsule in the gastrointestinal tract was checked via radiographic examination. The release of the solution from the HF-capsule was induced by a radio signal. In each volunteer, the solution was released into five different re-gions of the gastrointestinal tract: the stomach (B), jejunum (C,), ileum (Cz), ascending colon (D1), and descending colon (D,). Two control runs (Al, A,), involving oral administration of the solution, were used as a reference for calcu-lation of area under the curve. The oral adminis-tration of a conventional 250-mg tablet (A,) was also studied. The plasma concentration of cipro-floxacin and urine concentrations of ciprofloxa-tin, desethylene-(Ml), sulfo-(M2), and oxo-ciprofloxacin (M3) were determined fluorimetri-tally by high-performance liquid chromatogra-phy. Intraindividual comparisons indicated a pro-gressive decrease in the amount of ciprofloxacin absorbed (100 percent = mean of AUCA1 and AUCAJ from the jejunum (-61 percent, median), ileum (-75 percent), colon ascendens (-90 per-cent), and colon descendens (-95 percent). Abso-lute amounts of renally excreted ciprofloxacin and metabolites decreased due to the reduced absorption of ciprofloxacin, but the metabolite pattern was unchanged. It is concluded that the main absorption site for ciprofloxacin is the upper part of the intestinal tract (duodenum, je-junum).},
author = {Staib, A Horst and Beerman, D and Harder, Sebastian and Fuhr, Uwe and Liermann},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/1989 - Staib et al. - Absorption differences of ciprofloxacin along the human gastrointestinal tract determined using a remote control d.pdf:pdf},
journal = {Am.J.Med.},
pages = {66S--69S},
title = {{Absorption differences of ciprofloxacin along the human gastrointestinal tract determined using a remote control drug delivery device (HF-capsule)}},
url = {https://ac-els-cdn-com.proxy.library.emory.edu/0002934389900260/1-s2.0-0002934389900260-main.pdf?_tid=cb3ad45c-a921-48b1-a41f-37ae5870cbb8&acdnat=1529884684_8d6eefbccb5da68a315e06648bd05cbe},
volume = {87},
year = {1989}
}
@article{Myers2001,
author = {Myers, Kathryn A},
doi = {10.1001/jama.286.3.341},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2001 - Myers - Does This Patient Have Clubbing CLINICAL SCENARIOS.pdf:pdf},
journal = {JAMA : the journal of the American Medical Association},
number = {3},
pages = {341--347},
title = {{Does This Patient Have Clubbing ? CLINICAL SCENARIOS}},
volume = {286},
year = {2001}
}
@article{Prandoni2016,
abstract = {BackgroundThe prevalence of pulmonary embolism among patients hospitalized for syncope is not well documented, and current guidelines pay little attention to a diagnostic workup for pulmonary embolism in these patients. MethodsWe performed a systematic workup for pulmonary embolism in patients admitted to 11 hospitals in Italy for a first episode of syncope, regardless of whether there were alternative explanations for the syncope. The diagnosis of pulmonary embolism was ruled out in patients who had a low pretest clinical probability, which was defined according to the Wells score, in combination with a negative d-dimer assay. In all other patients, computed tomographic pulmonary angiography or ventilationâperfusion lung scanning was performed. ResultsA total of 560 patients (mean age, 76 years) were included in the study. A diagnosis of pulmonary embolism was ruled out in 330 of the 560 patients (58.9%) on the basis of the combination of a low pretest clinical probability of pulmonary embolism and negat...},
author = {Prandoni, Paolo and Lensing, Anthonie W.A. and Prins, Martin H. and Ciammaichella, Maurizio and Perlati, Marica and Mumoli, Nicola and Bucherini, Eugenio and Vison{\`{a}}, Adriana and Bova, Carlo and Imberti, Davide and Campostrini, Stefano and Barbar, Sofia},
doi = {10.1056/NEJMoa1602172},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2016 - Prandoni et al. - Prevalence of Pulmonary Embolism among Patients Hospitalized for Syncope.pdf:pdf},
isbn = {1533-4406 (Electronic)\r0028-4793 (Linking)},
issn = {0028-4793},
journal = {New England Journal of Medicine},
number = {16},
pages = {1524--1531},
pmid = {27367787},
title = {{Prevalence of Pulmonary Embolism among Patients Hospitalized for Syncope}},
url = {http://www.nejm.org/doi/10.1056/NEJMoa1602172},
volume = {375},
year = {2016}
}
@article{Carden2017,
abstract = {Abnormal sickle red blood cell (sRBC) biomechanics, including pathological deformability and adhesion, correlate with clinical severity in sickle cell disease (SCD). Clinical intravenous fluids (IVFs) of various tonicities are often used during treatment of vaso-occlusive pain episodes (VOE), the major cause of morbidity in SCD. However, evidence-based guidelines are lacking, and there is no consensus regarding which IVFs to use during VOE. Further, it is unknown how altering extracellular fluid tonicity with IVFs affects sRBC biomechanics in the microcirculation, where vaso-occlusion takes place. Here, we report how altering extracellular fluid tonicity with admixtures of clinical IVFs affects sRBC biomechanical properties by leveraging novel in vitro microfluidic models of the microcirculation, including 1 capable of deoxygenating the sRBC environment to monitor changes in microchannel occlusion risk and an "endothelialized" microvascular model that measures alterations in sRBC/endothelium adhesion under postcapillary venular conditions. Admixtures with higher tonicities (sodium = 141 mEq/L) affected sRBC biomechanics by decreasing sRBC deformability, increasing sRBC occlusion under normoxic and hypoxic conditions, and increasing sRBC adhesion in our microfluidic human microvasculature models. Admixtures with excessive hypotonicity (sodium = 103 mEq/L), in contrast, decreased sRBC adhesion, but overswelling prolonged sRBC transit times in capillary-sized microchannels. Admixtures with intermediate tonicities (sodium = 111-122 mEq/L) resulted in optimal changes in sRBC biomechanics, thereby reducing the risk for vaso-occlusion in our models. These results have significant translational implications for patients with SCD and warrant a large-scale prospective clinical study addressing optimal IVF management during VOE in SCD.},
author = {Carden, Marcus A. and Fay, Meredith E. and Lu, Xinran and Mannino, Robert G. and Sakurai, Yumiko and Ciciliano, Jordan C. and Hansen, Caroline E. and Chonat, Satheesh and Joiner, Clinton H. and Wood, David K. and Lam, Wilbur A.},
doi = {10.1182/blood-2017-04-780635},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2017 - Carden et al. - Extracellular fluid tonicity impacts sickle red blood cell deformability and adhesion.pdf:pdf},
issn = {15280020},
journal = {Blood},
number = {24},
pages = {2654--2663},
pmid = {28978568},
title = {{Extracellular fluid tonicity impacts sickle red blood cell deformability and adhesion}},
volume = {130},
year = {2017}
}
@article{Boriani2010,
abstract = {STUDY OBJECTIVE: To evaluate the efficacy and safety of tobramycin solution for inhalation (TSI) in patients with severe bronchiectasis. DESIGN: Open-label clinical trial consisting of three treatment cycles (14 days of drug therapy, and 14 days off drug) and an additional 40-week follow-up by chart review. SETTING: Nine clinical sites throughout the United States. SUBJECTS: Forty-one adult patients (>/= 18 years old) with diffuse bronchiectasis affecting two or more lung segments and a history of Pseudomonas aeruginosa infection. INTERVENTIONS: TSI, 300 mg tobramycin per dose bid. MEASUREMENTS AND RESULTS: During the 12-week treatment period, significant improvements (reduction of 1.5 U p = 0.006) occurred in mean pulmonary total symptom severity score, a composite score that assesses the severity of cough, shortness of breath, sputum production, fatigue, and wheezing. Significant improvements (reduction of 9.8 U p < 0.001) were also observed in St. George Respiratory Questionnaire scores, which measure health-related quality of life. Eradication or presumed eradication of P aeruginosa occurred in 6 of 27 evaluable subjects (22.2%). Tobramycin-resistant P aeruginosa developed in two subjects (minimal inhibitory concentration 16 microg/mL). Ten subjects withdrew from the study due to adverse events; in nine of these subjects, adverse events were considered probably or possibly related to treatment. The most common adverse events were cough, wheezing, and dyspnea. CONCLUSIONS: TSI therapy resulted in significant improvements in respiratory symptoms and health-related quality of life in subjects with severe bronchiectasis, but some subjects did not tolerate TSI therapy. Bronchiectasis patients receiving this therapy should be monitored for signs of intolerance.},
author = {Boriani, Giuseppe and Diemberger, Igor and Biffi, Mauro and Martignani, Cristian},
doi = {10.1378/chest.10-0808},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2010 - Boriani et al. - Balancing the risk of hemorrhage vs thromboembolism in patients with atrial fibrillation How to navigate between.pdf:pdf},
isbn = {0012-3692},
issn = {19313543},
journal = {Chest},
number = {5},
pages = {1032--1033},
pmid = {21051391},
title = {{Balancing the risk of hemorrhage vs thromboembolism in patients with atrial fibrillation: How to navigate between scylla and charybdis?}},
url = {www.chestpubs.org},
volume = {138},
year = {2010}
}
@article{Reynolds2008,
abstract = {Cardiogenic shock (CS) occurs in â5% to 8% of patients hospitalized with ST-elevation myocardial infarction (STEMI). Recent research has suggested that the peripheral vasculature and neurohormonal and cytokine systems play a role in the pathogenesis and persistence of CS. Early revascularization for CS improves survival substantially. New mechanical approaches to treatment are available, and clinical trials are feasible even in this high-risk population. Most importantly, hospital survivors have an excellent chance for long-term survival with good quality of life. This review will outline the causes, pathophysiology, and treatment of CS with a focus on CS complicating myocardial infarction (MI.) The case will be made for viewing CS as a serious disorder with a high early death rate, but one that is treatable and that, if approached aggressively, can result in full recovery.\n\nCS is a state of end-organ hypoperfusion due to cardiac failure. The definition of CS includes hemodynamic parameters: persistent hypotension (systolic blood pressure <80 to 90 mm Hg or mean arterial pressure 30 mm Hg lower than baseline) with severe reduction in cardiac index (<1.8 L {\textperiodcentered} minâ1 {\textperiodcentered} mâ2 without support or <2.0 to 2.2 L {\textperiodcentered} minâ1 {\textperiodcentered} mâ2 with support) and adequate or elevated filling pressure (eg, left ventricular [LV] end-diastolic pressure >18 mm Hg or right ventricular [RV] end-diastolic pressure >10 to 15 mm Hg). The diagnosis is usually made with the help of pulmonary artery (PA) catheterization; however, Doppler echocardiography may also be used to confirm elevation of LV filling pressures.1 Hypoperfusion may be manifest clinically by cool extremities, decreased urine output, and/or alteration in mental status. Hemodynamic abnormalities form a spectrum that ranges from mild hypoperfusion to profound shock, and the short-term outcome is directly related to the severity of hemodynamic derangement.\n\nMI with LV failure remains {\ldots}},
author = {Reynolds, Harmony R. and Hochman, Judith S.},
doi = {10.1161/CIRCULATIONAHA.106.613596},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2008 - Reynolds, Hochman - Cardiogenic shock current concepts and improving outcomes.pdf:pdf},
isbn = {1524-4539 (Electronic) 0009-7322 (Linking)},
issn = {00097322},
journal = {Circulation},
keywords = {Cardiovascular diseases,Myocardial infarction,Outcomes research,Shock},
number = {5},
pages = {686--697},
pmid = {18250279},
title = {{Cardiogenic shock current concepts and improving outcomes}},
volume = {117},
year = {2008}
}
@article{Bentzer2016,
abstract = {IMPORTANCE Fluid overload occurring as a consequence of overly aggressive fluid resuscitation may adversely affect outcome in hemodynamically unstable critically ill patients. Therefore, following the initial fluid resuscitation, it is important to identify which patients will benefit from further fluid administration. OBJECTIVE To identify predictors of fluid responsiveness in hemodynamically unstable patients with signs of inadequate organ perfusion. DATA SOURCES AND STUDY SELECTION Search of MEDLINE and EMBASE (1966 to June 2016) and reference lists from retrieved articles, previous reviews, and physical examination textbooks for studies that evaluated the diagnostic accuracy of tests to predict fluid responsiveness in hemodynamically unstable adult patients who were defined as having refractory hypotension, signs of organ hypoperfusion, or both. Fluid responsiveness was defined as an increase in cardiac output following intravenous fluid administration. DATA EXTRACTION Two authors independently abstracted data (sensitivity, specificity, and likelihood ratios [LRs]) and assessed methodological quality. A bivariate mixed-effects binary regression model was used to pool the sensitivities, specificities, and LRs across studies. RESULTS A total of 50 studies (N = 2260 patients) were analyzed. In all studies, indices were measured before assessment of fluid responsiveness. The mean prevalence of fluid responsiveness was 50% (95% CI, 42%-56%). Findings on physical examination were not predictive of fluid responsiveness with LRs and 95% CIs for each finding crossing 1.0. A low central venous pressure (CVP) (mean threshold <8 mm Hg) was associated with fluid responsiveness (positive LR, 2.6 [95% CI, 1.4-4.6]; pooled specificity, 76%), but a CVP greater than the threshold made fluid responsiveness less likely (negative LR, 0.50 [95% CI, 0.39-0.65]; pooled sensitivity, 62%). Respiratory variation in vena cava diameter measured by ultrasound (distensibility index >15%) predicted fluid responsiveness in a subgroup of patients without spontaneous respiratory efforts (positive LR, 5.3 [95% CI, 1.1-27]; pooled specificity, 85%). Patients with less vena cava distensibility were not as likely to be fluid responsive (negative LR, 0.27 [95% CI, 0.08-0.87]; pooled sensitivity, 77%). Augmentation of cardiac output or related parameters following passive leg raising predicted fluid responsiveness (positive LR, 11 [95% CI, 7.6-17]; pooled specificity, 92%). Conversely, the lack of an increase in cardiac output with passive leg raising identified patients unlikely to be fluid responsive (negative LR, 0.13 [95% CI, 0.07-0.22]; pooled sensitivity, 88%). CONCLUSIONS AND RELEVANCE Passive leg raising followed by measurement of cardiac output or related parameters may be the most useful test for predicting fluid responsiveness in hemodynamically unstable adults. The usefulness of respiratory variation in the vena cava requires confirmatory studies.},
author = {Bentzer, Peter and Griesdale, Donald E. and Boyd, John and MacLean, Kelly and Sirounis, Demetrios and Ayas, Najib T.},
doi = {10.1001/jama.2016.12310},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2016 - Bentzer et al. - Will this hemodynamically unstable patient respond to a bolus of intravenous fluids.pdf:pdf},
isbn = {0098-7484 (Print)\r0098-7484 (Linking)},
issn = {15383598},
journal = {JAMA - Journal of the American Medical Association},
number = {12},
pages = {1298--1309},
pmid = {27673307},
title = {{Will this hemodynamically unstable patient respond to a bolus of intravenous fluids?}},
volume = {316},
year = {2016}
}
@article{Moranville2015,
abstract = {AIMS: Sequential nephron blockade with thiazide-like diuretics is a strategy used to overcome diuretic resistance in acute decompensated heart failure (ADHF), but head-to-head studies are lacking and equipoise exists regarding the preferred thiazide-like diuretic in this setting. We thus compared the effectiveness of oral metolazone versus intravenous (IV) chlorothiazide as add-on therapy to loop diuretics in hospitalized patients with ADHF and renal dysfunction. METHODS: This retrospective cohort study evaluated the efficacy and safety of oral metolazone versus IV chlorothiazide as add-on therapy to loop diuretics in patients hospitalized with ADHF and renal dysfunction. The primary endpoint was net urine output (UOP) at 72 h after initiation of thiazide-like diuretics. Safety endpoints included worsening renal function, hypotension, and electrolyte abnormalities. RESULTS: Fifty-five patients were enrolled with 33 patients receiving metolazone and 22 patients receiving chlorothiazide. There was no difference in median net UOP at 72 h in those receiving metolazone (4828 mL, interquartile range [IQR] 2800-7209 mL) compared to chlorothiazide (3779 mL, IQR 1885-6535 mL) (P = 0.16). There was no difference in hypotension, worsening renal function, hyponatremia, or hypokalemia (P = NS for all comparisons). Hospital length of stay was shorter in the metolazone cohort (median 7 days) compared to chlorothiazide (median 15 days), suggesting the chlorothiazide cohort was likely sicker. CONCLUSION: Sequential nephron blockade with either metolazone or chlorothiazide appears to be efficacious and safe in ADHF, renal dysfunction, and diuretic resistance. Given the considerable cost difference favoring oral metolazone, larger randomized studies are warranted to confirm our findings and to exclude the possibility of confounding by indication.},
author = {Moranville, Michael P. and Choi, Suji and Hogg, Jennifer and Anderson, Allen S. and Rich, Jonathan D.},
doi = {10.1111/1755-5922.12109},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2015 - Moranville et al. - Comparison of Metolazone Versus Chlorothiazide in Acute Decompensated Heart Failure with Diuretic Resistance.pdf:pdf},
isbn = {1755-5922 (Electronic)\r1755-5914 (Linking)},
issn = {17555922},
journal = {Cardiovascular Therapeutics},
keywords = {Chlorothiazide,Diuretics,Heart failure,Metolazone,Renal dysfunction},
number = {2},
pages = {42--49},
pmid = {25712736},
title = {{Comparison of Metolazone Versus Chlorothiazide in Acute Decompensated Heart Failure with Diuretic Resistance}},
volume = {33},
year = {2015}
}
@article{Crow2003,
abstract = {BACKGROUND: Heart rate-corrected QT interval (QTc) is the traditional method of assessing the duration of repolarization. Prolonged heart rate-corrected QT interval is associated with higher risk of mortality in patients with coronary heart disease (CHD) and in the general population. However, the QTc is typically not evaluated when QRS duration is > or =120 ms, because increased QRS duration (QRSd) contributes to QT interval prolongation. In these circumstances, the JT interval has been proposed as a more valid way to assess ventricular repolarization. METHODS AND RESULTS: To allow for variation in heart rate, corrected JT interval (JTc) was defined as QTc-QRSd. Using data from the Atherosclerosis Risk in Communities Study, JTc and QTc were compared for their prognostic associations with incident CHD events among 14 696 men and women who were CHD-free at baseline, having either normal conduction or wide QRS complex. Among individuals with normal QRS duration, logistic regression adjusted for age, hypertensive status, diabetes, race, systolic blood pressure, smoking, HDL and LDL cholesterol, R-R interval, and menopausal status in women showed QTc and JTc were nonpredictive of future coronary events in men but significant in women. In individuals with wide QRS complex (QRSd > or =120 ms), similar analyses showed JTc had a significant prognostic advantage compared with QTc in men but not in women, among whom only 11 events occurred. CONCLUSIONS: The JTc is a simple measurement that is a significant independent predictor of incident CHD events in men with wide QRS complex.},
author = {Crow, Richard S. and Hannan, Peter J. and Folsom, Aaron R.},
doi = {10.1161/01.CIR.0000095027.28753.9D},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2003 - Crow, Hannan, Folsom - Prognostic Significance of Corrected QT and Corrected JT Interval for Incident Coronary Heart Disease in a.pdf:pdf},
isbn = {1524-4539 (Electronic)\r0009-7322 (Linking)},
issn = {00097322},
journal = {Circulation},
keywords = {Bundle-branch block,Electrocardiography,Prognosis},
number = {16},
pages = {1985--1989},
pmid = {14517173},
title = {{Prognostic Significance of Corrected QT and Corrected JT Interval for Incident Coronary Heart Disease in a General Population Sample Stratified by Presence or Absence of Wide QRS Complex: The ARIC Study With 13 Years of Follow-Up}},
volume = {108},
year = {2003}
}
@article{Stern2012,
abstract = {This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the author's clinical recommendations. A 50-year-old woman with bipolar depression presents with a widespread pruritic rash of 1 day's duration. She is afebrile and otherwise well. She has a history of child-hood eczema and is allergic to sulfonamide antibiotics. Her medications include thy-roxine daily, naproxen intermittently, and lamotrigine, which she began taking 3 weeks earlier. How should this case be evaluated and treated? The Cl inic a l Probl em In the United States, patients fill more than 300 million drug prescriptions and purchase millions of over-the-counter medications each month. 1 In many cases patients are using these medications for the first time. Cutaneous reactions are among the most common adverse effects of drugs, including penicillins, cephalo-sporins, sulfonamide antimicrobial agents, and allopurinol (with an incidence of up to 50 cases per 1000 new users), and particularly the aromatic amine antiseizure medications, including carbamazepine, phenytoin, and lamotrigine (with an inci-dence of up to 100 cases per 1000 new users). 2-7 Drug-related rash is reported for nearly all prescription medications, usually at rates exceeding 10 cases per 1000 new users. These reactions can range from asymptomatic mild eruptions to life-threaten-ing conditions. Cutaneous reactions may be difficult to distinguish from common rashes that are unrelated to medication use, particularly viral exanthems. Exanthematous drug eruptions (also called morbilliform or maculopapular drug eruptions) are the most common drug-induced eruptions. 2,7 They and the much rarer and more serious StevensâJohnson syndrome (SJS), toxic epidermal necrolysis (TEN), acute generalized exanthematous pustulosis (AGEP), and drug reaction with eosinophilia and systemic symptoms (DRESS) are idiosyncratic, T-cellâmediated, delayed (type IV) hypersensitivity reactions. 8-11 Classically, antigen-presenting cells present haptens, composed of the drug or its metabolite bound to a protein or peptide, to naive T cells. These antigen-specific T cells proliferate, infiltrate the skin, and release cytokines, chemokines, and other proinflammatory mediators that are responsible for the signs and symptoms of the drug-related rash. 12-15 According to an alternative theory known as the p-i (pharmacologic interaction of drugs with immune receptors) concept, small-molecule drugs or their metabolites, which are not complete antigens, activate T cells directly by binding to T-cell receptors. 12,13},
author = {Stern, Robert S.},
doi = {10.1056/NEJMcp1104080},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2012 - Stern - Exanthematous Drug Eruptions.pdf:pdf},
isbn = {1533-4406 (Electronic)\r0028-4793 (Linking)},
issn = {0028-4793},
journal = {New England Journal of Medicine},
number = {26},
pages = {2492--2501},
pmid = {22738099},
title = {{Exanthematous Drug Eruptions}},
url = {http://www.nejm.org/doi/abs/10.1056/NEJMcp1104080},
volume = {366},
year = {2012}
}
@article{Weitz2017,
abstract = {Although many patients with venous thromboembolism require extended treatment, it is uncertain whether it is better to use full- or lower-intensity anticoagulation therapy or aspirin. METHODS In this randomized, double-blind, phase 3 study, we assigned 3396 patients with venous thromboembolism to receive either once-daily rivaroxaban (at doses of 20 mg or 10 mg) or 100 mg of aspirin. All the study patients had completed 6 to 12 months of anticoagulation therapy and were in equipoise regarding the need for continued anticoagulation. Study drugs were administered for up to 12 months. The primary efficacy outcome was symptomatic recurrent fatal or nonfatal venous thromboem- bolism, and the principal safety outcome was major bleeding. RESULTS A total of 3365 patients were included in the intention-to-treat analyses (median treatment duration, 351 days). The primary efficacy outcome occurred in 17 of 1107 patients (1.5%) receiving 20 mg of rivaroxaban and in 13 of 1127 patients (1.2%) receiving 10 mg of rivaroxaban, as compared with 50 of 1131 patients (4.4%) receiving aspirin (hazard ratio for 20 mg of rivaroxaban vs. aspirin, 0.34; 95% confidence interval [CI], 0.20 to 0.59; hazard ratio for 10 mg of rivaroxaban vs. aspirin, 0.26; 95% CI, 0.14 to 0.47; P<0.001 for both comparisons). Rates of major bleeding were 0.5% in the group receiving 20 mg of rivaroxaban, 0.4% in the group receiving 10 mg of rivaroxaban, and 0.3% in the aspirin group; the rates of clinically relevant nonmajor bleeding were 2.7%, 2.0%, and 1.8%, respectively. The incidence of adverse events was similar in all three groups. The authors' full names, academic de- grees, and affiliations are listed in the Appendix. Address reprint requests to Dr. Weitz at the Thrombosis and Athero- sclerosis Research Institute, 237 Barton St. E., Hamilton, ON L8L 2X2, Canada, or at weitzj@ taari . ca. * A list of the Reduced-dosed Rivaroxaban in the Long-term Prevention of Recur- rent Symptomatic Venous Thromboem- bolism (EINSTEIN CHOICE) investiga- tors and collaborators is provided in the Supplementary Appendix, available at NEJM.org. This article was published on March 18, 2017, at NEJM.org. DOI: 10.1056/NEJMoa1700518 Copyright {\textcopyright} 2017 Massachusetts Medical Society. CONCLUSIONS Among patients with venous thromboembolism in equipoise for continued anti- coagulation, the risk of a recurrent event was significantly lower with rivaroxaban at either a treatment dose (20 mg) or a prophylactic dose (10 mg) than with aspirin, without a significant increase in bleeding rates. (Funded by Bayer Pharmaceuticals; EINSTEIN CHOICE ClinicalTrials.gov number, NCT02064439.)},
author = {Weitz, Jeffrey I. and Lensing, Anthonie W.A. and Prins, Martin H. and Bauersachs, Rupert and Beyer-Westendorf, Jan and Bounameaux, Henri and Brighton, Timothy A. and Cohen, Alexander T. and Davidson, Bruce L. and Decousus, Herv{\'{e}} and Freitas, Maria C.S. and Holberg, Gerlind and Kakkar, Ajay K. and Haskell, Lloyd and van Bellen, Bonno and Pap, Akos F. and Berkowitz, Scott D. and Verhamme, Peter and Wells, Philip S. and Prandoni, Paolo},
doi = {10.1056/NEJMoa1700518},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2017 - Weitz et al. - Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.pdf:pdf},
isbn = {0028-4793 1533-4406},
issn = {0028-4793},
journal = {New England Journal of Medicine},
number = {13},
pages = {1211--1222},
pmid = {28316279},
title = {{Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism}},
url = {http://www.nejm.org/doi/10.1056/NEJMoa1700518},
volume = {376},
year = {2017}
}
@article{Wang2002,
abstract = {T he heart is a 4-chambered muscle that functions as a blood pump; the 2 upper chambers are called the atria and the 2 lower chambers are the ventricles. The rhythm of the heart is normally controlled by a natural pace- maker (the sinoatrial node) in the right upper chamber that beats about 60 times per minute at rest and can increase with exercise. Electrical impulses travel from the natural pacemaker through the atria, then pass through a filter called the atrioventricular node (AV) between the atria and ventricles before running down specialized fibers that activate the ven- tricles. (Figure},
author = {Wang, P. J.},
doi = {10.1161/01.CIR.0000044341.43780.C7},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2002 - Wang - Supraventricular Tachycardia.pdf:pdf},
issn = {00097322},
journal = {Circulation},
number = {25},
pages = {206e--208},
pmid = {12485968},
title = {{Supraventricular Tachycardia}},
url = {http://circ.ahajournals.org/cgi/doi/10.1161/01.CIR.0000044341.43780.C7},
volume = {106},
year = {2002}
}
@article{Krishna2009,
abstract = {Intra-aortic balloon pump (IABP) remains the most widely used circulatory assist device in critically ill patients with cardiac disease. The National Centre of Health Statistics estimated that IABP was used in 42 000 patients in the USA in 2002. Advances in technology, includ-ing percutaneous insertion, smaller diameter catheters, sheathless insertion techniques, and enhanced automation, have permitted the use of counterpulsation in a variety of settings, with greater efficacy and safety. History Kantrowitz 1 described augmentation of coronary blood flow by retardation of the arterial pressure pulse in animal models in 1952. In 1958, Harken 2 suggested the removal of some of the blood volume via the femoral artery during systole and replacing it rapidly in diastole as a treatment for left ventricular (LV) failure, so called diastolic augmentation. Four years later, Moulopoulos and colleagues 3 developed an experimental prototype of an IABP whose inflation and deflation were timed to the cardiac cycle. In 1968, Kantrowitz 1 reported improved systemic arterial pressure and urine output with the use of an IABP in two subjects with cardio-genic shock, one of who survived to hospital dis-charge. Percutaneous IABs in sizes 8.5â9.5 French (rather than 15 French used earlier) were introduced in 1979, and shortly after this, Bergman and colleagues 4 described the first per-cutaneous insertion of IABP. The first prefolded IAB was developed in 1986.},
author = {Krishna, Murli and Zacharowski, Kai},
doi = {10.1093/bjaceaccp/mkn051},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2009 - Krishna, Zacharowski - Principles of intra-aortic balloon pump counterpulsation.pdf:pdf},
isbn = {1472-2615\r1477-4518},
issn = {17431816},
journal = {Continuing Education in Anaesthesia, Critical Care and Pain},
month = {feb},
number = {1},
pages = {24--28},
title = {{Principles of intra-aortic balloon pump counterpulsation}},
url = {https://watermark.silverchair.com/mkn051.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAbQwggGwBgkqhkiG9w0BBwagggGhMIIBnQIBADCCAZYGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQM94FAirnZFceMOy8gAgEQgIIBZ6UY1VVRKtmTC2yN0hjPopF17Zf0aZlcEaNqFGRrrDO10swa},
volume = {9},
year = {2009}
}
@article{Jurado2001,
author = {Jurado, Rafael L},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2001 - Jurado - Why Shouldn ' t We Determine the Erythrocyte Sedimentation Rate SPURIOUSLY ELEVATE SPURIOUSLY DECREASE.pdf:pdf},
pages = {548--549},
title = {{Why Shouldn ' t We Determine the Erythrocyte Sedimentation Rate ? SPURIOUSLY ELEVATE SPURIOUSLY DECREASE}},
volume = {33},
year = {2001}
}
@article{Barold2014,
abstract = {In patients with pacemakers, hyperkalaemia causes three important abnormalities that usually become manifest when the K level exceeds 7 mEq/L: (i) widening of the paced QRS complex from delayed intraventricular conduction velocity, (ii) Increased atrial and ventricular pacing thresholds that may cause failure to capture. In this respect, the atria are more susceptible to loss of capture than the ventricles, and (iii) Increased latency (usually with ventricular pacing) manifested by a greater delay of the interval from the pacemaker stimulus to the onset of depolarization. First-degree ventricular pacemaker exit block may progress to second-degree Wenckebach (type I) exit block characterized by gradual prolongation of the interval from the pacemaker stimulus to the onset of the paced QRS complex ultimately resulting in an ineffectual stimulus. The disturbance may then progress to 2 : 1, 3 : 1 pacemaker exit block, etc., and eventually to complete exit block with total lack of capture. Ventricular undersensing is uncommonly observed because of frequent antibradycardia pacing. During managed ventricular pacing, hyperkalaemia-induced marked first-degree atrioventricular block may induce a pacemaker syndrome. With implantable cardioverter-defibrillators (ICDs) oversensing of the paced or spontaneous T-wave may occur. The latter may cause inappropriate shocks. A raised impedance from the right ventricular coil to the superior vena cava coil may become an important sign of hyperkalaemia in the asymptomatic or the minimally symptomatic ICD patient.},
author = {Barold, S. Serge and Herweg, Bengt},
doi = {10.1093/europace/eut383},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2014 - Barold, Herweg - The effect of hyperkalaemia on cardiac rhythm devices.pdf:pdf},
issn = {15322092},
journal = {Europace},
keywords = {Cardiac pacemaker,Hyperkalaemia,Implantable cardioverter-defibrillator,Oversensing by ICD,Pacemaker failure},
number = {4},
pages = {467--476},
pmid = {24465006},
title = {{The effect of hyperkalaemia on cardiac rhythm devices}},
volume = {16},
year = {2014}
}
@article{Sakao2014,
abstract = {The loss of pulmonary vessels has been shown to be related to the severity of pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD). The severity of hypoxaemia is also related to pulmonary hypertension and pulmonary vascular resistance in these patients, suggesting that the hypoxic condition probably plays an important role in this form of pulmonary hypertension. However, pulmonary hypertension also develops in patients with mild COPD without hypoxaemia. Oxygen supplementation therapy often fails to reverse the pulmonary hypertension in these COPD patients, thus suggesting that the pulmonary vascular alterations in those patients may involve different sites of the pulmonary vasculature or a different form of vascular remodelling. It has recently been demonstrated that pulmonary vascular remodelling, resulting in pulmonary hypertension in COPD patients, can develop independently from parenchymal destruction and loss of lung vessels. We wonder whether the changes in the lung microenvironment due to hypoxia and vessel loss have a causative role in the development of pulmonary hypertension in patients with COPD. Herein we review the pathobiological features of the pulmonary vasculature in COPD patients and suggest that pulmonary hypertension can occur with and without emphysematous lung tissue destruction and with and without loss of lung vessels.},
author = {Sakao, Seiichiro and Voelkel, Norbert F. and Tatsumi, Koichiro},
doi = {10.1183/09059180.00007913},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2014 - Sakao, Voelkel, Tatsumi - The vascular bed in COPD Pulmonary hypertension and pulmonary vascular alterations.pdf:pdf},
issn = {16000617},
journal = {European Respiratory Review},
number = {133},
pages = {350--355},
pmid = {25176971},
title = {{The vascular bed in COPD: Pulmonary hypertension and pulmonary vascular alterations}},
volume = {23},
year = {2014}
}
@article{Cosio2017,
abstract = {Clinical electrophysiology has made the traditional classification of rapid atrial rhythms into flutter and tachycardia of little clinical use. Electrophysiological studies have defined multiple mechanisms of tachycardia, both re-entrant and focal, with varying ECG morphologies and rates, authenticated by the results of catheter ablation of the focal triggers or critical isthmuses of re-entry circuits. In patients without a history of heart disease, cardiac surgery or catheter ablation, typical flutter ECG remains predictive of a right atrial re-entry circuit dependent on the inferior vena cavaâtricuspid isthmus that can be very effectively treated by ablation, although late incidence of atrial fibrillation remains a problem. Secondary prevention, based on the treatment of associated atrial fibrillation risk factors, is emerging as a therapeutic option. In patients subjected to cardiac surgery or catheter ablation for the treatment of atrial fibrillation or showing atypical ECG patterns, macro-re-entrant and focal tachycardia mechanisms can be very complex and electrophysiological studies are necessary to guide ablation treatment in poorly tolerated cases.},
author = {Cos{\'{i}}o, Francisco G},
doi = {10.15420/aer.2017.5.2},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2017 - Cos{\'{i}}o - Atrial Flutter, Typical and Atypical A Review.pdf:pdf},
issn = {2050-3369},
journal = {Arrhythmia & Electrophysiology Review},
keywords = {Typical atrial flutter,atypical atrial flutter,classification of atrial tachycardias,flutter ablation,macro-re-entrant atrial tachycardia},
month = {jun},
number = {2},
pages = {55},
pmid = {28835836},
publisher = {Radcliffe Cardiology},
title = {{Atrial Flutter, Typical and Atypical: A Review}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/28835836 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC5522718 https://www.aerjournal.com/articles/atrial-flutter-typical-and-atypical-review},
volume = {6},
year = {2017}
}
@article{Kapoor2000,
author = {Kapoor, W.N.},
doi = {10.1056/NEJM200012213432507},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2000 - Kapoor - a Seizure Focus Through Prolonged Electroencephalo- Graphic Monitoring.pdf:pdf},
issn = {0028-4793},
journal = {The New England journal of medicine},
number = {25},
pages = {1856--62},
pmid = {11117979},
title = {{a Seizure Focus Through Prolonged Electroencephalo- Graphic Monitoring.}},
volume = {343},
year = {2000}
}
@article{DuPont2014,
abstract = {In the United States, approximately 179 million cases of acute diarrhea occur each year, amounting to 0.6 bouts per person per year. In one study, the estimated prevalence of diarrhea among adults the month before questioning was 3 to 7%, with the rate dependent on age, and 8% among children 5 years of age or younger.1 A similar rate of acute diarrhea among adults was reported recently in Germany.2 In the United States, 83% of deaths from acute diarrhea occur in adults 65 years of age or older. Hospital-associated Clostridium difficileâassociated diarrhea is the most prevalent cause of fatal . . .},
author = {DuPont, Herbert L.},
doi = {10.1056/NEJMra1301069},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2014 - DuPont - Acute Infectious Diarrhea in Immunocompetent Adults.pdf:pdf},
isbn = {0028-4793},
issn = {0028-4793},
journal = {New England Journal of Medicine},
number = {16},
pages = {1532--1540},
pmid = {24738670},
title = {{Acute Infectious Diarrhea in Immunocompetent Adults}},
url = {http://www.nejm.org/doi/10.1056/NEJMra1301069},
volume = {370},
year = {2014}
}
@article{Dubois2017,
author = {Dubois, B and Wilcox, C and Weintraub, J and Susman, J and Sperling, D and Sheynzon, V and Schlossberg, P and Chheang, S and Reis, S and Mobley, D},
doi = {10.1016/j.jvir.2016.12.755},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2017 - Dubois et al. - Efficacy and safety of partial splenic embolization in patients with splenomegaly associated cytopenias.pdf:pdf},
issn = {10510443},
journal = {Journal of Vascular and Interventional Radiology},
number = {2},
pages = {S69--S70},
publisher = {Elsevier},
title = {{Efficacy and safety of partial splenic embolization in patients with splenomegaly associated cytopenias}},
url = {http://linkinghub.elsevier.com/retrieve/pii/S1051044316316529},
volume = {28},
year = {2017}
}
@article{Michaud2013,
abstract = {Coronary arteriograms in 113 patients whose cases were followed for 2 to 12 years were analyzed in an attempt to discover why in some patients with angina pectoris there are long stable clinical courses and in others the courses proceed rapidly to death. It was found that patients with completed coronary occlusions, usually with distal portions reconstituted by collateral, had favorable prognoses with prolonged longevity. Patients with multiple high grade narrowings of the coronary arteries, on the other hand, had poor prognoses with high attrition rates. The more stenotic lesions present in the coronary arteries, the higher the attrition rates. Completed coronary occlusions, therefore, have been classified as nonprecarious while local coronary stenoses greater than 50 percent of the lumen diameter have been classified as degrees of precariousness according to the number of lesions present. When compared with classification by number of diseased vessels and by arteriographic score of Friesinger, the nonprecarious cases had better prognoses than the precarious.},
author = {Michaud, Katarzyna},
doi = {10.1007 / 978-1-4471-2407-8_7},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2013 - Michaud - Ischemic Heart Disease.pdf:pdf},
isbn = {978-1-4471-2406-1},
issn = {0889-8537},
journal = {Cardiac Pathology},
number = {4},
pages = {117--131},
pmid = {442626},
title = {{Ischemic Heart Disease}},
url = {http://link.springer.com/10.1007/978-1-4471-2407-8_7%0Ahttp://dx.doi.org/10.1016/B978-0-12-386456-7.03305-0},
volume = {130},
year = {2013}
}
@article{Haghikia2013,
abstract = {Peripartum cardiomyopathy (PPCM) is a life-threatening heart disease developing towards the end of pregnancy or in the months following delivery in previously healthy women in terms of cardiac disease. Enhanced oxidative stress and the subsequent cleavage of the nursing hormone Prolactin into an anti-angiogenic 16 kDa subfragment emerged as a potential causal factor of the disease. We established a prospective registry with confirmed PPCM present in 115 patients (mean baseline left ventricular ejection fraction, LVEF: 27 +/- 9 %). Follow-up data (6 +/- 3 months) showed LVEF improvement in 85 % and full recovery in 47 % while 15 % failed to recover with death in 2 % of patients. A positive family history of cardiomyopathy was present in 16.5 %. Pregnancy-associated hypertension was associated with a better outcome while a baseline LVEF </= 25 % was associated with a worse outcome. A high recovery rate (96 %) was observed in patients obtaining combination therapy with beta-blocker, angiotensin-converting enzyme (ACE) inhibitors/angiotensin-receptor-blockers (ARBs) and bromocriptine. Increased serum levels of Cathepsin D, the enzyme that generates 16 kDa Prolactin, miR-146a, a direct target of 16 kDa Prolactin, N-terminal-pro-brain-natriuretic peptide (NT-proBNP) and asymmetric dimethylarginine (ADMA) emerged as biomarkers for PPCM. In conclusion, low baseline LVEF is a predictor for poor outcome while pregnancy-induced hypertensive disorders are associated with a better outcome in this European PPCM cohort. The high recovery rate in this collective is associated with a treatment concept using beta-blockers, ACE inhibitors/ARBs and bromocriptine. Increased levels of Cathepsin D activity, miR-146a and ADMA in serum of PPCM patients support the pathophysiological role of 16 kDa Prolactin for PPCM and may be used as a specific diagnostic marker profile.},
author = {Haghikia, A and Podewski, E and Libhaber, E and Labidi, S and Fischer, D and Roentgen, P and Tsikas, D and Jordan, J and Lichtinghagen, R and {Von Kaisenberg}, C. S. and Struman, I and Bovy, N and Sliwa, K and Bauersachs, J and Hilfiker-Kleiner, Denise},
doi = {10.1007/s00395-013-0366-9},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2013 - Haghikia et al. - Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopath.pdf:pdf},
isbn = {1435-1803 (Electronic)\r0300-8428 (Linking)},
issn = {03008428},
journal = {Basic Research in Cardiology},
keywords = {Biomarker,MicroRNA,Peripartum cardiomyopathy,Prolactin,Registry},
month = {jul},
number = {4},
pages = {366},
pmid = {23812247},
publisher = {Springer},
title = {{Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/23812247 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC3709080},
volume = {108},
year = {2013}
}
@article{Aguilera2011,
abstract = {Normal and abnormal radiographic appearances of cardiac conduction devices are presented, with emphasis on relevant chest radiographic anatomy and potential complications that may occur after implantation of these devices.},
author = {Aguilera, Amanda L. and Volokhina, Yulia V. and Fisher, Kendra L.},
doi = {10.1148/rg.316115529},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2011 - Aguilera, Volokhina, Fisher - Radiography of Cardiac Conduction Devices A Comprehensive Review.pdf:pdf},
isbn = {1527-1323 (Electronic)},
issn = {0271-5333},
journal = {RadioGraphics},
number = {6},
pages = {1669--1682},
pmid = {21997988},
title = {{Radiography of Cardiac Conduction Devices: A Comprehensive Review}},
url = {http://pubs.rsna.org/doi/10.1148/rg.316115529},
volume = {31},
year = {2011}
}
@article{Eifling2011,
abstract = {Electrical storm is an increasingly common and life-threatening syndrome that is defined by 3 or more sustained episodes of ventricular tachycardia, ventricular fibrillation, or appropriate shocks from an implantable cardioverter-defibrillator within 24 hours. The clinical presentation can be dramatic. Electrical storm can manifest itself during acute myocardial infarction and in patients who have structural heart disease, an implantable cardioverter-defibrillator, or an inherited arrhythmic syndrome. The presence or absence of structural heart disease and the electrocardiographic morphology of the presenting arrhythmia can provide important diagnostic clues into the mechanism of electrical storm. Electrical storm typically has a poor outcome.The effective management of electrical storm requires an understanding of arrhythmia mechanisms, therapeutic options, device programming, and indications for radiofrequency catheter ablation. Initial management involves determining and correcting the underlying ischemia, electrolyte imbalances, or other causative factors. Amiodarone and $\beta$-blockers, especially propranolol, effectively resolve arrhythmias in most patients. Nonpharmacologic treatment, including radiofrequency ablation, can control electrical storm in drug-refractory patients. Patients who have implantable cardioverter-defibrillators can present with multiple shocks and may require drug therapy and device reprogramming. After the acute phase of electrical storm, the treatment focus should shift toward maximizing heart-failure therapy, performing revascularization, and preventing subsequent ventricular arrhythmias. Herein, we present an organized approach for effectively evaluating and managing electrical storm.},
author = {Eifling, Michael and Razavi, Mehdi and Massumi, Ali},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2011 - Eifling, Razavi, Massumi - The evaluation and management of electrical storm.pdf:pdf},
isbn = {1068-607X},
issn = {1526-6702},
journal = {Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital},
keywords = {Anti-Arrhythmia Agents,Anti-Arrhythmia Agents: therapeutic use,Anti-arrhythmia agents/therapeutic use,Arrhythmias,Cardiac,Cardiac: diagnosis,Cardiac: physiopathology,Cardiac: therapy,Cardiomyopathies/complications,Catheter Ablation,Catheter ablation,Death,Defibrillators,Electric Countershock,Electric Countershock: instrumentation,Electrocardiography,Heart Conduction System,Heart Conduction System: physiopathology,Heart arrest/etiology/therapy,Humans,Implantable,Myocardial infarction/complications,Recurrence,Risk factors,Tachycardia,Treatment Outcome,Ventricular fibrillation/complications/diagnosis/d,cardiac/prevention and control,implantable/adverse effects,sudden,ventricular/complications/drug therap},
number = {2},
pages = {111--21},
pmid = {21494516},
title = {{The evaluation and management of electrical storm.}},
url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-79955117743&partnerID=tZOtx3y1%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3066819&tool=pmcentrez&rendertype=abstract},
volume = {38},
year = {2011}
}
@article{Kindermann2012,
abstract = {Myocarditis is an inflammatory disease of the heart frequently resulting from viral infections and/or post-viral immune-mediated responses. It is one of the important causes of dilated cardiomyopathy worldwide. The diagnosis is presumed on clinical presentation and noninvasive diagnostic methods such as cardiovascular magnetic resonance imaging. Endomyocardial biopsy remains the gold standard for in vivo diagnosis of myocarditis. The therapeutic and prognostic benefits of endomyocardial biopsy results have recently been demonstrated in several clinical trials. Although remarkable advances in diagnosis, understanding of pathophysiological mechanisms, and treatment of acute myocarditis were gained during the last years, no standard treatment strategies could be defined as yet, apart from standard heart failure therapy and physical rest. In severe cases, mechanical support or heart transplantation may become necessary. There is some evidence that immunosuppressive and immunomodulating therapy are effective for chronic, virus-negative inflammatory cardiomyopathy. Further investigations by controlled, randomized studies are needed to definitively determine their role in the treatment of myocarditis. {\textcopyright} 2012 American College of Cardiology Foundation.},
author = {Kindermann, Ingrid and Barth, Christine and Mahfoud, Felix and Ukena, Christian and Lenski, Matthias and Yilmaz, Ali and Klingel, Karin and Kandolf, Reinhard and Sechtem, Udo and Cooper, Leslie T. and Bhm, Michael},
doi = {10.1016/j.jacc.2011.09.074},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2012 - Kindermann et al. - Update on myocarditis.pdf:pdf},
isbn = {1558-3597 (Electronic)\r0735-1097 (Linking)},
issn = {07351097},
journal = {Journal of the American College of Cardiology},
keywords = {heart failure,inflammatory cardiomyopathy,myocarditis},
number = {9},
pages = {779--792},
pmid = {22361396},
publisher = {Elsevier Inc.},
title = {{Update on myocarditis}},
url = {http://dx.doi.org/10.1016/j.jacc.2011.09.074},
volume = {59},
year = {2012}
}
@article{Dodick2006,
abstract = {Col{\'{a}}s R, Munoz R, Temprano R, G{\'{o}}mez C, Pascual J. Chronic daily headache with analgesic overuse: Epidemiology and impact on quality of life.Neurology.2004;62:1338-1342.Objective:To analyze the prevalence and demography of chronic daily headache (CDH) with analgesic overuse.Methods:A population of 9984 inhabitants aged 14 or older living in Santo{\~{n}}a, Spain, was studied. The authors personally interviewed 4855 subjects, using a quota sampling approach. Those with headache for 10 days/month and some analgesic use were asked to fill in a diary over the course of 1 month. Then, subjects were classified into CDH with or without analgesic overuse subtypes. Quality of life (Short Form-36 Health Survey [SF-36]) was also assessed in this second interview.Results:Headache for 10 days/month with analgesic consumption was reported by 332 subjects. Seven had secondary headache. Seventy-four (standardized prevalence 1.41%, 95% CI 1.1 to 1.8) fulfilled the criteria for CDH with analgesic overuse. Prevalence in women (2.6%, 2.0 to 3.3) was much higher than in men (0.19%, 0.006 to 0.52). Mean age was 56 years (range 19 to 82 years). As recalled by the subjects, the mean age at onset of CDH was 38 years (range 9 to 82 years), whereas the mean age at onset of CDH with frequent analgesic consumption was 45 years (range 19 to 80 years) and that of primary headache was 22 years (range 5 to 60 years). CDH subjects showed a significant decrease in each SF-36 health-related score as compared with healthy control subjects. Transformed migraine was diagnosed in 49 (prevalence 0.9%), chronic tension-type headache in 20 (0.4%), and new daily persistent headache in 5 (0.1%). Thirty-five percent of patients overused simple analgesics, 22% ergotics, 12.5% opioids, and 2.7% triptans; the remaining 27.8% were overusing different combinations.Conclusion:CDH with analgesic overuse is a common disorder in the general population, mainly in women in their fifties, in whom 5% meet its diagnostic criteria.Comment: This paper is important and also worrying. Spain and other Latin countries have historically allowed access to prescription only medicines, via pharmacies, without a physician's authorization (I write this partly based on my own anecdotal experience of purchasing them without authorization). This probably explains the high proportion of ergot-related-analgesic abuse and may suggest the same fate for the triptans when they become more widely available. It would be helpful for the IHS and AHS to provide a framework to ensure responsible access to these important prescription-only pharmaceuticals.-David S. Millson Schulte-Mattler WJ, Krack P, BoNTTH Study Group. Treatment of chronic tension-type headache with botulinum toxin A: A randomized, double-blind, placebo-controlled multicenter study.Pain. 2004;109:110-114.A beneficial effect of botulinum toxin on tension-type headache was reported in open-label studies but scientifically rigorous clinical studies are lacking. Therefore we conducted a prospective, multicenter, randomized, double-blind, placebo-controlled trial. Multiple pericranial muscles of 112 patients with chronic tension-type headache were treated either with 500 mouse units of botulinum toxin (Dysport(R)) or with placebo. The diagnoses were made strictly following the International Headache Society criteria. Co-existence of migraine was an exclusion criterion. Injections were made following a fixed scheme and not adjusted to the patient's symptoms. Patients kept a headache diary that was used to calculate the area under the headache curve of 6 weeks before and 12 weeks after the treatment as the main effect measure. Secondary effect measures were the number of days with headache, the number of days with intake of analgesics, the duration of the nocturnal sleep, and the Beck Depression Inventory score. There were no significant differences between the verum group and the placebo group in any of these variables. Seven patients of the verum group had transient weakness of the eyelids, the neck, or both, indicating that a higher dose tha used in this study does not seem sensible for the treatment of headache. The statistical power of the study was high enough to warrant the conclusion that there is no clinically significant effect of botulinum toxin A on chronic tension-type headache.Comment: It is important to ensure that this study, which demonstrates convincingly that botulinum toxin A was ineffective in the treatment of chronic tension-type headache, is given an equal'share of voice' as other studies suggesting that this treatment is effective. I wonder if the pharmaceutical news wires and public relations teams of'Botox' companies will be supporting this dissemination? I suspect not.-David S. MillsonI have become convinced of the effectiveness of botulinum neurotoxins in prophylaxis for many patients with episodic and chronic primary headaches, so I have reviewed this article carefully. It is an excellent study, well conducted and described. So, the unexpected results are not due to poor design. However, over the years the methods of administering botulinum neurotoxin have changed, increasing in number of sites injected, and decreasing in doses per injection. This parallels the theory that the toxin may work in pain by inhibiting sensory afferent neuropeptide release rather than by paralyzing muscles, and so a wider cachement area makes sense for injections. Also, many clinicians have switched to a combination of fixed site injections and a'follow the pain' approach to inhibit the'noisy' afferents. In this study, very few injections were given, compared to what is widely done now in the US. For example, the investigators gave only two injections per side in frontalis, temporalis, and occipitalis, and only one injection per side in occipitalis, splenius capitis, semispinalis, and, most surprising to me, trapezius. Most injectors in the United States give more injections in most of these sites, especially frontalis, temporalis, and trapezius. It is possible that the negative results are a result of this difference in methodology. Three large placebo controlled regulatory studies on botulinum neurotoxin type A for various primary headache types are close to completion in the US, so we should get some of the answers on efficacy and methodology in the next year.-Stewart J. Tepper Zwart J.-A., Dyb G, K. Hagen K, Svebak S, Stovner LJ, and Holmen J. Analgesic overuse among subjects with headache, neck, and low-back pain.Neurology.2004;62:1540-1544.Objectives:To examine the prevalence of chronic headache (15 days/month) associated with analgesic overuse in relation to age and gender, and the association between analgesic overuse and chronic pain (i.e., migraine, non-migrainous headache, neck, and low-back pain).Methods:In the Nord-Tr{\o}ndelag Health Study 1995 to 1997 (HUNT-2), a total of 51,383 subjects responded to headache questions (Head-HUNT), of which 51,050 completed questions related to musculoskeletal symptoms and 49,064 questions regarding the use of analgesics.Results:The prevalence of chronic headache associated with analgesic use daily or almost daily for 1 month was 1% (1.3% for women and 0.7% for men) and for analgesic overuse duration of 3 months 0.9% (1.2% for women and 0.6% for men). Chronic headache was more than seven times more likely among those with analgesic overuse (1 month) than those without (odds ratio [OR]= 7.5, 95% CI: 6.6 to 8.5). Upon analysis of the different chronic pain subgroups separately, the association with analgesic overuse was strongest for chronic migraine (OR= 10.3, 95% CI: 8.1 to 13.0), intermediate for chronic nonmigrainous headache (OR= 6.2, 95% CI: 5.3 to 7.2), and weakest for chronic neck (OR= 2.6, 95% CI: 2.3 to 2.9) and chronic low-back (OR= 3.0, 95% CI: 2.7 to 3.3) pain. The association became stronger with increasing duration of analgesic use for all groups and was most evident among those with headache, especially those with migraine.Conclusions:Chronic headache associated with analgesic overuse is prevalent, and especially chronic migraine is more strongly associated with frequent intake of analgesics th n other common pain conditions like chronic neck and chronic low-back pain.},
author = {Dodick, David W.},
doi = {10.1056/NEJMcp042897},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2006 - Dodick - Chronic Daily Headache.pdf:pdf},
isbn = {0017-8748},
issn = {0028-4793},
journal = {New England Journal of Medicine},
number = {2},
pages = {158--165},
pmid = {21321350},
title = {{Chronic Daily Headache}},
url = {http://www.nejm.org/doi/abs/10.1056/NEJMcp042897},
volume = {354},
year = {2006}
}
@article{Madias2014,
abstract = {BACKGROUND AND OBJECTIVES: Currently, there are no specific diagnostic electrocardiogram (ECG) signs for Takotsubo syndrome (TTS) to differentiate it from acute coronary syndromes (ACS). Myocardial oedema has been detected by cardiac magnetic resonance imaging in patients with TTS. Recently it has been postulated that myocardial oedema may be the cause of low QRS voltage (LQRSV) in the admission ECG and attenuation of the amplitude of the QRS complexes (AAQRS) in serial ECGs, noted in a few published cases of patients with TTS. The objective of this study was to evaluate whether the admission ECG of patients with documented TTS reveals LQRSV and whether AAQRS is found when serial ECGs are compared in such patients.\n\nMETHODS: This study evaluated the prevalence of LQRSV in the admission ECG and AAQRS in serial ECGs in patients with TTS. ECGs of 368 patients with TTS from published reports in the international literature were evaluated for LQRSV (â¤5 mm in limb leads and/or â¤10 mm in precordial leads) and AAQRS in serial ECGs.\n\nRESULTS: LQRSV was seen in 91.5% of 200 patients with TTS and one ECG, with a distribution of 49.0, 42.8, 51.0, 52.0, and 46.9%, in lead aVR, and inferior, anterior, lateral, and high lateral ECG lead groups, respectively. AAQRS was seen in 93.5% of 168 patients with TTS and two or more ECGs, with a distribution of 78.3, 74.5, 60.1, 70.7, and 74.5% in lead aVR, and inferior, anterior, lateral, and high lateral ECG lead groups, respectively.\n\nCONCLUSIONS: LQRSV and AAQRS are highly prevalent ECG signs in patients with TTS, and should be useful in aiding in its diagnosis and differentiation from ACS, on first contact with the patient on admission to the hospital, and the ensuing 24 hours, in conjunction with echocardiography and coronary arteriography.},
author = {Madias, John E},
doi = {10.1177/2048872613504311},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2014 - Madias - Transient attenuation of the amplitude of the QRS complexes in the diagnosis of Takotsubo syndrome.pdf:pdf},
issn = {20488734},
journal = {European Heart Journal: Acute Cardiovascular Care},
keywords = {Attenuation of the QRS complexes,Takotsubo syndrome,cardiac magnetic resonance imaging,diagnosis,electrocardiogram,low ECG QRS voltage,myocardial oedema},
month = {mar},
number = {1},
pages = {28--36},
pmid = {24562801},
publisher = {SAGE Publications},
title = {{Transient attenuation of the amplitude of the QRS complexes in the diagnosis of Takotsubo syndrome}},
url = {www.ncbi.nlm.nih.gov/ http://journals.sagepub.com/doi/10.1177/2048872613504311 http://www.ncbi.nlm.nih.gov/pubmed/24562801 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC3932773},
volume = {3},
year = {2014}
}
@article{Schuetz2015,
abstract = {OBJECTIVE: To analyze prospectively the hypothalamic-pituitary-adrenal (HPA) axis and clinical outcome in patients treated with prednisone for exacerbated chronic obstructive pulmonary disease (COPD).\n\nDESIGN: Prospective observational study.\n\nSUBJECTS AND METHODS: Patients presenting to the emergency department were randomized to receive 40âmg prednisone daily for 5 or 14 days in a placebo-controlled manner. The HPA axis was longitudinally assessed with the 1â$\mu$g corticotropin test and a clinical hypocortisolism score at baseline, on day 6 before blinded treatment, at hospital discharge, and for up to 180 days of follow-up. Prednisone was stopped abruptly, irrespective of the test results. Patients discharged with pathological test results received instructions about emergency hydrocortisone treatment.\n\nRESULTS: A total of 311 patients were included in the analysis. Mean basal and stimulated serum total cortisol levels were highest on admission (496Â±398 and 816Â±413ânmol/l respectively) and lowest on day 6 (235Â±174 and 453Â±178ânmol/l respectively). Pathological stimulation tests were found in 63, 38, 9, 3, and 2% of patients on day 6, at discharge, and on days 30, 90, and 180 respectively, without significant difference between treatment groups. Clinical indicators of hypocortisolism did not correlate with stimulation test results, but cortisol levels were inversely associated with re-exacerbation risk. There were no hospitalizations or deaths as a result of adrenal crisis.\n\nCONCLUSION: Dynamic changes in the HPA axis occur during and after the treatment of acute exacerbations of COPD. In hypocortisolemic patients who were provided with instructions about stress prophylaxis, the abrupt termination of prednisone appeared safe.},
author = {Schuetz, Philipp and DLeuppi, J{\"{o}}rg and Bingisser, Roland and Bodmer, Michael and Briel, Matthias and Drescher, Tilman and Duerring, Ursula and Henzen, Christoph and Leibbrandt, Yolanda and Maier, Sabrina and Miedinger, David and Mueller, Beat and Scherr, Andreas and Schindler, Christian and Stoeckli, Rolf and Viatte, Sebastien and {Von Garnier}, Christophe and Tamm, Michael and Rutishauser, Jonas},
doi = {10.1530/EJE-15-0182},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2015 - Schuetz et al. - Prospective analysis of adrenal function in patients with acute exacerbations of COPD The reduction in the use o.pdf:pdf},
isbn = {0804-4643},
issn = {1479683X},
journal = {European Journal of Endocrinology},
number = {1},
pages = {19--27},
pmid = {25855628},
title = {{Prospective analysis of adrenal function in patients with acute exacerbations of COPD: The reduction in the use of corticosteroids in exacerbated COPD (REDUCE) trial}},
volume = {173},
year = {2015}
}
@article{Hurst2005a,
abstract = {The concept of the ventricular gradient was conceived in the mind of Frank Wilson in the early 1930s. Wilson, a mathematical genius, believed that the calculation of the ventricular gradient yielded information that was not otherwise obtainable. The method of analysis was not utilized by clinicians at large because the concept was not easy to understand and because the method used to compute the direction of the ventricular gradient was so time consuming that clinicians could not use it. Grant utilized the concept to create vector electrocardiography, but he believed that if his method of analysis was used, it was not often necessary to compute the direction of the ventricular gradient. He did, however, describe an easy way to compute the direction of the ventricular gradient. The current major clinical use of the ventricular gradient is to identify primary and secondary T-wave abnormalities in an electrocardiogram showing left or right ventricular hypertrophy or left or right ventricular conduction abnormalities. In addition, the author uses the term ventricular time gradient instead of ventricular gradient in an effort to clarify the concept. Finally, the author discusses the possible clinical significance of a normally directed, but shorter than normal, ventricular time gradient, an attribute that has not been emphasized previously.},
author = {Hurst, J. Willis},
doi = {10.1002/clc.4960280504},
file = {:Users/shahbook/Box Sync/Mendeley_Articles//2005 - Hurst - Thoughts about the ventricular gradient and its current clinical use.pdf:pdf;:Users/shahbook/Box Sync/Mendeley_Articles//2005 - Hurst - Thoughts about the ventricular gradient and its current clinical use.pdf:pdf},
isbn = {0160-9289 (Print)\r0160-9289 (Linking)},
issn = {01609289},
journal = {Clinical Cardiology},
keywords = {Ventricular time gradient},
number = {5},
pages = {219--224},
pmid = {15971455},
title = {{Thoughts about the ventricular gradient and its current clinical use}},
volume = {28},
year = {2005}
}
@article{McGee2003,
abstract = {No abstract},
author = {McGee, David C.; Gould Michael K.},
doi = {10.1056/NEJMra011883},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2003 - McGee - Preventing complications of central venous catheterization.pdf:pdf},
isbn = {1533-4406 (Electronic)\r0028-4793 (Linking)},
issn = {0028-4793},
journal = {The New England journal of medicine},
number = {26},
pages = {2684--2686; author reply 2684--2686},
pmid = {12830790},
title = {{Preventing complications of central venous catheterization.}},
url = {http://www.nejm.org/doi/pdf/10.1056/NEJMra011883},
volume = {348},
year = {2003}
}
@article{Hermans2013,
abstract = {IMPORTANCE: Rotator cuff disease (RCD) is the most common cause of shoulder pain seen by physicians. OBJECTIVE: To perform ameta-analysis to identify the most accurate clinical examination findings for RCD. DATA SOURCES: Structured search in MEDLINE, EMBASE, and CINAHL from their inception through May 2013. STUDY SELECTION: For inclusion, a study must havemet the following criteria: (1) description of history taking, physical examination, or clinical tests concerning RCD; (2) detailing of sensitivity and specificity; (3) use of a reference standard with diagnostic criteria prespecified; (4) presentation of original data, or original data could be obtained from the authors; and (5) publication in a language mastered by one of the authors (Danish, Dutch, English, French, German, Norwegian, Spanish, Swedish). MAIN OUTCOMES AND MEASURES: Likelihood ratios (LRs) of symptoms and signs of RCD or of a tear, compared with an acceptable reference standard; quality scores assigned using the Rational Clinical Examination score and bias evaluated with the Quality Assessment of Diagnostic Accuracy Studies tool. RESULTS: Twenty-eight studies assessed the examination of referred patients by specialists. Only 5 studies reached Rational Clinical Examination quality scores of level 1-2. The studies with quality scores of level 1-2 included 30 to 203 shoulders with the prevalence of RCD ranging from 33% to 81%. Among pain provocation tests, a positive painful arc test result was the only finding with a positive LR greater than 2.0 for RCD (3.7 [95% CI, 1.9-7.0]), and a normal painful arc test result had the lowest negative LR (0.36 [95% CI, 0.23-0.54]). Among strength tests, a positive external rotation lag test (LR, 7.2 [95% CI, 1.7-31]) and internal rotation lag test (LR, 5.6 [95% CI, 2.6-12]) were the most accurate findings for full-thickness tears. A positive drop arm test result (LR, 3.3 [95% CI, 1.0-11]) might help identify patients with RCD. A normal internal rotation lag test result was most accurate for identifying patients without a full-thickness tear (LR, 0.04 [95% CI, 0.0-0.58]). CONCLUSIONS AND RELEVANCE: Because specialists performed all the clinical maneuvers for RCD in each of the included studies with no finding evaluated in more than 3 studies, the generalizability of the results to a nonreferred population is unknown. A positive painful arc test result and a positive external rotation resistance test result were the most accurate findings for detecting RCD, whereas the presence of a positive lag test (external or internal rotation) result was most accurate for diagnosis of a full-thickness rotator cuff tear.},
author = {Hermans, Job and Luime, Jolanda J. and Meuffels, Duncan E. and Reijman, Max and Simel, David L. and Bierma-Zeinstra, Sita M.A.},
doi = {10.1001/jama.2013.276187},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2013 - Hermans et al. - Does this patient with shoulder pain have rotator cuff disease The rational clinical examination systematic revi.pdf:pdf},
issn = {00987484},
journal = {JAMA - Journal of the American Medical Association},
number = {8},
pages = {837--847},
pmid = {23982370},
title = {{Does this patient with shoulder pain have rotator cuff disease? The rational clinical examination systematic review}},
volume = {310},
year = {2013}
}
@article{Catanzaro2008,
abstract = {T-wave inversions produced by myocardial infarction (MI) are classically narrow and symmetric. Electrocardiography T-wave changes including low-amplitude and abnormally inverted T waves may be the result of noncardiac path physiology. We present a series of cases that presented with different electrocardiography T-wave changes. The first case involved a 64-year-old woman who presented to the emergency department with diffuse splayed T-wave inversions and was found to have an MI in the context of an acute cerebrovascular accident. We contrasted this case with that of a 76-year-old man with hypercholesterolemia who presented with T-wave widening and a prolonged QT interval and was found to have a subarachnoid hemorrhage secondary to a basilar aneurysm and no MI. Several mechanisms have been suggested to explain the cardiac and cerebral injury, including microvascular spasm and increased levels of circulating catecholamines. Accurate interpretation of T-wave changes can assist the clinician toward a timely therapeutic intervention and accurate diagnosis. {\textcopyright} 2008 Elsevier Inc. All rights reserved.},
author = {Catanzaro, John N. and Meraj, Perwaiz M. and Zheng, Shuyi and Bloom, Gregory and Roethel, Marie and Makaryus, Amgad N.},
doi = {10.1016/j.ajem.2007.10.017},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2008 - Catanzaro et al. - Electrocardiographic T-wave changes underlying acute cardiac and cerebral events.pdf:pdf},
isbn = {1532-8171 (Electronic)\n0735-6757 (Linking)},
issn = {07356757},
journal = {American Journal of Emergency Medicine},
month = {jul},
number = {6},
pages = {716--720},
pmid = {18606329},
publisher = {W.B. Saunders},
title = {{Electrocardiographic T-wave changes underlying acute cardiac and cerebral events}},
url = {https://www-sciencedirect-com.proxy.library.emory.edu/science/article/pii/S0735675707006857?via%3Dihub},
volume = {26},
year = {2008}
}
@article{Gams2018,
author = {Gams, M A J Richard A and Neal, M A J Joseph A and Antonio, San},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2018 - Gams, Neal, Antonio - Hydantoin-Induced Pseudo-Pseudolymphoma.pdf:pdf},
number = {December 1961},
title = {{Hydantoin-Induced Pseudo-Pseudolymphoma}},
year = {2018}
}
@article{Perloff2011,
abstract = {Dextrocardia was known in the 17th century and was 1 of the first congenital malformations of the heart to be recognized. Fifty years elapsed before Matthew Baillie published his account of complete transposition in a human of the thoracic and abdominal viscera to the opposite side from what is natural. In 1858, Thomas Peacock stated that "the heart may be congenitally misplaced in various ways, occupying either an unusual position within the thorax, or being situated external to that cavity." In 1915, Maude Abbott described ectopia cordis, and Richard Paltauf's remarkable illustrations distinguished the various types of dextrocardia. In 1928, the first useful classification of the cardiac malpositions was proposed, and in 1966, Elliott et al's radiologic classification set the stage for clinical recognition. The first section of this review deals with the 3 basic cardiac malpositions in the presence of bilateral asymmetry. The second section deals with cardiac malpositions in the presence of bilateral left-sidedness or right-sidedness. Previous publications on cardiac malpositions are replete with an arcane vocabulary that confounds rather than clarifies. Even if the terms themselves are understood, inherent complexity weighs against clarity. This review was designed as a guided tour of an unfamiliar subject. {\textcopyright} 2011 Elsevier Inc. All rights reserved.},
author = {Perloff, Joseph K},
doi = {10.1016/j.amjcard.2011.06.055},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2011 - Perloff - The cardiac malpositions.pdf:pdf},
isbn = {1879-1913 (Electronic)\r0002-9149 (Linking)},
issn = {00029149},
journal = {American Journal of Cardiology},
number = {9},
pages = {1352--1361},
pmid = {21861958},
title = {{The cardiac malpositions}},
url = {www.ajconline.org},
volume = {108},
year = {2011}
}
@article{JouppilaP1989,
author = {{Jouppila P} and {Kirkinen P.}},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/1989 - Jouppila P, Kirkinen P. - Noninvasive assessment.pdf:pdf},
journal = {Clinical Obstetrics & Gynecology},
number = {4},
pages = {703--709},
title = {{Noninvasive assessment}},
volume = {32},
year = {1989}
}
@article{Wang2017,
author = {Wang, Binhao and Zhang, Li and Cong, Peixin and Chu, Huimin and Liu, Ying and Liu, Jinqiu and Surkis, William and Xia, Yunlong},
doi = {10.1111/jce.13203},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2017 - Wang et al. - A New Formula for Estimating the True QT Interval in Left Bundle Branch Block.pdf:pdf},
issn = {15408167},
journal = {Journal of Cardiovascular Electrophysiology},
keywords = {JT index,QT formula,QT interval,acquired long-QT syndrome,left bundle branch block},
number = {6},
pages = {684--689},
pmid = {28297125},
title = {{A New Formula for Estimating the True QT Interval in Left Bundle Branch Block}},
volume = {28},
year = {2017}
}
@article{Thwaites2017a,
abstract = {F ever in the returning traveler is a common clinical scenario that often leads to hospitalization and may be the only symptom of a serious or life-threatening illness. 1 Three percent of 784 Americans who traveled abroad for short periods reported an episode of febrile illness, 2 and fever was the chief symptom in 28% of 24,920 ill travelers who presented to travel clinics on their return home. 3 The absolute number of travelers is large and rising, with the International Tourism Organization reporting 1.2 billion trips in 2015, an increase of 4.4% from the previous year. 4 The challenge presented by returning travelers with febrile illnesses is changing for two reasons. First, increasing numbers of travelers are older than 60 years of age or are seeking health care elsewhere (" medical tour-ists "), and these travelers are more likely than others to have clinically significant coexisting conditions and consequently increased morbidity from infections. Sec-ond, the likelihood of multidrug resistance in the infecting organisms is increas-ing. 5-7 The recent Ebola epidemic in West Africa, the emergence of the Middle East respiratory syndrome coronavirus (MERS-CoV), and the reemergence of Zika and chikungunya viruses have highlighted the importance of being alert to the possi-bility that an emerging pathogen is causing a febrile episode. Fever in the returning traveler is an evolving clinical challenge, with respect to both the infections responsible for the fever and the sources and quality of informa-tion available to assist the physician. We review available sources of global informa-tion on outbreaks and the epidemiologic features of infectious diseases and offer a practical approach to emerging or transmissible infectious diseases that may pose a life-threatening risk to patients, as well as clinicians and laboratory workers. Surv eill a nce a nd Sources of Infor m ation},
author = {Thwaites, Guy E. and Day, Nicholas P.J.},
doi = {10.1056/NEJMra1508435},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2017 - Thwaites, Day - Estudio de fiebre en el viajero.pdf:pdf},
issn = {0028-4793},
journal = {New England Journal of Medicine},
number = {6},
pages = {548--560},
pmid = {28177860},
title = {{Estudio de fiebre en el viajero}},
url = {http://www.nejm.org/doi/10.1056/NEJMra1508435},
volume = {6},
year = {2017}
}
@article{Wadei2006,
abstract = {Anatomic and physiologic changes introduced by gastric surgery result in clinically significant dumping syndrome in approximately 10% of patients. Dumping is the effect of alteration in the motor functions of the stomach, including disturbances in the gastric reservoir and transporting function. Gastrointestinal hormones play an important role in dumping by mediating responses to surgical resection. Treatment options of dumping syndrome include diet, medications, and surgical revision. Poor nutrition status can be anticipated in patients who fail conservative therapy. Management of refractory dumping syndrome can be a challenge. This review highlights current knowledge about the mechanisms of dumping syndrome and available therapy.},
author = {Wadei, Hani M. and Mai, Martin L. and Ahsan, Nasimul and Gonwa, Thomas A.},
doi = {10.2215/CJN.01340406},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2006 - Wadei et al. - Hepatorenal syndrome pathophysiology and management.pdf:pdf},
isbn = {9042969075},
issn = {1555905X},
journal = {Clinical journal of the American Society of Nephrology : CJASN},
number = {5},
pages = {1066--1079},
pmid = {17699328},
title = {{Hepatorenal syndrome: pathophysiology and management.}},
volume = {1},
year = {2006}
}
@article{Kissling2014,
abstract = {STUDY OBJECTIVE: To compare the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide added to background intravenous loop diuretic therapy among patients hospitalized with heart failure.\n\nDESIGN: Single-center, retrospective review.\n\nSETTING: Cardiovascular hospital within a university-affiliated teaching institution.\n\nPATIENTS: Eighty-two patients hospitalized for heart failure between September 1, 2009, and August 31, 2011, who were receiving background intravenous furosemide therapy (total daily doseÂ â¥Â 160Â mg); of those patients, 28 patients also received oral hydrochlorothiazide (median dose 25Â mg [interquartile range 25-50Â mg]), and 54 patients also received intravenous chlorothiazide (median dose 500Â mg [interquartile range 250-750Â mg]).\n\nMEASUREMENTS AND MAIN RESULTS: The primary outcome was change in 24-hour urine output. Urine output was recorded from the 24Â hours before and after the first administration of either oral hydrochlorothiazide or intravenous chlorothiazide. Baseline characteristics, with the exception of female sex (p=0.01) and home loop diuretic dose (p=0.03), were similar between groups. Twenty-four-hour urine output before administration of the thiazide diuretic was not significantly different between groups. After treatment, 24-hour urine output increased in both groups; however, urine output increased to a lesser extent with oral hydrochlorothiazide (from meanÂ Â±Â SD 2104Â Â±Â 830Â ml to 3038Â Â±Â 917Â ml) than with intravenous chlorothiazide (from 2342Â Â±Â 978Â ml to 4128Â Â±Â 1755Â ml) (p=0.005). Hypokalemia occurred frequently in both groups: 71.4% and 83.3% in the oral hydrochlorothiazide and intravenous chlorothiazide groups, respectively (p=0.21).\n\nCONCLUSION: Among hospitalized patients with heart failure receiving intravenous loop diuretics, the addition of either oral hydrochlorothiazide or intravenous chlorothiazide augmented diuresis. Urine output increased to a greater extent with intravenous chlorothiazide compared with oral hydrochlorothiazide. However, given the positive response observed, ease of administration, and lower drug cost, oral hydrochlorothiazide should still be considered as an option for combination diuretic therapy in this patient population.},
author = {Kissling, Kevin T. and Pickworth, Kerry K.},
doi = {10.1002/phar.1456},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2014 - Kissling, Pickworth - Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlo.pdf:pdf},
isbn = {0277-0008},
issn = {18759114},
journal = {Pharmacotherapy},
keywords = {combination therapy,heart failure,thiazide diuretics},
number = {8},
pages = {882--887},
pmid = {24990816},
title = {{Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure}},
volume = {34},
year = {2014}
}
@article{Tassaux2005,
abstract = {RATIONALE: During pressure-support ventilation, the ventilator cycles into expiration when inspiratory flow decreases to a given percentage of peak inspiratory flow ("expiratory trigger"). In obstructive disease, the slower rise and decrease of inspiratory flow entails delayed cycling, an increase in intrinsic positive end-expiratory pressure, and nontriggering breaths. OBJECTIVES: We hypothesized that setting expiratory trigger at a higher than usual percentage of peak inspiratory flow would attenuate the adverse effects of delayed cycling. METHODS: Ten intubated patients with obstructive disease undergoing pressure support were studied at expiratory trigger settings of 10, 25, 50, and 70% of peak inspiratory flow. MEASUREMENTS: Continuous recording of diaphragmatic EMG activity with surface electrodes, and esophageal and gastric pressures with a dual-balloon nasogastric tube. MAIN RESULTS: Compared with expiratory trigger 10, expiratory trigger 70 reduced the magnitude of delayed cycling (0.25 +/- 0.18 vs. 1.26 +/- 0.72 s, p < 0.05), intrinsic positive end-expiratory pressure (4.8 +/- 1.9 vs. 6.5 +/- 2.2 cm H(2)O, p < 0.05), nontriggering breaths (2 +/- 3 vs. 9 +/- 5 breaths/min, p < 0.05), and triggering pressure-time product (0.9 +/- 0.8 vs. 2.1 +/- 0.7 cm H2O . s, p < 0.05). CONCLUSIONS: Setting expiratory trigger at a higher percentage of peak inspiratory flow in patients with obstructive disease during pressure support improves patient-ventilator synchrony and reduces inspiratory muscle effort. Further studies should explore whether these effects can influence patient outcome.},
author = {Tassaux, Didier and Gainnier, Marc and Battisti, Anne and Jolliet, Philippe},
doi = {10.1164/rccm.200407-880OC},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2005 - Tassaux et al. - Impact of expiratory trigger setting on delayed cycling and inspiratory muscle workload.pdf:pdf},
isbn = {1073-449X (Print)\r1073-449X (Linking)},
issn = {1073449X},
journal = {American Journal of Respiratory and Critical Care Medicine},
keywords = {Chronic obstructive pulmonary disease,Cycling,Expiratory trigger,Mechanical ventilation,Pressure support},
number = {10},
pages = {1283--1289},
pmid = {16109983},
title = {{Impact of expiratory trigger setting on delayed cycling and inspiratory muscle workload}},
volume = {172},
year = {2005}
}
@article{Idell2018,
author = {Idell, Steven and Rahman, Najib M.},
doi = {10.1513/AnnalsATS.201711-848PS},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2018 - Idell, Rahman - Intrapleural fibrinolytic therapy for empyema and pleural loculation Knowns and unknowns.pdf:pdf},
issn = {23256621},
journal = {Annals of the American Thoracic Society},
keywords = {Complicated parapneumonic pleural effusions,Empyema,Fibrinolysins,Plasminogen activator inhibitor-1,Plasminogen activators},
number = {5},
pages = {515--517},
pmid = {29361235},
title = {{Intrapleural fibrinolytic therapy for empyema and pleural loculation: Knowns and unknowns}},
volume = {15},
year = {2018}
}
@article{Dungu2014,
abstract = {Objectives This study was devised to describe the different cardiac magnetic resonance (CMR) appearances in light chain amyloid (AL) and transthyretin-related amyloidosis (ATTR). Background CMR is increasingly used to investigate patients with suspected amyloidosis. Global subendocardial late gadolinium enhancement (LGE) has been reported as typical of AL amyloidosis, whereas different patterns have been noted in ATTR amyloidosis. Methods We performed de novo analyses on original DICOM magnetic resonance imaging in 46 patients with cardiac AL amyloidosis and 51 patients with ATTR type who had been referred to a specialist amyloidosis center between 2007 and 2012 after CMR. Histological examination was performed in all cases, with immunohistochemistry, to confirm systemic amyloidosis. Results Patients' median age was 68 Â± 10 years, and 74% were male. Left ventricular mass was markedly increased in ATTR amyloidosis (228 g [202 to 267 g]) compared with AL type (167 g [137 to 191 g]) (p < 0.001). LGE was detected in all but 1 cardiac amyloidosis patient (AL type) and was substantially more extensive in ATTR compared with AL amyloidosis. Ninety percent of ATTR patients demonstrated transmural LGE compared with 37% of AL patients (p < 0.001). Right ventricular LGE was apparent in all ATTR patients but in only 33 AL patients (72%) (p < 0.001). Despite these findings, survival was significantly better in cardiac ATTR amyloidosis compared with AL type. We derived an LGE scoring system (Query Amyloid Late Enhancement) that independently differentiated ATTR from AL amyloidosis and, when incorporated into a logistic regression model with age and wall thickness, detected ATTR type with 87% sensitivity and 96% specificity. Conclusions Transmural patterns of LGE distinguished ATTR from AL cardiac amyloidosis with high accuracy in this real-world analysis of CMR. Precise diagnosis of cardiac amyloidosis is crucial given the role of chemotherapy in AL type and with novel therapies for ATTR type currently in development.},
author = {Dungu, Jason N. and Valencia, Oswaldo and Pinney, Jennifer H. and Gibbs, Simon D J and Rowczenio, Dorota and Gilbertson, Janet A. and Lachmann, Helen J. and Wechalekar, Ashutosh and Gillmore, Julian D. and Whelan, Carol J. and Hawkins, Philip N. and Anderson, Lisa J.},
doi = {10.1016/j.jcmg.2013.08.015},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2014 - Dungu et al. - CMR-based differentiation of AL and ATTR cardiac amyloidosis.pdf:pdf},
issn = {1936878X},
journal = {JACC: Cardiovascular Imaging},
keywords = {amyloid,cardiomyopathy,magnetic resonance imaging},
number = {2},
pages = {133--142},
pmid = {24412186},
title = {{CMR-based differentiation of AL and ATTR cardiac amyloidosis}},
volume = {7},
year = {2014}
}
@article{Vandenberk2016,
abstract = {BACKGROUND Drug safety precautions recommend monitoring of the corrected QT interval. To determine which QT correction formula to use in an automated QT-monitoring algorithm in our electronic medical record, we studied rate correction performance of different QT correction formulae and their impact on risk assessment for mortality. METHODS AND RESULTS All electrocardiograms (ECGs) in patients >18Â years with sinus rhythm, normal QRS duration and rate <90Â beats per minute (bpm) in the University Hospitals of Leuven (Leuven, Belgium) during a 2-month period were included. QT correction was performed with Bazett, Fridericia, Framingham, Hodges, and Rautaharju formulae. In total, 6609 patients were included (age, 59.8Â±16.2Â years; 53.6% male and heart rate 68.8Â±10.6Â bpm). Optimal rate correction was observed using Fridericia and Framingham; Bazett performed worst. A healthy subset showed 99% upper limits of normal for Bazett above current clinical standards: men 472Â ms (95% CI, 464-478Â ms) and women 482Â ms (95% CI 474-490Â ms). Multivariate Cox regression, including age, heart rate, and prolonged QTc, identified Framingham (hazard ratio [HR], 7.31; 95% CI, 4.10-13.05) and Fridericia (HR, 5.95; 95% CI, 3.34-10.60) as significantly better predictors of 30-day all-cause mortality than Bazett (HR, 4.49; 95% CI, 2.31-8.74). In a point-prevalence study with haloperidol, the number of patients classified to be at risk for possibly harmful QT prolongation could be reduced by 50% using optimal QT rate correction. CONCLUSIONS Fridericia and Framingham correction formulae showed the best rate correction and significantly improved prediction of 30-day and 1-year mortality. With current clinical standards, Bazett overestimated the number of patients with potential dangerous QTc prolongation, which could lead to unnecessary safety measurements as withholding the patient of first-choice medication.},
author = {Vandenberk, Bert and Vandael, Eline and Robyns, Tomas and Vandenberghe, Joris and Garweg, Christophe and Foulon, Veerle and Ector, Joris and Willems, Rik},
doi = {10.1161/JAHA.116.003264},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2016 - Vandenberk et al. - Which QT correction formulae to use for QT monitoring.pdf:pdf},
isbn = {2047-9980},
issn = {20479980},
journal = {Journal of the American Heart Association},
keywords = {Electrocardiography,Mortality,Population,QT interval electrocardiography,Risk factors,Risk prediction},
number = {6},
pmid = {27317349},
title = {{Which QT correction formulae to use for QT monitoring?}},
volume = {5},
year = {2016}
}
@article{Butalia2016,
author = {Butalia, Sonia and Palda, Valerie A},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2016 - Butalia, Palda - CLINICIAN ' S CORNER Does This Patient With Diabetes Have Osteomyelitis of the Lower Extremity.pdf:pdf},
number = {7},
title = {{CLINICIAN ' S CORNER Does This Patient With Diabetes Have Osteomyelitis of the Lower Extremity ?}},
volume = {299},
year = {2016}
}
@article{Drazner2008,
abstract = {BACKGROUND: We determined whether estimated hemodynamics from history and physical examination (H&P) reflect invasive measurements and predict outcomes in advanced heart failure (HF). The role of the H&P in medical decision making has declined in favor of diagnostic tests, perhaps due to lack of evidence for utility.\n\nMETHODS AND RESULTS: We compared H&P estimates of filling pressures and cardiac index with invasive measurements in 194 patients in the ESCAPE trial. H&P estimates were compared with 6-month outcomes in 388 patients enrolled in ESCAPE. Measured right atrial pressure (RAP) was <8 mm Hg in 82% of patients with RAP estimated from jugular veins as <8 mm Hg, and was >12 mm Hg in 70% of patients when estimated as >12 mm Hg. From the H&P, only estimated RAP > or =12 mm Hg (odds ratio [OR] 4.6; P<0.001) and orthopnea > or =2 pillows (OR 3.6; P<0.05) were associated with pulmonary capillary wedge pressure (PCWP) > or =30 mm Hg. Estimated cardiac index did not reliably reflect measured cardiac index (P=0.09), but "cold" versus "warm" profile was associated with lower median measured cardiac index (1.75 vs. 2.0 L/min/m(2); P=0.004). In Cox regression analysis, discharge "cold" or "wet" profile conveyed a 50% increased risk of death or rehospitalization.\n\nCONCLUSIONS: In advanced HF, the presence of orthopnea and elevated jugular venous pressure are useful to detect elevated PCWP, and a global assessment of inadequate perfusion ("cold" profile) is useful to detect reduced cardiac index. Hemodynamic profiles estimated from the discharge H&P identify patients at increased risk of early events.},
author = {Drazner, Mark H. and Hellkamp, Anne S. and Leier, Carl V. and Shah, Monica R. and Miller, Leslie W. and Russell, Stuart D. and Young, James B. and Califf, Robert M. and Nohria, Anju},
doi = {10.1161/CIRCHEARTFAILURE.108.769778},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2008 - Drazner et al. - Value of clinician assessment of hemodynamics in advanced heart failure the ESCAPE trial.pdf:pdf},
isbn = {1941-3297 (Electronic)\r1941-3289 (Linking)},
issn = {19413297},
journal = {Circulation. Heart failure},
keywords = {and physical examination,diagnosis â² heart failure,emphasis on h,examination,h,has been,he role of the,history and physical,p,p examination,patient care,threatened by the declining,traditionally the cornerstone of,â² hemodynamics â² history},
number = {3},
pages = {170--177},
pmid = {19675681},
title = {{Value of clinician assessment of hemodynamics in advanced heart failure: the ESCAPE trial.}},
volume = {1},
year = {2008}
}
@article{Kaushik2000,
abstract = {Bradycardia is common in critical care units. It may be transient, asymptomatic and of little consequence, or life-threatening. Bradycardia may result from abnormalities of the sinus node, atrioventricular node, or the His-Purkinje system. It may also be precipitated by drug effects or enhanced vagal tone. Proper diagnosis is pivotal to determining prognosis and management. Temporary and permanent pacing is now readily available, markedly improving the morbidity and mortality associated with bradyarrhythmias.},
author = {Kaushik, V and Leon, A R and Forrester, J S and Trohman, R G},
doi = {10.1097/00003246-200010001-00003},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2000 - Kaushik et al. - Bradyarrhythmias, temporary and permanent pacing.pdf:pdf},
issn = {0090-3493},
journal = {Critical care medicine},
number = {10 Suppl},
pages = {N121--N128},
pmid = {11055680},
title = {{Bradyarrhythmias, temporary and permanent pacing}},
volume = {28},
year = {2000}
}
@article{Anderson1987,
abstract = {The difference in death rate among medical and surgical inpatients having alkalemia is incompletely defined. This prospective study was done to identify the incidence, mortality, and clinical factors that resulted in a poor outcome in both groups of patients. We screened a total of 10,811 consecutive arterial blood gas values; in 4,427 (40.9%) the pH was greater than 7.44, and in 2,577 (23.8%) the pH was greater than 7.48. The study group consisted of 409 patients (213 medical, 196 surgical) whose pH value was greater than 7.48; 253 of these patients (61.9%) had pure respiratory alkalosis, 120 (29.3%) had mixed respiratory and metabolic alkalosis, 27 (6.6%) had a mixed acid base disorder, and nine (2.2%) had pure metabolic alkalosis. Overall group mortality was 27.9% and increased as pH values rose, reaching 48.5% when the pH was greater than 7.60. The overall mortality among medical patients (36.6%) exceeded that among the surgical patients (12.4%) (P less than .05), an observation that applied over a wide range of pH values. Patients having mixed respiratory and metabolic alkalosis had a significantly poorer outcome (44.2% mortality) than the alkalemic group as a whole (27.9% mortality) (P less than .05). Alkalemia-associated illnesses are common in hospitalized patients and are associated with high mortality in both medical and surgical patients, though the death rate is higher among medical patients. Mixed respiratory and metabolic alkalosis appears to be associated with a particularly poor prognosis.},
author = {Anderson, L E and Henrich, W L},
issn = {0038-4348 (Print)},
journal = {Southern medical journal},
keywords = {Alkalosis,Artificial,Blood,Blood Gas Analysis,Hospitalization,Humans,Hydrogen-Ion Concentration,Length of Stay,Prognosis,Prospective Studies,Respiration,Respiratory,adverse effects,epidemiology,etiology,mortality},
month = {jun},
number = {6},
pages = {729--733},
pmid = {3589765},
title = {{Alkalemia-associated morbidity and mortality in medical and surgical patients.}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/3589765},
volume = {80},
year = {1987}
}
@article{Konstantinides2008a,
author = {Konstantinides, Stavros},
doi = {10.1056/NEJMra072753},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2008 - Konstantinides - Acute Pulmonary Embolism.pdf:pdf},
isbn = {1533-4406},
issn = {1533-4406},
journal = {Health (San Francisco)},
pmid = {18322285},
title = {{Acute Pulmonary Embolism}},
year = {2008}
}
@article{Sahn1978,
abstract = {Four hundred M-mode echocardiographic surveys were distributed to determine interobserver variability in M-mode echocardiographic measurements. This was done with a view toward examining the need and determining the criteria for standardization of measurement. Each survey consisted of five M-mode echocardiograms with a calibration marker, measured by the survey participants anonymously. The echoes were judged of adequate quality for measurement of structures. Seventy-six of the 400 (19%) were returned, allowing comparison of interobserver variability as well as examination of the measurement criteria which were used. Mean measurements and percent uncertainty were derived for each structure for each criterion of measurement. For example, for the aorta, 33% of examiners measured the aorta as an outer/inner or leading edge dimension, and 20% measured it as an outer/outer dimension. The percent uncertainty for the measurement (1.97 SD divided by the mean) showed a mean of 13.8% for the 25 packets of five echoes measured using the former criteria and 24.2% using the latter criteria. For ventricular chamber and cavity measurements, almost one-half of the examiners used the peak of the QRS and one-half of the examiners used the onset of the QRS for determining end-diastole. Estimates of the percent of measurement uncertainty for the septum, posterior wall and left ventricular cavity dimension in this study were 10--25%. They were much higher (40--70%) for the right ventricular cavity and right ventricular anterior wall. The survey shows significant interobserver and interlaboratory variation in measurement when examining the same echoes and indicates a need for ongoing education, quality control and standardization of measurement criteria. Recommendations for new criteria for measurement of M-mode echocardiograms are offered.},
author = {Sahn, D J and DeMaria, A and Kisslo, J and Weyman, A},
doi = {10.1161/01.CIR.58.6.1072},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/1978 - Sahn et al. - Recommendations regarding quantitation in M-mode echocardiography Results of a survey of echocardiographic measurem.pdf:pdf},
isbn = {0009-7322 (Print)},
issn = {00097322},
journal = {Circulation},
month = {dec},
number = {6},
pages = {1072--1083},
pmid = {709763},
publisher = {American Heart Association, Inc.},
title = {{Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements}},
url = {http://www.ncbi.nlm.nih.gov/pubmed/709763},
volume = {58},
year = {1978}
}
@article{Ribeil2017,
abstract = {Sickle cell disease results from a homozygous missense mutation in the $\beta$-globin gene that causes polymerization of hemoglobin S. Gene therapy for patients with this disorder is complicated by the complex cellular abnormalities and challenges in achieving effective, persistent inhibition of polymerization of hemoglobin S. We describe our first patient treated with lentiviral vectorâmediated addition of an antisickling $\beta$-globin gene into autologous hematopoietic stem cells. Adverse events were consistent with busulfan conditioning. Fifteen months after treatment, the level of therapeutic antisickling $\beta$-globin remained high (approximately 50% of $\beta$-likeâglobin chains) without recurrence of sickle crises and with correction of the biologic hallmarks of the disease. (Funded by Bluebird Bio and others; HGB-205 ClinicalTrials.gov number, NCT02151526.)},
author = {Ribeil, Jean-Antoine and Hacein-Bey-Abina, Salima and Payen, Emmanuel and Magnani, Alessandra and Semeraro, Michaela and Magrin, Elisa and Caccavelli, Laure and Neven, Benedicte and Bourget, Philippe and {El Nemer}, Wassim and Bartolucci, Pablo and Weber, Leslie and Puy, Herv{\'{e}} and Meritet, Jean-Fran{\c{c}}ois and Grevent, David and Beuzard, Yves and Chr{\'{e}}tien, Stany and Lefebvre, Thibaud and Ross, Robert W. and Negre, Olivier and Veres, Gabor and Sandler, Laura and Soni, Sandeep and de Montalembert, Mariane and Blanche, St{\'{e}}phane and Leboulch, Philippe and Cavazzana, Marina},
doi = {10.1056/NEJMoa1609677},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2017 - Ribeil et al. - Gene Therapy in a Patient with Sickle Cell Disease.pdf:pdf},
issn = {0028-4793},
journal = {New England Journal of Medicine},
number = {9},
pages = {848--855},
pmid = {28249145},
title = {{Gene Therapy in a Patient with Sickle Cell Disease}},
url = {http://www.nejm.org/doi/10.1056/NEJMoa1609677},
volume = {376},
year = {2017}
}
@article{Alam2011,
abstract = {Shock, regardless of etiology is characterized by decreased delivery of oxygen and nutrients to the tissues and our interventions are directed towards reversing the cellular ischemia and preventing its consequences. The treatment strategies that are most effective in achieving this goal obviously depend upon the different types of shock (hemorrhagic, septic, neurogenic and cardiogenic). This brief review focuses on the two leading etiologies of shock in the surgical patients: bleeding and sepsis, and addresses a number of new developments that have profoundly altered the treatment paradigms. The emphasis here is on new research that has dramatically altered our treatment strategies rather than the basic pathophysiology of shock. {\textcopyright} 2010 Surgical Associates Ltd.},
author = {Alam, Hasan B.},
doi = {10.1016/j.ijsu.2010.09.001},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2011 - Alam - Advances in resuscitation strategies.pdf:pdf},
isbn = {1743-9191},
issn = {17439191},
journal = {International Journal of Surgery},
keywords = {Bleeding,Blood,Fluids,Hemorrhage,Resuscitation,Sepsis,Shock},
number = {1},
pages = {5--12},
pmid = {20833279},
title = {{Advances in resuscitation strategies}},
volume = {9},
year = {2011}
}
@article{Seifter2014,
abstract = {T his review describes a method of analyzing acidâbase disorders that incorporates insights from the traditional, bicarbonate-centered model and the Stewart (or strong ion) model (Table 1). 1-6 Acidâbase balance and electrolyte homeostasis are intricately connected at the cellular level and in clinical disorders. This article emphasizes the integration of the principles of mass balance and electroneutrality â which are prominently featured in the strong ion model (also known as the physicochemical model) â for interpretation of acidâbase phenomena. Most acidâbase abnormalities can be diagnosed and interpreted with the use of the traditional approach. Why, then, should the strong ion theory be in-corporated into teaching about acidâbase balance? Although the Stewart model is not primarily a mathematical expression of a confirmed reality, it is relevant be-cause it is a powerful construct that can shed light on an important biologic system. Included in this article are several case vignettes that show the explanatory power of the strong ion approach in clinical practice. Some of these examples have been presented in a companion article on the physiological approach to acidâbase balance by Berend et al. 7 Other cases that are interpreted with a strong ion ap-proach are included in the Supplementary Appendix, available with the full text of this article at NEJM.org. The more complex chemistry of the hydrogen-ion concen-tration in intracellular and extracellular fluid compartments is beyond the scope of this article. Bic a r bonate-Center ed a nd S trong Ion A pproaches},
author = {Seifter, Julian L.},
doi = {10.1056/NEJMra1215672},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2014 - Seifter - Integration of AcidâBase and Electrolyte Disorders.pdf:pdf},
isbn = {1533-4406 (Electronic)\r0028-4793 (Linking)},
issn = {0028-4793},
journal = {New England Journal of Medicine},
number = {19},
pages = {1821--1831},
pmid = {25372090},
title = {{Integration of AcidâBase and Electrolyte Disorders}},
url = {http://www.nejm.org/doi/10.1056/NEJMra1215672},
volume = {371},
year = {2014}
}
@article{Overgaard2008a,
abstract = {Inotropic and vasopressor agents have increasingly become a therapeutic cornerstone for the management of several important cardiovascular syndromes. In broad terms, these substances have excitatory and inhibitory actions on the heart and vascular smooth muscle, as well as important metabolic, central nervous system, and presynaptic autonomic nervous system effects. They are generally administered with the assumption that short- to medium-term clinical recovery will be facilitated by enhancement of cardiac output (CO) or vascular tone that has been severely compromised by often life-threatening clinical conditions. The clinical efficacy of these agents has been investigated largely through examination of their impact on hemodynamic end points, and clinical practice has been driven in part by expert opinion, extrapolation from animal studies, and physician preference. Our aim is to review the mechanisms of action of common inotropes and vasopressors and to examine the contemporary evidence for their use in important cardiac conditions.},
author = {Overgaard, Christopher B. and D{\v{z}}av{\'{i}}k, Vladim{\'{i}}r},
doi = {10.1161/CIRCULATIONAHA.107.728840},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2008 - Overgaard, D{\v{z}}av{\'{i}}k - Inotropes and vasopressorsReview of physiology and clinical use in cardiovascular disease.pdf:pdf;:Users/shahbook/Box Sync/Mendeley_Articles/2008 - Overgaard, D{\v{z}}av{\'{i}}k - Inotropes and vasopressorsReview of physiology and clinical use in cardiovascular disease(2).pdf:pdf},
isbn = {0009-7322\r1524-4539},
issn = {00097322},
journal = {Circulation},
keywords = {Drugs,Heart failure,Inotropic agents,Shock,Vasopressin},
number = {10},
pages = {1047--1056},
pmid = {18765387},
title = {{Inotropes and vasopressors:Review of physiology and clinical use in cardiovascular disease}},
volume = {118},
year = {2008}
}
@article{Choi2003,
author = {Choi, T S and Doh, K S and Kim, S H and Jang, M S and Suh, K S and Kim, S T},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2003 - Choi et al. - Clinical and Laboratory Investigations Clinicopathological and genotypic aspects of anticonvulsant- induced pseudol.pdf:pdf},
keywords = {anticonvulsant,clinicopathological findings,genotypic features,pseudolymphoma},
pages = {730--736},
title = {{Clinical and Laboratory Investigations Clinicopathological and genotypic aspects of anticonvulsant- induced pseudolymphoma syndrome}},
year = {2003}
}
@article{Iannotfi1992,
author = {Iannotfi, P and Schneck, L and Gabriel, P},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/1992 - Iannotfi, Schneck, Gabriel - The Normal.pdf:pdf},
number = {Model 374},
title = {{The Normal}},
year = {1992}
}
@article{Khan2016,
abstract = {Kidney stones form when the urine becomes supersaturated with respect to a mineral, leading to crystal formation, growth, aggregation and retention within the kidneys. In this Primer, Khan et al. describe the contributing pathways to stone formation and the available treatments, as well as highlight the emerging management strategies.},
archivePrefix = {arXiv},
arxivId = {15334406},
author = {Khan, Saeed R. and Pearle, Margaret S. and Robertson, William G. and Gambaro, Giovanni and Canales, Benjamin K. and Doizi, Steeve and Traxer, Olivier and Tiselius, Hans G{\"{o}}ran},
doi = {10.1038/nrdp.2016.8},
eprint = {15334406},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2016 - Khan et al. - Kidney stones.pdf:pdf},
isbn = {0000000000000},
issn = {2056676X},
journal = {Nature Reviews Disease Primers},
pmid = {27188687},
title = {{Kidney stones}},
volume = {2},
year = {2016}
}
@article{Mcmurray2010,
author = {Mcmurray, John J V},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2010 - Mcmurray - Systolic Heart Failure.pdf:pdf},
journal = {Medicine},
title = {{Systolic Heart Failure}},
year = {2010}
}
@article{Stevenson1989,
abstract = {The cardiovascular physical examination is used commonly as a basis for diagnosis and therapy in chronic heart failure, although the relationship between physical signs, increased ventricular filling pressure, and decreased cardiac output has not been established for this population. We prospectively compared physical signs with hemodynamic measurements in 50 patients with known chronic heart failure (ejection fraction, .18 +/- .06). Rales, edema, and elevated mean jugular venous pressure were absent in 18 of 43 patients with pulmonary capillary wedge pressures greater than or equal to 22 mm Hg, for which the combination of these signs had 58% sensitivity and 100% specificity. Proportional pulse pressure correlated well with cardiac index (r = .82), and when less than 25% pulse pressure had 91% sensitivity and 83% specificity for a cardiac index less than 2.2 L/min/m2. In chronic heart failure, reliance on physical signs for elevated ventricular filling pressure might result in inadequate therapy. Conversely, the adequacy of cardiac output is assessed reliably by pulse pressure. Our results facilitate decisions regarding treatment in chronic heart failure.},
author = {Stevenson, Lynne Warner and Perloff, Joseph K.},
doi = {10.1001/jama.1989.03420060100040},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/1989 - Stevenson, Perloff - The Limited Reliability of Physical Signs for Estimating Hemodynamics in Chronic Heart Failure.pdf:pdf},
isbn = {0098-7484 (Print)\r0098-7484 (Linking)},
issn = {15383598},
journal = {JAMA: The Journal of the American Medical Association},
month = {feb},
number = {6},
pages = {884--888},
pmid = {2913385},
publisher = {American Medical Association},
title = {{The Limited Reliability of Physical Signs for Estimating Hemodynamics in Chronic Heart Failure}},
url = {http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.1989.03420060100040},
volume = {261},
year = {1989}
}
@article{Shah2008,
abstract = {Background: The third heart sound (S3) is thought to be caused by the abrupt deceleration of left ventricular (LV) inflow during early diastole, increased LV filling pressures, and decreased LV compliance. We sought to determine whether the ratio of early mitral inflow velocity to diastolic velocity of the mitral annulus (E/E') could confirm the proposed mechanism of the S3. Methods: A total of 90 subjects underwent phonocardiography, echocardiography, tissue Doppler imaging, and left-sided heart catheterization. Results: Phonocardiography detected an S3in 21 patients (23%). Subjects with an S3had lower ejection fraction (P = .0006) and increased E deceleration rate (P < .0001), E/E' (P < .0001) and filling pressures (P < .0001). The phonocardiographic S3confidence score correlated with E/E' (r = 0.46; P < .0001) and E deceleration rate (r = 0.43, P = .0001). Of the echocardiographic variables, only E/E' was independently associated with the S3confidence score (P = .009), independently of invasively determined LV filling pressures (P = .001). Conclusions: The most important determinants of the pathologic S3are an increased deceleration rate of early mitral inflow, elevated LV filling pressures, and abnormal compliance of the myocardium as measured by tissue Doppler imaging. {\textcopyright} 2008 American Society of Echocardiography.},
author = {Shah, Sanjiv J. and Marcus, Gregory M. and Gerber, Ivor L. and McKeown, Barry H. and Vessey, Joshua C. and Jordan, Mark V. and Huddleston, Michele and Foster, Elyse and Chatterjee, Kanu and Michaels, Andrew D.},
doi = {10.1016/j.echo.2007.06.007},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2008 - Shah et al. - Physiology of the Third Heart Sound Novel Insights from Tissue Doppler Imaging.pdf:pdf},
issn = {08947317},
journal = {Journal of the American Society of Echocardiography},
month = {apr},
number = {4},
pages = {394--400},
publisher = {Mosby},
title = {{Physiology of the Third Heart Sound: Novel Insights from Tissue Doppler Imaging}},
url = {https://www-sciencedirect-com.proxy.library.emory.edu/science/article/pii/S0894731707004750?via%3Dihub},
volume = {21},
year = {2008}
}
@article{Redfield2016,
abstract = {Key Clinical PointsHeart Failure with Preserved Ejection Fraction In patients who have signs and symptoms of heart failure but a preserved ejection fraction, objective evidence of abnormal cardiac structure and function should be confirmed by means of echocardiography, electrocardiography, chest radiography, and measurement of natriuretic peptide levels. Natriuretic peptide levels may be normal in patients who have heart failure with a preserved ejection fraction, particularly in obese patients or those with symptoms only on exertion. Right heart catheterization may be required in patients in whom there is indeterminate noninvasive testing or evidence of pulmonary hypertension. Medications that improve outcomes in patients who have heart failure with a reduced ejection fraction have not been shown to be of benefit in those who have heart failure with a preserved ejection fraction. Treatment of heart failure with a preserved ejection fraction should include diuretics for volume overload, treatment for card...},
author = {Redfield, Margaret M.},
doi = {10.1056/NEJMcp1511175},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2016 - Redfield - Heart Failure with Preserved Ejection Fraction.pdf:pdf},
isbn = {2211-5943},
issn = {0028-4793},
journal = {New England Journal of Medicine},
number = {19},
pages = {1868--1877},
pmid = {24184240},
title = {{Heart Failure with Preserved Ejection Fraction}},
url = {http://www.nejm.org/doi/10.1056/NEJMcp1511175},
volume = {375},
year = {2016}
}
@article{Simoons2004,
author = {Simoons, M},
doi = {10.1016/j.euje.2004.01.004},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2004 - Simoons - Role of echocardiography in acute coronary syndromes.pdf:pdf},
issn = {15252167},
journal = {European Journal of Echocardiography},
number = {2},
pages = {97--98},
title = {{Role of echocardiography in acute coronary syndromes}},
url = {https://academic.oup.com/ehjcimaging/article-lookup/doi/10.1016/j.euje.2004.01.004},
volume = {5},
year = {2004}
}
@article{Jentzer2010,
abstract = {Volume overload is an important clinical target in heart failure management, typically addressed using loop diuretics. An important and challenging subset of heart failure patients exhibit fluid overload despite significant doses of loop diuretics. One approach to overcome loop diuretic resistance is the addition of a thiazide-type diuretic to produce diuretic synergy via "sequential nephron blockade," first described more than 40 years ago. Although potentially able to induce diuresis in patients otherwise resistant to high doses of loop diuretics, this strategy has not been subjected to large-scale clinical trials to establish safety and clinical efficacy. We summarize the existing literature evaluating the combination of loop and thiazide diuretics in patients with heart failure in order to describe the possible benefits and hazards associated with this therapy. Combination diuretic therapy using any of several thiazide-type diuretics can more than double daily urine sodium excretion to induce weight loss and edema resolution, at the risk of inducing severe hypokalemia in addition to hyponatremia, hypotension, and worsening renal function. We provide considerations about prudent use of this therapy and review potential misconceptions about this long-used diuretic approach. Finally, we seek to highlight the need for pragmatic clinical trials for this commonly used therapy. {\textcopyright} 2010 American College of Cardiology Foundation.},
author = {Jentzer, Jacob C. and Dewald, Tracy A. and Hernandez, Adrian F.},
doi = {10.1016/j.jacc.2010.06.034},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2010 - Jentzer, Dewald, Hernandez - Combination of loop diuretics with thiazide-type diuretics in heart failure.pdf:pdf},
isbn = {0735-1097},
issn = {07351097},
journal = {Journal of the American College of Cardiology},
keywords = {Abbreviations and Acronyms,CDT,LD,TD,combination diuretic therapy,loop diuretic(s),thiazide-type diuretic(s)},
number = {19},
pages = {1527--1534},
pmid = {21029871},
publisher = {Elsevier Inc.},
title = {{Combination of loop diuretics with thiazide-type diuretics in heart failure}},
url = {http://dx.doi.org/10.1016/j.jacc.2010.06.034},
volume = {56},
year = {2010}
}
@article{Jensen2013,
author = {Jensen, Dennis M},
doi = {10.1007/s11894-013-0333-5.Lower},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2013 - Jensen - NIH Public Access.pdf:pdf},
keywords = {angiography,colitis,colonic hemorrhage,colonoscopy,diverticulosis,hemoclip,hemorrhoid,hemostasis,neoplasm,thermal probe,ulcer,vascular ectasia},
number = {7},
title = {{NIH Public Access}},
volume = {15},
year = {2013}
}
@article{Zimetbaum2003,
abstract = {Current Concepts},
author = {Zimetbaum},
doi = {10.1056/NEJMra022700},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2003 - Zimetbaum - 030306 Use of the Electrocardiogram in Acute Myocardial Infarction.pdf:pdf},
issn = {1533-4406},
pages = {1--8},
pmid = {12621138},
title = {{030306 Use of the Electrocardiogram in Acute Myocardial Infarction}},
url = {papers2://publication/uuid/DCBC3AF0-4811-44C0-86FC-F9BD6688F76D},
year = {2003}
}
@article{Smith2016a,
abstract = {Key Clinical PointsChronic Cough Chronic cough (cough >8 weeks in duration) is common and can be disabling. Chronic cough is a feature of many respiratory diseases, and common triggers (asthma, esophageal reflux, and postnasal drip) should be routinely ruled out by testing or by treatment trials. Investigation and treatment algorithms are based largely on consensus opinion, and more data are needed from randomized trials. Limited data from clinical trials support a benefit of low-dose morphine, gabapentin or pregabalin, and speech therapy for patients with cough persisting after other investigations and empirical treatments. Newer evidence suggests that cough reflex hyperresponsiveness underlies chronic cough, although more research is needed into the mechanisms and associated potential treatments.},
author = {Smith, Jaclyn A. and Woodcock, Ashley},
doi = {10.1056/NEJMcp1414215},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2016 - Smith, Woodcock - Chronic Cough.pdf:pdf},
isbn = {0009922806},
issn = {0028-4793},
journal = {New England Journal of Medicine},
number = {16},
pages = {1544--1551},
pmid = {27797316},
title = {{Chronic Cough}},
url = {http://www.nejm.org/doi/10.1056/NEJMcp1414215},
volume = {375},
year = {2016}
}
@article{Dill1974,
abstract = {Observations on hematocrit (Hct) and hemoglobin (Hb) were made in 6 men before and after running long enough to cause a 4% decrease in body weight. Subscripts B and A were used to denote before dehydration and after dehydration, respectively. Relations were derived between BV(b), BV(a), HB(b), Hb(a), Hct(b), and Hct(a) with which the percentage decreases in BV, CV, and PV can be calculated, as well as the concentration of hemoglobin in red cells, g/100 ml-1 (MCHC). When subjects reach the same level of dehydration the water loss from the various body compartments may vary reflecting the difference in salt losses in sweat. Changes in PV calculated from the increase in plasma protein concentration averaged -7.5% compared with -12.2% calculated from changes in Hb and Hct. The difference could be accounted for by a loss of 6% plasma protein from the circulation.},
archivePrefix = {arXiv},
arxivId = {arXiv:1011.1669v3},
author = {Dill, D B and Costill, D L},
doi = {10.1152/jappl.1974.37.2.247},
eprint = {arXiv:1011.1669v3},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/1974 - Dill, Costill - Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration.pdf:pdf},
isbn = {0021-8987 (Print)\r0021-8987 (Linking)},
issn = {8750-7587},
journal = {Journal of Applied Physiology},
number = {2},
pages = {247--248},
pmid = {4850854},
title = {{Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration.}},
url = {http://www.physiology.org/doi/10.1152/jappl.1974.37.2.247},
volume = {37},
year = {1974}
}
@article{Team2018,
author = {Team, The Multidisciplinary and Roles, Their and Process, The Evaluation},
file = {:Users/shahbook/Box Sync/Mendeley_Articles/2018 - Team, Roles, Process - Heart Failure and Transplant Program.pdf:pdf},
title = {{Heart Failure and Transplant Program}},
year = {2018}
}
